10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-04321

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

(Exact name of registrant as specified in its charter)

Delaware	88-6187397
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
375 Park Avenue, 9th Floor, New York, NY	10152
(Address of principal executive offices)	(Zip Code)

(212) 478-9200

(Registrant’s telephone number, including area code)

430 Park Avenue, 14th Floor, New York, NY 10022

(Registrant’s former address)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
None	N/A	N/A

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	o
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

The registrant had outstanding 12,975,926 Class I shares, 7,111 Class D shares, and 40,634 Class S shares as of November 1, 2023.

Table of Contents

		Page
PART I	Financial Information	3
Item 1.	Consolidated Financial Statements (Unaudited)	3
	Consolidated Statements of Assets and Liabilities as of September 30, 2023 (Unaudited) and December 31, 2022	3
	Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and for the Three Months Ended September 30, 2022 and for the Period February 8, 2022 (inception) through September 30, 2022 (Unaudited)	4
	Consolidated Statements of Changes in Net Assets for the Three and Nine Months Ended September 30, 2023 and for the Three Months Ended September 30, 2022 and for the Period February 8, 2022 (inception) through September 30, 2022 (Unaudited)	5
	Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and for the Period February 8, 2022 (inception) through September 30, 2022 (Unaudited)	6
	Consolidated Schedules of Investments as of September 30, 2023 (Unaudited) and December 31, 2022	7
	Notes to Consolidated Financial Statements (Unaudited)	15
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	35
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	55
Item 4.	Controls and Procedures	57
PART II	Other Information	58
Item 1.	Legal Proceedings	58
Item 1A.	Risk Factors	58
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	59
Item 3.	Defaults Upon Senior Securities	59
Item 4.	Mine Safety Disclosures	59
Item 5.	Other Information	59
Item 6.	Exhibits	60
Signatures		61

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on our current expectations and estimates, our prospective portfolio investments, our industry, our beliefs and opinions, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

•our future operating results;

•our business prospects and the prospects of our portfolio companies;

•the dependence of our future success on the general economy and its impact on the industries in which we invest;

•changes in the markets in which we invest and changes in financial and lending markets generally;

•the impact of a protracted decline in the liquidity of credit markets on our business;

•the impact of increased competition;

•an economic downturn and its impact on the ability of our portfolio companies to operate and the investment opportunities available to us;

•interest rate volatility, including the replacement of LIBOR with alternative rates and rising interest rates, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

•the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;

•the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

•the impact of geopolitical conditions, including the ongoing conflict between Ukraine and Russia and ongoing war in the Middle East, and its impact on financial market volatility, global economic markets, and various sectors, industries and markets for commodities globally, such as oil and natural gas;

•our contractual arrangements and relationships with third parties;

•the valuation of our investments in portfolio companies, particularly those having no liquid trading market;

•actual and potential conflicts of interest with Churchill and its affiliates;

•the ability of our portfolio companies to achieve their objectives;

•the use of borrowed money to finance a portion of our investments;

•the adequacy of our financing sources and working capital;

•the timing of cash flows, if any, from the operations of our portfolio companies;

•the ability of Churchill to locate suitable investments for us and to monitor and administer our investments and Nuveen Asset Management to manage certain of our Liquid Investments;

•the ability of Churchill to attract and retain highly talented professionals;

•our ability to qualify for and maintain our tax treatment as a regulated investment company (a “RIC”) and operate as a business development company (“BDC”);

•the impact of future legislation and regulation on our business and our portfolio companies;

1

•our ability to successfully invest capital raised in our offering;

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of these assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, certain margins and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of a projection or a forward-looking statement in this report should not be regarded as a representation by us that our plans and objectives will be achieved. These forward-looking statements apply only as of the date of this report. Moreover, we assume no duty and do not undertake to update the forward-looking statements, except as otherwise provided by law.

2

Part I - Financial Information

Item 1. Consolidated Financial Statements (Unaudited)

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES

(dollars in thousands, except share and per share data)

	September 30, 2023		December 31, 2022
	(Unaudited)
Assets
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $451,244 and $352,998, respectively)	$	445,777	$	349,518
Cash and cash equivalents	6,344		65,785
Due from affiliate expense support (See Note 4)	2,853		2,215
Interest receivable	5,594		4,282
Receivable for investments sold	1,011		196
Prepaid expenses	71		29
Total assets	$	461,650	$	422,025
Liabilities
Secured borrowings (net of $551 and $647 deferred financing costs, respectively) (See Note 5)	$	120,199	$	154,353
Distributions payable	3,070		3,109
Payable for investments purchased	29,747		—
Interest payable	446		533
Due to affiliate expense support (See Note 4)	2,853		2,215
Board of Trustees' fees payable	128		128
Accounts payable and accrued expenses	1,924		1,386
Due to transfer agent	1,145		—
Total liabilities	$	159,512	$	161,724
Commitments and contingencies (See Note 6)
Net Assets: (See Note 7)
Common shares of beneficial interest, par value $0.01 per share, unlimited shares authorized, 12,279,387 and 10,540,040 Class I shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	$	123	$	105
Paid-in-capital in excess of par value	306,173		263,396
Total distributable earnings (loss)	(4,158)		(3,200)
Total net assets	$	302,138	$	260,301
Total liabilities and net assets	$	461,650	$	422,025
Net asset value per Class I share	$	24.61	$	24.70

The accompanying notes are an integral part of these consolidated financial statements.

3

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022(1)
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	11,496	$	6,555	$	31,671	$	12,692
Payment-in-kind interest income	573		211		1,647		450
Dividend income	17		—		115		—
Other income	100		446		131		446
Total investment income	12,186		7,212		33,564		13,588
Expenses:
Organizational expenses	—		148		—		1,081
Interest and debt financing expenses	2,637		1,325		7,711		1,892
Interest expense on Note (See Note 4)	—		—		—		226
Professional fees	250		291		665		742
Management fees	547		—		712		—
Income based incentive fees	1,219		—		1,592		—
Board of Trustees’ fees	128		128		380		257
Administration fees (See Note 4)	124		74		362		149
Other general and administrative expenses	326		71		588		129
Offering costs	187		78		468		118
Total expenses	5,418		2,115		12,478		4,594
Expense support (See Note 4)	(212)		(245)		(541)		(1,422)
Management fees waived (Note 4)	(547)		—		(712)		—
Incentive fees waived (Note 4)	(1,219)		—		(1,592)		—
Net expenses	3,440		1,870		9,633		3,172
Net investment income (loss)	8,746		5,342		23,931		10,416
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	67		3		685		(264)
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments	252		(1,257)		(1,987)		(2,262)
Total net realized and unrealized gain (loss) on investments	319		(1,254)		(1,302)		(2,526)
Net increase (decrease) in net assets resulting from operations	$	9,065	$	4,088	$	22,629	$	7,890
Per share data:
Net investment income (loss) per share - Class I common share	$	0.75	$	0.51	$	2.18	$	0.99
Net increase (decrease) in net assets resulting from operations per share - Class I common share	$	0.78	$	0.39	$	2.06	$	0.75
Weighted average common shares outstanding - Class I common share	11,758,707		10,540,040		10,985,133		10,483,067

____________________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

The accompanying notes are an integral part of these consolidated financial statements.

4

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022(1)
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)	$	8,746	$	5,342	$	23,931	$	10,416
Net realized gain (loss) on investments	67		3		685		(264)
Net change in unrealized appreciation (depreciation) on investments	252		(1,257)		(1,987)		(2,262)
Net increase (decrease) in net assets resulting from operations	9,065		4,088		22,629		7,890
Shareholder Distributions:
Class I:
Distribution declared from net investment income	(8,823)		(9,170)		(23,128)		(9,170)
Distribution declared from realized gains	(460)		—		(460)		—
Net increase (decrease) in net assets resulting from shareholder distributions	(9,283)		(9,170)		(23,588)		(9,170)
Capital share transactions:
Class I:
Issuance of common shares, net	34,970		—		42,690		263,501
Reinvestment of shareholder distributions	106		—		106		—
Net increase (decrease) in net assets resulting from capital share transactions - Class I	35,076		—		42,796		263,501
Total increase (decrease) in net assets	34,858		(5,082)		41,837		262,221
Net assets, at beginning of period	267,280		267,303		260,301		—
Net assets, at end of period	$	302,138	$	262,221	$	302,138	$	262,221

____________________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

The accompanying notes are an integral part of these consolidated financial statements.

5

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(dollars in thousands, except share and per share data)

	Nine Months Ended September 30,
	2023		2022(1)
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$	22,629	$	7,890
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(120,285)		(55,661)
Proceeds from principal repayments and sales of investments	24,852		27,692
Payment-in-kind interest	(1,647)		(450)
Amortization of premium/accretion of discount, net	(607)		(325)
Net realized (gain) loss on investments	(685)		264
Net change in unrealized (appreciation) depreciation on investments	1,987		2,262
Amortization of deferred financing costs	122		—
Changes in operating assets and liabilities:
Due from affiliate expense support	(638)		(2,039)
Receivable for investments sold	(815)		(209)
Interest receivable	(1,186)		(4,640)
Prepaid expenses	(42)		(50)
Payable for investments purchased	29,747		—
Interest payable	(87)		287
Due to affiliate expense support	638		2,039
Board of Trustees' fees payable	—		128
Accounts payable and accrued expenses	538		720
Due to transfer agent	1,145		—
Net cash provided by (used in) operating activities	(44,334)		(22,092)
Cash flows from financing activities:
Proceeds from issuance of common shares	42,690		1
Proceeds from secured borrowings	54,250		125,000
Repayments of secured borrowings	(88,500)		(32,731)
Distributions paid	(23,521)		—
Payments of deferred financing costs	(26)		—
Net cash provided by (used in) financing activities	(15,107)		92,270
Net increase (decrease) in cash and cash equivalents	(59,441)		70,178
Cash and cash equivalents, beginning of period	65,785		—
Cash and cash equivalents, end of period	$	6,344	$	70,178
Supplemental information and non-cash activities:
Purchases of investments	$	—	$	(296,231)
Cash paid during the period for interest	7,676		1,796
Financing costs paid through expense support	—		373
Cash paid during the period for excise taxes	2		—
Issuance of Class I common shares, net	—		263,500
Reinvestment of Shareholder Distributions	106		—

____________________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

The accompanying notes are an integral part of these consolidated financial statements.

6

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)

September 30, 2023

(dollar amounts in thousands)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit		Cost		Fair Value		% of Net Assets (5)
Investments
Debt Investments
Aerospace & Defense
Turbine Engine Specialist, Inc	(4)	First Lien Term Loan	S + 9.50%	14.82	%	3/1/2029	$	1,978	$	1,928	$	1,929	0.64	%
Total Aerospace & Defense									1,928		1,929		0.64	%
Automotive
Adient US LLC	(6) (12)(13)	First Lien Term Loan	S + 3.25%	8.65	%	4/13/2028	500		503		501		0.17	%
Belron Finance US LLC	(6) (12)(13)	First Lien Term Loan	S + 2.43%	7.82	%	4/13/2028	499		501		498		0.16	%
Randys Holdings, Inc	(4) (6) (7)	First Lien Term Loan	S + 6.50%	11.90	%	11/1/2028	3,967		3,895		3,915		1.30	%
Randys Holdings, Inc (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.50%	11.90	%	11/1/2028	1,332		—		(17)		(0.01)	%
Total Automotive									4,899		4,897		1.62	%
Banking, Finance, Insurance, Real Estate
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(4) (6) (7) (11)	First Lien Term Loan	S + 5.75%	11.15	%	10/14/2028	5,980		3,839		3,726		1.23	%
Ryan Specialty Group LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	9/1/2027	499		500		500		0.16	%
SS&C Technology Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.25%	7.65	%	3/22/2029	199		199		199		0.07	%
SS&C Technology Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.25%	7.65	%	3/22/2029	300		301		300		0.10	%
Total Banking, Finance, Insurance, Real Estate									4,839		4,725		1.56	%
Beverage, Food & Tobacco
Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)	(4) (6) (10)(13)	First Lien Term Loan	S + 6.25%	11.65	%	9/25/2029	4,246		4,162		4,162		1.38	%
Cold Spring Brewing Company	(4) (6)	First Lien Term Loan	S + 4.75%	10.07	%	12/19/2025	6,288		6,287		6,287		2.08	%
Fortune International, LLC	(4) (6)	First Lien Term Loan	S + 4.75%	10.15	%	1/17/2026	6,896		6,853		6,805		2.25	%
Fresh Edge	(4) (6)	Subordinated Debt	S + 4.50% (Cash) + 5.125% (PIK)	15.09	%	4/3/2029	2,916		2,848		2,833		0.94	%
Harvest Hill Beverage Company	(4)	Subordinated Debt	S + 9.00%	14.32	%	2/28/2029	2,800		2,721		2,748		0.91	%
Nonni's Foods, LLC	(4) (6)	First Lien Term Loan	S + 5.50%	10.97	%	12/1/2023	6,909		6,908		6,838		2.26	%
SW Ingredients Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		7/3/2026	10,153		10,153		9,902		3.28	%
Palmetto Acquisitionco, Inc.	(4) (6)	First Lien Term Loan	S + 5.75%	11.15	%	9/18/2029	3,348		3,290		3,290		1.09	%
Palmetto Acquisitionco, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.15	%	9/18/2029	1,217		(5)		(21)		(0.01)	%
Total Beverage, Food & Tobacco									43,217		42,844		14.18	%
Capital Equipment
Clarios Global LP (f/k/a Johnson Controls Inc)	(6) (10)(12)(13)	First Lien Term Loan	S + 3.75%	9.15	%	5/6/2030	500		502		500		0.17	%
EFC Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 2.50% (PIK)		5/1/2028	2,420		2,354		2,375		0.79	%
GenServe LLC	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.22	%	4/12/2024	6,895		6,873		6,800		2.25	%
Hayward Industries, Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	5/30/2028	499		495		496		0.16	%
Ovation Holdings, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.65	%	2/3/2029	704		226		223		0.07	%
Ovation Holdings, Inc.	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	2/3/2029	2,980		2,920		2,934		0.97	%
Messer Industries GmbH	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	3/2/2026	498		499		498		0.16	%
NCR Corporation	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	8/28/2026	500		501		501		0.17	%
RTH Buyer LLC (dba "Rhino Tool House)	(4) (6)	First Lien Term Loan	S + 6.25%	11.72	%	4/4/2029	2,680		2,628		2,657		0.88	%
RTH Buyer LLC (dba "Rhino Tool House) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.72	%	4/4/2029	627		300		298		0.10	%
Total Capital Equipment									17,298		17,282		5.72	%
Chemicals, Plastics, & Rubber
Chroma Color Corporation (dba "Chroma Color)	(4) (6)	First Lien Term Loan	S + 5.75%	11.15	%	4/21/2029	1,749		1,715		1,716		0.57	%
Chroma Color Corporation (dba "Chroma Color) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.15	%	4/21/2029	381		(4)		(7)		—	%
INEOS US Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.15	%	11/8/2027	499		499		497		0.17	%
INEOS US Petrochem LLC	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	1/29/2026	499		499		498		0.17	%
Kraton Polymers LLC	(6) (12)(13)	First Lien Term Loan	S + 3.25%	8.65	%	3/15/2029	499		493		494		0.16	%
Nouryon Finance B.V.	(6) (12)(13)	First Lien Term Loan	S + 4.00%	9.40	%	4/3/2028	499		500		494		0.16	%
Spartech	(4) (6) (7)	First Lien Term Loan	S + 4.75%	10.15	%	5/8/2028	3,940		3,940		3,320		1.10	%
SupplyOne, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		2/1/2025	10,189		10,189		10,189		3.37	%
Tronox Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.50%	8.90	%	8/16/2028	500		498		497		0.16	%
Total Chemicals, Plastics, & Rubber									18,329		17,698		5.86	%
Construction & Building
Gannett Fleming	(4) (6)	First Lien Term Loan	S + 6.60%	12.00	%	12/20/2028	1,985		1,949		1,970		0.65	%
Hyphen Solutions, LLC	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.90	%	10/27/2026	6,895		6,855		6,688		2.21	%
MEI Rigging & Crating	(4) (6)	First Lien Term Loan	S + 6.50%	11.82	%	6/29/2029	3,166		3,103		3,105		1.03	%
MEI Rigging & Crating (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.82	%	6/29/2029	501		(2)		(10)		—	%
Quikrete Holdings, Inc.	(6) (12)	First Lien Term Loan	S + 2.75%	8.15	%	3/19/2029	499		500		499		0.17	%
SPI LLC	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.32	%	12/21/2027	6,895		6,814		6,895		2.28	%
Summit Materials, LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	12/14/2027	499		502		501		0.16	%
WSB Engineering Holdings Inc.	(4) (6)	First Lien Term Loan	S + 6.00%	11.40	%	8/31/2029	1,644		1,619		1,619		0.54	%
WSB Engineering Holdings Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.40	%	8/31/2029	1,096		(8)		(16)		(0.01)	%
Total Construction & Building									21,332		21,251		7.03	%
Consumer Goods: Durable
Copeland (Emerson Climate Technologies)	(6) (12)	First Lien Term Loan	S + 3.00%	8.32	%	5/31/2030	750		753		750		0.25	%
Freedom U.S. Acquisition Corporation	(4) (6)	First Lien Term Loan	S + 4.50%	9.90	%	11/10/2023	7,000		7,000		6,974		2.31	%
NMC Skincare Intermediate Holdings II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.32	%	10/31/2024	6,892		6,834		6,606		2.19	%
SRAM LLC	(6) (12)	First Lien Term Loan	S + 2.75%	8.15	%	5/18/2028	500		501		499		0.16	%
Topgolf Callaway Brands Corp	(6) (12)(13)	First Lien Term Loan	S + 3.50%	8.90	%	3/15/2030	499		500		497		0.16	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S + 5.75%	11.15	%	9/7/2028	1,535		1,505		1,520		0.50	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S + 5.50%	10.90	%	9/7/2028	2,030		2,012		1,991		0.66	%
Total Consumer Goods: Durable									19,105		18,837		6.23	%
Consumer Goods: Non-Durable
Accupac, Inc.	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.40	%	1/14/2026	6,893		6,876		6,666		2.21	%
Elevation Labs	(4) (6)	First Lien Term Loan	S + 5.75%	11.15	%	6/30/2028	1,305		1,294		1,260		0.42	%
Elevation Labs (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.15	%	6/30/2028	599		(2)		(21)		(0.01)	%
Image International Intermediate Holdco II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.90	%	7/10/2024	6,992		6,958		6,868		2.27	%
Perrigo Company plc	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	4/20/2029	499		499		498		0.16	%
Protective Industrial Products (“PIP”)	(4) (6)	First Lien Term Loan	S + 5.00%	10.32	%	12/29/2027	1,346		1,295		1,346		0.45	%
Revision Buyer LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		12/1/2028	10,151		9,982		10,151		3.36	%
Ultima Health Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,321		1,298		1,281		0.42	%
US Foods, Inc	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	11/22/2028	750		753		752		0.25	%
Total Consumer Goods: Non-Durable									28,953		28,801		9.53	%
Containers, Packaging & Glass
New ILC Dover, Inc.	(4) (6) (7)	First Lien Term Loan	S + 5.00%	10.40	%	1/31/2026	6,893		6,885		6,893		2.28	%
Oliver Packaging	(4)	Subordinated Debt	N/A	11.00	%	1/6/2029	1,326		1,304		1,266		0.42	%
PG Buyer, LLC	(4) (6)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		9/2/2026	8,184		8,184		8,184		2.71	%
Total Containers, Packaging & Glass									16,373		16,343		5.41	%
Energy: Electricity
Covanta Holding Corp	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	11/30/2028	35		35		35		0.01	%
Covanta Holding Corp	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	11/30/2028	464		464		462		0.15	%
Total Energy: Electricity									499		497		0.16	%
Energy: Oil & Gas
AmSpec Group, Inc.	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.15	%	7/2/2024	6,891		6,891		6,891		2.28	%
Dresser Utility Solutions, LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.57	%	10/1/2025	3,447		3,447		3,447		1.14	%
Dresser Utility Solutions, LLC (Incremental)	(4) (6)	First Lien Term Loan	S + 5.25%	10.57	%	10/1/2025	3,446		3,413		3,409		1.13	%
Marco APE Opco Holdings, LLC	(4)	Subordinated Debt	N/A	15.00% (PIK)		9/2/2026	9,523		9,071		8,306		2.75	%
Total Energy: Oil & Gas									22,822		22,053		7.30	%
Environmental Industries
GFL Environmental T/L (1/23)	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	5/31/2027	500		502		501		0.16	%
Impact Parent Corporation (d/b/a Impact Environmental Group)	(4) (6)	First Lien Term Loan	S + 6.00%	11.47	%	3/23/2029	2,081		2,040		2,043		0.68	%
Impact Parent Corporation (d/b/a Impact Environmental Group) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.47	%	3/23/2029	972		851		838		0.28	%
Impact Parent Corporation (d/b/a Impact Environmental Group) (Incremental)	(4) (6)	First Lien Term Loan	S + 6.00%	11.47	%	3/23/2029	427		418		419		0.13	%
Impact Parent Corporation (d/b/a Impact Environmental Group) (Second Amendment Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.47	%	3/23/2029	1,716		(8)		(31)		(0.01)	%
North Haven Stack Buyer, LLC	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.90	%	7/16/2027	6,894		6,871		6,793		2.25	%
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(4) (6)	First Lien Term Loan	S + 5.25%	10.65	%	8/31/2028	818		811		806		0.27	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	7/3/2029	3,429		3,378		3,380		1.12	%
Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.65	%	7/3/2029	2,571		(6)		(36)		(0.01)	%
Total Environmental Industries									14,857		14,713		4.87	%
Healthcare & Pharmaceuticals
Grifols Worldwide Operations LTD	(6) (10)(12)(13)	First Lien Term Loan	S + 2.00%	7.40	%	11/15/2027	500		496		492		0.16	%
Health Management Associates	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	3/30/2029	3,430		3,365		3,399		1.12	%
Health Management Associates (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.90	%	3/30/2029	611		183		190		0.06	%
Heartland Veterinary Partners LLC (Incremental)	(4)	Subordinated Debt	S + 7.50%	12.82	%	12/10/2027	1,000		984		978		0.33	%
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)	(4) (11)	Subordinated Debt	S + 7.50%	12.82	%	12/10/2027	5,000		2,790		2,680		0.89	%
Jazz Pharmaceuticals plc	(6) (10)(12)(13)	First Lien Term Loan	S + 3.50%	8.90	%	5/5/2028	748		750		748		0.25	%
Organon & Co	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	6/2/2028	750		754		750		0.25	%
New You Bariatric Group, LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.65	%	8/26/2024	6,892		6,892		6,641		2.20	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(4) (6)	First Lien Term Loan	S + 5.75%	11.07	%	10/5/2029	2,248		2,204		2,220		0.73	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.75%	11.07	%	10/5/2029	734		348		339		0.11	%
Select Medical Corporation	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	3/6/2027	748		752		747		0.25	%
US Radiology Specialists, Inc.	(6) (7) (12)	First Lien Term Loan	S + 5.25%	10.65	%	12/15/2027	1,868		1,794		1,817		0.60	%
W2O Holdings, LLC	(4) (6)	First Lien Term Loan	S + 5.25%	10.72	%	6/12/2025	6,895		6,895		6,895		2.28	%
Wellspring Pharmaceutical	(4) (6)	First Lien Term Loan	S + 5.75%	11.47	%	8/22/2028	4,064		3,995		3,937		1.30	%
Wellspring Pharmaceutical (Delayed Draw)	(4)	First Lien Term Loan	S + 5.75%	11.22	%	8/22/2028	1,890		1,878		1,831		0.61	%
Total Healthcare & Pharmaceuticals									34,080		33,664		11.14	%
High Tech Industries
Acclaim MidCo, LLC (dba ClaimLogiQ)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	6/13/2029	2,221		2,178		2,179		0.72	%
Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.65	%	6/13/2029	891		(4)		(17)		(0.01)	%
GTCR W Merger Sub LLC (Worldpay)	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	9/20/2030	340		338		340		0.11	%
II-VI Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	7/2/2029	499		501		498		0.16	%
Infobase Acquisition, Inc.	(4) (6)	First Lien Term Loan	S + 5.50%	10.97	%	6/14/2028	733		727		725		0.24	%
Infobase Acquisition, Inc. (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.50%	10.97	%	6/14/2028	122		—		(1)		—	%
Informatica LLC	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	10/27/2028	748		752		747		0.25	%
Infinite Bidco LLC (Infinite Electronics) (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.72	%	3/2/2028	1,972		1,919		1,920		0.64	%
ITSavvy LLC	(4) (6)	First Lien Term Loan	S + 5.50%	10.97	%	8/8/2028	1,780		1,765		1,780		0.59	%
ITSavvy LLC (Delayed Draw)	(4) (11)	First Lien Term Loan	S + 5.50%	10.90	%	8/8/2028	335		296		299		0.10	%
Instructure Holdings Inc	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	10/30/2028	499		501		498		0.17	%
MKS Instruments Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	8/17/2029	499		501		499		0.17	%
Red Ventures LLC	(6) (12)	First Lien Term Loan	S + 3.00%	8.40	%	3/3/2030	499		499		496		0.16	%
Specialist Resources Global Inc. (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 5.00%	10.32	%	9/23/2025	6,894		6,894		6,894		2.28	%
UPC Finance Partnership	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	1/31/2029	500		486		494		0.16	%
Total High Tech Industries									17,353		17,351		5.74	%
Hotel, Gaming & Leisure
Cinemark USA Inc.	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.15	%	5/24/2030	499		499		499		0.16	%
Delta 2 (Lux) (Formula One) T/L B (09/23)	(6) (10)(12)(13)	First Lien Term Loan	S + 3.25%	8.65	%	1/15/2030	750		750		751		0.25	%
Total Hotel, Gaming & Leisure									1,249		1,250		0.41	%
Media: Advertising, Printing & Publishing
Getty Images Inc	(6) (12)	First Lien Term Loan	S + 4.50%	9.90	%	2/19/2026	498		500		500		0.17	%
Viking Target, LLC	(4) (6)	First Lien Term Loan	S + 5.00%	10.32	%	8/9/2024	6,379		6,360		6,367		2.10	%
Total Media: Advertising, Printing & Publishing									6,860		6,867		2.27	%
Media: Broadcasting & Subscription
DIRECTV (AKA DIRECTV Financing LLC)	(6) (12)(13)	First Lien Term Loan	S + 5.00%	10.40	%	8/2/2027	389		386		381		0.13	%
Gray Television, Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	1/2/2026	500		498		498		0.16	%
Nexstar Media Inc	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	9/18/2026	500		500		500		0.17	%
Virgin Media Bristol LLC	(6) (10)(12)(13)	First Lien Term Loan	S + 3.25%	8.65	%	1/31/2029	750		743		734		0.24	%
WideOpenWest Finance LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	12/20/2028	499		494		493		0.16	%
Ziggo Financing Partnership	(6) (10)(12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	4/30/2028	500		489		489		0.16	%
Total Media: Media: Broadcasting & Subscription									3,110		3,095		1.02	%
Metals and Mining
Arsenal AIC Parent LLC	(6) (12)	First Lien Term Loan	S + 4.50%	9.90	%	8/18/2030	500		503		500		0.17	%
Total Metals and Mining									503		500		0.17	%
Services: Business
ALKU Intermediate Holdings, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.57	%	5/22/2029	2,718		2,665		2,667		0.88	%
BroadcastMed Holdco, LLC	(4)	Subordinated Debt	N/A	10% (Cash) 3.75% (PIK)		11/12/2027	2,673		2,627		2,580		0.85	%
Brown & Joseph, LLC	(4) (6)	First Lien Term Loan	S + 5.50%	10.82	%	6/20/2024	6,639		6,602		6,639		2.20	%
Class Valuation	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	444		437		405		0.13	%
CrossCountry Consulting	(4) (6) (7)	First Lien Term Loan	S + 5.75%	11.07	%	6/1/2029	1,383		1,359		1,383		0.45	%
CrossCountry Consulting (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S + 5.75%	11.07	%	6/1/2029	560		(5)		—		—	%
CV Intermediate Holdco Corp.	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	10,000		9,875		9,123		3.02	%
Evergreen Services Group	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.65	%	6/15/2029	4,037		3,967		3,921		1.30	%
Evergreen Services Group (Delayed Draw)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.65	%	6/15/2029	966		957		938		0.31	%
ICON Publishing Ltd	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	7/3/2028	92		92		92		0.03	%
ICON Publishing Ltd	(6) (10)(12)(13)	First Lien Term Loan	S + 2.25%	7.65	%	7/3/2028	369		370		369		0.12	%
Ingram Micro T/L (09/23) TARGET FACILITY	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	6/30/2028	500		500		500		0.17	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC)	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.65	%	8/1/2029	2,431		2,395		2,396		0.79	%
Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.25%	11.65	%	8/1/2029	2,342		296		269		0.09	%
Kofile, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.75% (PIK)		7/29/2026	10,263		10,263		9,629		3.19	%
KRIV Acquisition, Inc	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	7/6/2029	5,221		5,078		5,068		1.68	%
KRIV Acquisition, Inc (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.90	%	7/6/2029	779		(10)		(23)		(0.01)	%
OMNIA Partners, LLC	(4) (6) (7)	First Lien Term Loan	S + 4.25%	9.65	%	7/25/2028	1,371		1,358		1,358		0.45	%
OMNIA Partners, LLC (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 4.25%	9.65	%	7/25/2028	129		(1)		(1)		—	%
Open Text Corp	(6) (10)(12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	1/31/2030	748		750		749		0.25	%
Phaidon International	(4) (6) (10)(13)	First Lien Term Loan	S + 5.50%	10.82	%	8/22/2029	6,626		6,568		6,521		2.16	%
Red Dawn SEI Buyer, Inc.	(4)	Subordinated Debt	S + 8.25%	13.65	%	11/22/2026	6,650		6,650		6,601		2.18	%
Red Dawn SEI Buyer, Inc. (Incremental)	(4)	Subordinated Debt	S + 8.50%	13.90	%	11/22/2026	3,350		3,350		3,347		1.11	%
Tempo Acquisition LLC	(6) (12)(13)	First Lien Term Loan	S + 3.00%	8.40	%	8/31/2028	500		502		501		0.17	%
Transit Buyer LLC (dba“Propark”)	(4) (6)	First Lien Term Loan	S + 6.25%	11.72	%	1/31/2029	2,532		2,487		2,511		0.83	%
Transit Buyer LLC (dba“Propark”) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.72	%	1/31/2029	1,157		(21)		(10)		—	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	5/28/2029	597		593		585		0.19	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	5/27/2029	2,970		2,944		2,911		0.96	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	5/27/2029	2,978		2,978		2,919		0.97	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	5/28/2029	398		398		390		0.13	%
Total Services: Business									76,024		74,338		24.60	%
Services: Consumer
A Place for Mom, Inc.	(4) (6)	First Lien Term Loan	S + 4.50%	9.82	%	2/10/2026	6,872		6,872		6,748		2.23	%
ADPD Holdings, LLC (a/k/a NearU)	(4) (6) (7)	First Lien Term Loan	S + 6.00%	11.47	%	8/16/2028	4,953		4,915		4,634		1.53	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.47	%	8/16/2028	1,000		—		(64)		(0.02)	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S + 6.00%	11.47	%	8/16/2028	920		—		(59)		(0.02)	%
Apex Services Partners, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.90	%	7/31/2025	2,978		2,958		2,977		0.99	%
Apex Services Partners, LLC (Delayed Draw) (Incremental)	(4) (6) (7)	First Lien Term Loan	S + 5.50%	10.90	%	7/31/2025	2,978		2,968		2,977		0.99	%
COP Exterminators Acquisition, Inc.	(4)	Subordinated Debt	N/A	9.00% (Cash) + 4.00% (PIK)		1/28/2030	642		625		625		0.21	%
COP Exterminators Acquisition, Inc. (Delayed Draw)	(4) (11)	Subordinated Debt	N/A	9.00% (Cash) + 4.00% (PIK)		1/28/2030	503		(7)		(14)		—	%
Excel Fitness	(4) (6)	First Lien Term Loan	S + 5.25%	10.65	%	4/27/2029	5,940		5,880		5,735		1.90	%
Legacy Service Partners, LLC (“LSP”)	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	1/9/2029	4,075		4,001		4,001		1.32	%
Legacy Service Partners, LLC (“LSP”) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.90	%	1/9/2029	1,898		1,410		1,384		0.46	%
Norton Lifelock Inc.	(6) (12)(13)	First Lien Term Loan	S + 2.00%	7.40	%	9/12/2029	499		499		498		0.16	%
Perennial Services, Group, LLC	(4) (6)	First Lien Term Loan	S + 6.00%	11.40	%	9/8/2029	1,697		1,672		1,672		0.55	%
Perennial Services, Group, LLC (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.40	%	9/8/2029	1,516		193		175		0.05	%
Prime Security Services Borrower LLC	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	9/23/2026	748		750		748		0.25	%
Total Services: Consumer									32,736		32,037		10.60	%
Sovereign & Public Finance
LMI Consulting, LLC (LMI)	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	7/18/2028	736		724		731		0.24	%
LMI Consulting, LLC (LMI) (Incremental)	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	7/18/2028	2,963		2,878		2,940		0.98	%
Total Sovereign & Public Finance									3,602		3,671		1.22	%
Telecommunications
Arise Holdings Inc.	(4) (6)	First Lien Term Loan	S + 4.25%	9.72	%	12/9/2025	6,893		6,853		6,414		2.12	%
Intelsat Jackson Holdings S.A.	(6) (10)(12)(13)	First Lien Term Loan	S + 4.25%	9.65	%	2/1/2029	488		489		488		0.16	%
Iridium Satellite LLC	(6) (12)(13)	First Lien Term Loan	S + 2.50%	7.90	%	11/4/2026	500		502		501		0.17	%
Total Telecommunications									7,844		7,403		2.45	%
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(4) (6)	First Lien Term Loan	S + 5.50%	10.90	%	12/23/2026	5,940		5,843		5,774		1.91	%
Kenco Group, Inc.	(4) (6)	First Lien Term Loan	S + 5.00%	10.40	%	11/15/2029	5,112		5,020		5,099		1.69	%
Kenco Group, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 5.00%	10.40	%	11/15/2029	850		(15)		(2)		—	%
Uber Technologies Inc	(6) (12)(13)	First Lien Term Loan	S + 2.75%	8.15	%	3/3/2030	748		751		749		0.25	%
Total Transportation: Cargo									11,599		11,620		3.85	%
Transportation: Consumer
Air Canada	(6) (12)(13)	First Lien Term Loan	S + 3.50%	8.90	%	8/11/2028	499		501		500		0.17	%
American Student Transportaton Partners, Inc	(4)	Subordinated Debt	N/A	10.00% (Cash) + 3.50% (PIK)		9/11/2029	1,606		1,562		1,562		0.52	%
United Airlines Inc	(6) (12)(13)	First Lien Term Loan	S + 3.75%	9.15	%	4/21/2028	748		753		750		0.25	%
Total Transportation: Consumer									2,816		2,812		0.94	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(4) (6)	First Lien Term Loan	S + 6.00%	11.40	%	4/3/2030	2,539		2,490		2,492		0.83	%
Pinnacle Supply Partners, LLC (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.00%	11.40	%	4/3/2030	1,455		(13)		(27)		(0.01)	%
Total Utilities: Electric									2,477		2,465		0.82	%
Wholesale
CDI AcquisitionCo, Inc.	(4) (6)	First Lien Term Loan	S + 4.00%	9.47	%	12/24/2024	6,729		6,714		6,729		2.22	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)	(4) (6)	First Lien Term Loan	S + 6.50%	11.90	%	1/19/2029	4,595		4,513		4,557		1.51	%
INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.50%	11.90	%	1/19/2029	1,139		(20)		(9)		—	%
ISG Merger Sub, LLC (dba Industrial Service Group)	(4) (6)	First Lien Term Loan	S + 6.25%	11.65	%	12/7/2028	2,460		2,415		2,440		0.81	%
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S + 6.25%	11.65	%	12/7/2028	1,281		509		505		0.17	%
New Era Technology, Inc	(4) (6) (7)	First Lien Term Loan	S + 6.25%	11.65	%	10/31/2026	6,741		6,720		6,553		2.17	%
Solaray, LLC	(4) (6) (7)	First Lien Term Loan	S + 6.50%	11.90	%	9/9/2023	6,907		6,902		6,731		2.23	%
Total Wholesale									27,753		27,506		9.11	%
Total Debt Investments									442,457		436,449		144.45	%

Portfolio Company (1) (2)	Footnotes	Investment	Acquisition Date	Share / Unit	Cost		Fair Value		% of Net Assets (5)
Equity Investments
Aerospace & Defense
BPC Kodiak LLC (Turbine Engine Specialist, Inc)	(4) (8) (9) (15)	LLC Interest	9/1/2023	1,180,000	1,180		1,180		0.39	%
Total Aerospace & Defense					1,180		1,180		0.39	%
Beverage, Food & Tobacco
Fresh Edge - Common	(4) (8) (9)	Class B Common Units	10/3/2022	454	—		—		—	%
Fresh Edge - Preferred	(4) (8) (9)	Class A Preferred Units	10/3/2022	454	454		413		0.14	%
Marlin Coinvest LP	(4) (8) (9)	Limited Partnership Interests	5/9/2023	200,000	200		456		0.15	%
Spice World	(4) (8) (9) (13)	LLC Common Units	3/31/2022	1,000	126		125		0.04	%
Sugar PPC Holdings LLC	(4) (8) (9) (13)	Parent Units	9/29/2023	2,000	200		200		0.07	%
Total Beverage, Food & Tobacco					980		1,194		0.40	%
Capital Equipment
EFC Holdings, LLC	(4) (8) (9) (13)	Series A Preferred Units	3/1/2023	114	114		119		0.04	%
EFC Holdings, LLC	(4) (8) (9) (13)	Class A Common Units	3/1/2023	114	46		62		0.02	%
Total Capital Equipment					160		181		0.06	%
Chemicals, Plastics & Rubber
SupplyOne, Inc.	(4) (8) (9)	LLC Common Units	3/31/2022	1,000	504		812		0.27	%
Total Chemicals, Plastics & Rubber					504		812		0.27	%
Construction & Building
Gannett Fleming	(4) (8) (9) (15)	Limited Partnership Interests	12/20/2022	84,949	85		99		0.04	%
Gannett Fleming	(4) (8) (9)	Series F Units	5/27/2023	113,901	118		133		0.04	%
Trench Plate Rental Co.	(4) (8) (9)	Common Equity	3/31/2022	1,000	127		105		0.03	%
Total Construction & Building					330		337		0.11	%
Consumer Goods: Non-Durable
RVGD Aggregator LP (Revision Skincare)	(4) (8) (9)	Limited Partnership Interests	3/31/2022	100	98		108		0.04	%
Ultima Health Holdings, LLC	(4) (8) (9)	Preferred Units	9/12/2022	11	130		126		0.04	%
WCI Holdings LLC	(4) (8) (9) (13)	Class A1 Units	2/6/2023	534,934	535		589		0.19	%
Total Consumer Goods: Non-Durable					763		823		0.27	%
Containers, Packaging & Glass
Oliver Packaging	(4) (8) (9)	Class A Common Units	7/12/2022	6,710	671		523		0.17	%
PG Aggregator, LLC	(4) (8) (9)	LLC Units	3/31/2022	100	109		140		0.05	%
Total Containers, Packaging & Glass					780		663		0.22	%
Healthcare & Pharmaceuticals
Health Management Associates	(4) (8) (9)	Class A Common Units	3/31/2023	161,953	162		179		0.06	%
Total Healthcare & Pharmaceuticals					162		179		0.06	%
High Tech Industries
ITSavvy LLC	(4) (8) (9)	Class A Common Units	8/8/2022	119	119		237		0.08	%
Total High Tech Industries					119		237		0.08	%
Services: Business
BroadcastMed Holdco, LLC	(4) (8) (9)	Series A-3 Preferred Units	10/4/2022	43,679	655		600		0.20	%
Class Valuation	(4) (8) (9)	Class A Common Units	12/7/2022	1,038	105		28		0.01	%
FCP-Cranium Holdings, LLC (Brain labs)	(4) (8) (9)(10)(13)	Series A Preferred Shares	9/11/2023	1,026	389		400		0.13	%
FCP-Cranium Holdings, LLC (Brain labs)	(4) (8) (9)(10)(13)	Series B Preferred Shares	9/11/2023	375	600		600		0.20	%
FCP-Cranium Holdings P/S A	(4) (8) (9)(10)(13)	Class A Common Shares	9/11/2023	375	—		—		—	%
Kofile, Inc.	(4) (8) (9)	Class A-2 Common Units	3/31/2022	100	108		61		0.02	%
KRIV Acquisition, Inc	(4) (8) (9)	Class A Units	7/17/2023	200	200		200		0.07	%
Total Services: Business					2,057		1,889		0.63	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(4) (8) (9)	Limited Partnership Interests	8/11/2022	1,419	142		91		0.03	%
COP Exterminators Investment, LLC	(4) (8) (9)	Class A Units	7/31/2023	770,000	862		862		0.29	%
Legacy Service Partners, LLC (“LSP”)	(4) (8) (9)	Class B Units	1/9/2023	1,963	196		203		0.07	%
Perennial Services Investors LLC	(4) (8) (9) (13)	Class A Units	9/8/2023	1,957	196		196		0.06	%
Total Services: Consumer					1,396		1,352		0.45	%
Sovereign & Public Finance
LMI Renaissance	(4) (8) (9)	Limited Partnership Interests	6/30/2022	106,984	107		217		0.07	%
Total Sovereign & Public Finance					107		217		0.07	%
Transportation: Consumer
ASTP Holdings Co-Investment LP	(4) (8) (9)	Limited Partnership Interest	9/11/2023	160,609	137		161		0.05	%
Total Transportation: Consumer					137		161		0.05	%
Utilities: Electric
Pinnacle Supply Partners, LLC	(4) (8) (9)	Subject Partnership Units	4/3/2023	111,875	112		103		0.03	%
Total Utilities: Electric					112		103		0.03	%
Total Equity Investments					8,787		9,328		3.09	%
Cash Equivalents	(14)				5,417		5,417		1.79	%
Total Investments					$	456,661	$	451,194	149.33	%

____________________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a portfolio company is generally presumed to be “non-controlled” when the Fund owns 25% or less of the portfolio company’s voting securities and “controlled” when the Fund owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Fund owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Fund owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Fund are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over SOFR and the current contractual interest rate in effect at September 30, 2023. As of September 30, 2023, effective rates for 1M S, 3M S, 6M S and 12M S are 5.32%, 5.40%, 5.47% and 5.47%, respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

(5)Percentage is based on net assets of $302,138 as of September 30, 2023.

(6)Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings” for more information.

(7)Investment is a unitranche position.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of September 30, 2023, the Fund held thirty-three restricted securities with an aggregate fair value of $9,328, or 3.09% of the Fund’s net assets.

(9)Equity investments are non-income producing securities unless otherwise noted.

(10)This portfolio company is not domiciled in the United States. As of September 30, 2023, the total fair value of investments domiciled in Canada, Ireland, Luxembourg, Netherland and United Kingdom are $5,411, $1,240, $1,239, $489, and $8,624 respectively, representing 1.79%, 0.41%, 0.41%, 0.16%, and 2.86% of the Fund’s net assets, respectively. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Investments valued using observable inputs (Level 2), if applicable. See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information.

(13)The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of September 30, 2023, total non-qualifying assets at fair value represented 8.62% of the Fund's total assets calculated in accordance with the 1940 Act.

(14)Cash equivalents balance represents amounts held in interest-bearing money market funds issued by U.S. Bank National Association and First American.

(15)Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

The accompanying notes are an integral part of these consolidated financial statements.

7

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit		Cost		Fair Value		% of Net Assets (5)
Investments
Debt Investments
Automotive
Randys Holdings, Inc	(4) (6) (7)	First Lien Term Loan	S+ 6.50%	11.09	%	11/1/2028	$	3,996	$	3,918	$	3,919	1.51	%
Randys Holdings, Inc (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.50%	11.09	%	11/1/2028	1,332		—		(26)		(0.01)	%
Total Automotive									3,918		3,893		1.50	%
Banking, Finance, Insurance, Real Estate
Patriot Growth Insurance Service (Delayed Draw) (Incremental)	(4) (6) (7) (11)	First Lien Term Loan	L+ 5.75%	10.52	%	10/14/2028	5,999		375		266		0.10	%
Total Banking, Finance, Insurance, Real Estate									375		266		0.10	%
Beverage, Food & Tobacco
Cold Spring Brewing Company	(4) (6)	First Lien Term Loan	S+ 4.75%	9.11	%	12/19/2025	6,805		6,805		6,804		2.61	%
Fortune International, LLC	(4) (6)	First Lien Term Loan	L+ 4.75%	9.52	%	1/17/2026	6,948		6,891		6,802		2.61	%
Fresh Edge	(4)	Subordinated Debt	S+ 9.00%	13.36	%	4/2/2029	2,890		2,820		2,820		1.08	%
Mr. Greens	(4)	Subordinated Debt	N/A	10.00% (Cash) 2.00% (PIK)		1/26/2026	10,153		9,807		10,153		3.90	%
Nonni's Foods, LLC	(4) (6)	First Lien Term Loan	L+ 5.00%	9.39	%	12/1/2023	6,963		6,958		6,915		2.66	%
SW Ingredients Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 1.00% (PIK)		7/3/2026	10,076		10,076		9,521		3.67	%
Total Beverage, Food & Tobacco									43,357		43,015		16.53	%
Capital Equipment
GenServe LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.25%	9.84	%	4/12/2024	6,947		6,891		6,937		2.66	%
Total Capital Equipment									6,891		6,937		2.66	%
Chemicals, Plastics, & Rubber
Spartech	(4) (6) (7)	First Lien Term Loan	L+ 4.75%	9.52	%	5/8/2028	3,970		3,970		3,863		1.48	%
SupplyOne, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		2/1/2025	10,113		10,113		10,113		3.89	%
Total Chemicals, Plastics, & Rubber									14,083		13,976		5.37	%
Construction & Building
Gannett Fleming	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	12/20/2028	2,000		1,960		1,960		0.76	%
Hyphen Solutions, LLC	(4) (6) (7)	First Lien Term Loan	L+ 5.50%	9.89	%	10/27/2026	6,947		6,898		6,804		2.61	%
SPI LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.00%	9.59	%	12/21/2027	6,948		6,855		6,804		2.61	%
Total Construction & Building									15,713		15,568		5.98	%

The accompanying notes are an integral part of these consolidated financial statements.

8

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Consumer Goods: Durable
Freedom U.S. Acquisition Corporation	(4) (6)	First Lien Term Loan	L+ 4.50%	9.27	%	11/10/2023	7,000	7,000	6,955	2.67	%
NMC Skincare Intermediate Holdings II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	L+ 5.00%	9.77	%	10/31/2024	6,946	6,849	6,672	2.56	%
Xpressmyself.com LLC (a/k/a SmartSign)	(4) (6)	First Lien Term Loan	S+ 5.00%	9.59	%	9/7/2028	2,045	2,026	2,026	0.78	%
Total Consumer Goods: Durable								15,875	15,653	6.01	%
Consumer Goods: Non-Durable
Accupac, Inc.	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	1/14/2026	6,946	6,923	6,815	2.62	%
Elevation Labs	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	6/30/2028	1,315	1,303	1,301	0.50	%
Elevation Labs (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.25%	9.84	%	6/30/2028	599	(3)	(6)	—	%
Image International Intermediate Holdco II, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	L+ 5.50%	10.27	%	7/10/2024	6,992	6,950	6,873	2.64	%
Revision Buyer LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		12/1/2028	10,075	9,889	9,896	3.80	%
Ultima Health Holdings, LLC	(4)	Subordinated Debt	N/A	11.00% (Cash) 1.50% (PIK)		3/12/2029	1,306	1,282	1,278	0.49	%
Total Consumer Goods: Non-Durable								26,344	26,157	10.05	%
Containers, Packaging & Glass
New ILC Dover, Inc.	(4) (6) (7)	First Lien Term Loan	L+ 5.00%	9.77	%	1/31/2026	6,947	6,935	6,946	2.67	%
Oliver Packaging	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.00% (PIK)		1/6/2029	1,332	1,308	1,265	0.48	%
PG Buyer, LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.50% (PIK)		9/2/2026	8,092	8,092	8,092	3.11	%
Total Containers, Packaging & Glass								16,335	16,303	6.26	%
Energy: Oil & Gas
AmSpec Group, Inc.	(4) (6) (7)	First Lien Term Loan	L+ 5.75%	10.52	%	7/2/2024	6,946	6,946	6,945	2.67	%
Dresser Utility Solutions, LLC	(4) (6)	First Lien Term Loan	L+ 4.25%	8.64	%	10/1/2025	3,473	3,473	3,473	1.33	%
Dresser Utility Solutions, LLC (Incremental)	(4) (6)	First Lien Term Loan	L+ 5.25%	9.64	%	10/1/2025	3,473	3,429	3,399	1.30	%
Marco APE Opco Holdings, LLC	(4)	Subordinated Debt	N/A	10.50% (Cash) 4.25% (PIK)		9/2/2026	8,633	8,103	7,458	2.87	%
Total Energy: Oil & Gas								21,951	21,275	8.17	%
Environmental Industries
North Haven Stack Buyer, LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	9.86	%	7/16/2027	6,947	6,918	6,845	2.63	%
Nutrition 101 Buyer LLC (a/k/a 101, Inc.)	(4) (6)	First Lien Term Loan	S+ 5.25%	9.61	%	8/31/2028	824	816	816	0.31	%
Total Environmental Industries								7,734	7,661	2.94	%
Healthcare & Pharmaceuticals
Heartland Veterinary Partners LLC (Incremental)	(4)	Subordinated Debt	S+ 7.50%	12.09	%	12/10/2027	1,000	982	980	0.38	%

The accompanying notes are an integral part of these consolidated financial statements.

9

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value		% of Net Assets (5)
Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)	(4) (11)	Subordinated Debt	S+ 7.50%	12.09	%	12/10/2027	5,000	—	(100)		(0.04)	%
New You Bariatric Group, LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	8/26/2024	6,946	6,946	6,838		2.63	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)	(4) (6)	First Lien Term Loan	S+ 5.75%	10.34	%	10/5/2029	2,265	2,217	2,221		0.85	%
SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.75%	10.34	%	10/5/2029	735	—	(14)		(0.01)	%
Southern Veterinary Partners	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	9.86	%	10/5/2027	3,085	3,026	3,022		1.16	%
US Radiology Specialists, Inc.	(6) (7) (12)	First Lien Term Loan	L+ 5.25%	10.02	%	12/15/2027	1,882	1,798	1,704		0.66	%
W2O Holdings, LLC	(4) (6)	First Lien Term Loan	L+ 4.75%	9.52	%	6/12/2025	6,947	6,947	6,905		2.65	%
Wellspring Pharmaceutical	(4) (6)	First Lien Term Loan	S+ 5.75%	10.53	%	8/22/2028	4,095	4,017	4,020		1.54	%
Wellspring Pharmaceutical (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.75%	10.53	%	8/22/2028	1,895	(14)	(35)		(0.01)	%
Total Healthcare & Pharmaceuticals								25,919	25,541	-	9.81	%
High Tech Industries
Infobase Acquisition, Inc.	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	6/14/2028	738	731	729		0.28	%
Infobase Acquisition, Inc. (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.50%	10.09	%	6/14/2028	122	—	(2)		0.00%
ITSavvy LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	8/8/2028	1,793	1,776	1,793		0.69	%
ITSavvy LLC (Delayed Draw)	(4) (11)	First Lien Term Loan	S+ 5.25%	9.84	%	8/8/2028	480	(5)	—		0.00%
Specialist Resources Global Inc. (Delayed Draw)	(4) (6)	First Lien Term Loan	L+ 4.50%	8.89	%	9/23/2025	6,947	6,947	6,894		2.65	%
Total High Tech Industries								9,449	9,414		3.62	%
Media: Advertising, Printing & Publishing
Viking Target, LLC	(4) (6)	First Lien Term Loan	L+ 5.00%	9.77	%	8/9/2024	6,945	6,906	6,916		2.66	%
Total Media: Advertising, Printing & Publishing								6,906	6,916		2.66	%
Services: Business
BroadcastMed Holdco, LLC	(4)	Subordinated Debt	N/A	10.00% (Cash) 3.75% (PIK)		11/12/2027	2,649	2,597	2,598		1.00	%
Brown & Joseph, LLC	(4) (6)	First Lien Term Loan	S+ 5.75%	10.34	%	6/20/2024	6,945	6,896	6,920		2.66	%
Class Valuation	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	444	436	415		0.16	%
CrossCountry Consulting	(4) (6) (7)	First Lien Term Loan	S+ 5.75%	10.34	%	6/1/2029	1,393	1,367	1,376		0.53	%
CrossCountry Consulting (Delayed Draw)	(4) (7) (11)	First Lien Term Loan	S+ 5.75%	10.34	%	6/1/2029	560	(5)	(7)		—	%
CV Intermediate Holdco Corp.	(4)	Subordinated Debt	N/A	11.00	%	9/30/2026	10,000	9,848	9,333		3.59	%
Evergreen Services Group	(4) (6) (7)	First Lien Term Loan	S+ 6.00%	10.59	%	6/15/2029	4,068	3,991	3,971		1.52	%
Evergreen Services Group (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	6/15/2029	970	694	680		0.26	%
Kofile, Inc.	(4)	Subordinated Debt	N/A	10.00% (Cash) 1.75% (PIK)		7/29/2026	10,128	10,128	9,987		3.84	%

The accompanying notes are an integral part of these consolidated financial statements.

10

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Phaidon International	(4) (6) (10) (13)	First Lien Term Loan	S+ 5.50%	9.86	%	8/22/2029	7,000	6,932	6,916	2.66	%
Red Dawn SEI Buyer, Inc.	(4)	Subordinated Debt	L+ 8.25%	13.02	%	11/22/2026	6,650	6,650	6,650	2.54	%
Red Dawn SEI Buyer, Inc. (Incremental)	(4)	Subordinated Debt	L+ 8.50%	13.27	%	11/22/2026	3,350	3,350	3,350	1.29	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	5/27/2029	2,993	2,964	2,881	1.11	%
Trilon Group, LLC	(4) (6)	First Lien Term Loan	S+ 6.25%	10.84	%	5/28/2029	600	594	593	0.23	%
Trilon Group, LLC (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 6.25%	10.84	%	5/28/2029	400	37	32	0.01	%
Trilon Group, LLC (Delayed Draw)	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	5/27/2029	3,000	3,000	2,888	1.11	%
Total Services: Business								59,479	58,583	22.51	%
Services: Consumer
A Place for Mom, Inc.	(4) (6) (7)	First Lien Term Loan	S+ 4.50%	9.09	%	2/10/2026	6,936	6,936	6,657	2.56	%
ADPD Holdings, LLC (a/k/a NearU)	(4) (6) (7)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	4,848	4,807	4,800	1.84	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	1,000	—	(10)	—	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	150	—	(1)	—	%
ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw)	(4) (6) (7) (11)	First Lien Term Loan	S+ 6.00%	10.59	%	8/16/2028	1,000	—	(10)	—	%
Apex Services Partners, LLC (Incremental)	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	7/31/2025	3,000	2,973	2,981	1.14	%
Apex Services Partners, LLC (Delayed Draw) (Incremental)	(4) (6) (7)	First Lien Term Loan	S+ 5.50%	10.09	%	7/31/2025	3,000	2,987	2,981	1.14	%
Excel Fitness	(4) (6)	First Lien Term Loan	S+ 5.25%	9.84	%	4/27/2029	5,985	5,920	5,690	2.19	%
Total Services: Consumer								23,623	23,088	8.87	%
Sovereign & Public Finance
LMI Consulting, LLC (LMI)	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	7/18/2028	742	728	718	0.28	%
LMI Consulting, LLC (LMI) (Incremental)	(4) (6)	First Lien Term Loan	S+ 6.50%	11.09	%	7/18/2028	2,985	2,889	2,889	1.11	%
Total Sovereign & Public Finance								3,617	3,607	1.39	%
Telecommunications
Arise Holdings Inc.	(4) (6)	First Lien Term Loan	S+ 4.25%	8.84	%	12/9/2025	6,946	6,894	6,720	2.58	%
Total Telecommunications								6,894	6,720	2.58	%
Transportation: Cargo
FSK Pallet Holding Corp. (DBA Kamps Pallets)	(4) (6)	First Lien Term Loan	L+ 5.00%	9.77	%	12/23/2026	5,985	5,870	5,869	2.25	%
Kenco Group, Inc.	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	11/15/2029	5,150	5,049	5,049	1.94	%
Kenco Group, Inc. (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 5.50%	10.09	%	11/15/2029	850	(17)	(17)	(0.01)	%
Total Transportation: Cargo								10,902	10,901	4.18	%

The accompanying notes are an integral part of these consolidated financial statements.

11

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost	Fair Value	% of Net Assets (5)
Wholesale
AMC Buyer, LLC	(4) (6)	First Lien Term Loan	S+ 5.50%	10.09	%	11/2/2024	6,947	6,919	6,947	2.67	%
CDI AcquisitionCo, Inc.	(4) (6)	First Lien Term Loan	S+ 4.50%	9.28	%	12/24/2024	6,865	6,840	6,827	2.62	%
ISG Merger Sub, LLC (dba Industrial Service Group)	(4) (6)	First Lien Term Loan	S+ 6.25%	10.61	%	12/7/2028	2,479	2,429	2,429	0.93	%
ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)	(4) (6) (11)	First Lien Term Loan	S+ 6.25%	10.61	%	12/7/2028	1,282	(6)	(25)	(0.01)	%
New Era Technology, Inc	(4) (6) (7)	First Lien Term Loan	L+ 6.25%	11.02	%	10/31/2026	6,947	6,919	6,650	2.56	%
Solaray, LLC	(4) (6) (7)	First Lien Term Loan	S+ 5.75%	10.34	%	9/9/2023	6,963	6,955	6,878	2.64	%
Total Wholesale								30,056	29,706	11.41	%
Total Debt Investments								349,421	345,180	132.60	%
Equity Investments
Beverage, Food & Tobacco
Fresh Edge	(4) (8) (9)	Class A Preferred Units	N/A	—	%	N/A	—	454	454	0.17	%
Fresh Edge	(4) (8) (9)	Class B Common Units	N/A	—	%	N/A	—	—	—	—	%
Mr. Greens	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	1	101	276	0.11	%
Spice World	(4) (8) (9)	LLC Common Units	N/A	—	%	N/A	1	126	101	0.04	%
Total Beverage, Food & Tobacco								681	831	0.32	%
Chemicals, Plastics & Rubber
SupplyOne, Inc.	(4) (8) (9)	LLC Common Units	N/A	—	%	N/A	1	504	980	0.38	%
Total Chemicals, Plastics & Rubber								504	980	0.38	%
Construction & Building
Gannett Fleming	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	85	85	85	0.03	%
Trench Plate Rental Co.	(4) (8) (9)	Common Equity	N/A	—	%	N/A	1	127	134	0.05	%
Total Construction & Building								212	219	0.08	%
Consumer Goods: Non-Durable
RVGD Aggregator LP (Revision Skincare)	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	—	98	133	0.05	%
Ultima Health Holdings, LLC	(4) (8) (9)	Preferred Units	N/A	—	%	N/A	—	130	130	0.05	%
Total Consumer Goods: Non-Durable								228	263	0.10	%
Containers, Packaging & Glass
Oliver Packaging	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	6	610	639	0.25	%

The accompanying notes are an integral part of these consolidated financial statements.

12

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

Portfolio Company (1) (2)	Footnotes	Investment	Spread Above Reference Rate (3)	Interest Rate (3)		Maturity Date	Par Amount / Unit	Cost		Fair Value		% of Net Assets (5)
PG Aggregator, LLC	(4) (8) (9)	LLC Units	N/A	—	%	N/A	—	109		135		0.05	%
Total Containers, Packaging & Glass								719		774		0.30	%
High Tech Industries
ITSavvy LLC	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	—	119		158		0.06	%
Total High Tech Industries								119		158		0.06	%
Services: Business
BroadcastMed Holdco, LLC	(4) (8) (9)	Series A-3 Preferred Units	N/A	—	%	N/A	44	655		655		0.25	%
CV Holdco, LLC	(4) (8) (9)	Class A Common Units	N/A	—	%	N/A	1	102		49		0.02	%
Kofile, Inc.	(4) (8) (9)	Class A-2 Common Units	N/A	—	%	N/A	—	108		78		0.03	%
Total Services: Business								865		782		0.30	%
Services: Consumer
ADPD Holdings, LLC (a/k/a NearU)	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	1	142		151		0.06	%
Total Services: Consumer								142		151		0.06	%
Sovereign & Public Finance
LMI Renaissance	(4) (8) (9)	Limited Partnership Interests	N/A	—	%	N/A	107	107		180		0.07	%
Total Sovereign & Public Finance								107		180		0.07	%
Total Equity Investments								3,577		4,338		1.67	%
Total Investments								$	352,998	$	349,518	134.27	%

____________________

(1)All investments are non-controlled/non-affiliated investments as defined by the Investment Company Act of 1940, as amended (the "1940 Act"). The 1940 Act classifies investments based on the level of control that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally presumed to be “non-controlled” when the Fund owns 25% or less of the portfolio company’s voting securities and “controlled” when the Fund owns more than 25% of the portfolio company’s voting securities. The 1940 Act also classifies investments further based on the level of ownership that the Fund maintains in a particular portfolio company. As defined in the 1940 Act, a company is generally deemed as “non-affiliated” when the Fund owns less than 5% of a portfolio company’s voting securities and “affiliated” when the Fund owns 5% or more of a portfolio company’s voting securities.

(2)Unless otherwise indicated, issuers of debt and equity held by the Fund are domiciled in the United States.

(3)The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“LIBOR” or "L"), as well as Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over LIBOR and SOFR and the current contractual interest rate in effect at December 31, 2022. As of December 31, 2022, effective rates for 1M L and 3M L are 4.39% and 4.77%, respectively. As of December 31, 2022, effective rates for 1M S, 3M S and 6M S are 4.36%, 4.59% and 4.78%, respectively. For portfolio companies with multiple interest rate contracts, the interest rate shown is a weighted average current interest rate in effect as of December 31, 2022. Certain investments are subject to a LIBOR or SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

(4)Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

(5)Percentage is based on net assets of $260,301 as of December 31, 2022.

The accompanying notes are an integral part of these consolidated financial statements.

13

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

CONSOLIDATED SCHEDULE OF INVESTMENTS

December 31, 2022

(dollar amounts in thousands, including share data)

(6)Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings”.

(7)Investment is a unitranche position.

(8)Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2022, the Fund held seventeen restricted securities with an aggregate fair value of $4,338, or 1.7% of the Fund’s net assets. The acquisition dates of these securities were as follows: CV Holdco, LLC - March 31, 2022, Kofile, Inc. - March 31, 2022, Mr. Greens - March 31, 2022, PG Aggregator, LLC - March 31, 2022, RVGD Aggregator LP (Revision Skincare) - March 31, 2022. Spice World - March 31, 2022, Supply One - March 31, 2022, Trench Plate Rental Co. - March 31, 2022, LMI Renaissance - June 30, 2022, Oliver Packaging - July 6, 2022, ITSavvy LLC- August 8, 2022, ADPD Holdings, LLC (a/k/a NearU) - August 11, 2022 and Ultima Health Holdings, LLC - September 12, 2022, Fresh Edge Class A and Fresh Edge Class B - October 3, 2022, BroadcastMed Holdco, LLC - October 4, 2022 and Gannett Fleming - December 20, 2022.

(9)Equity investments are non-income producing securities unless otherwise noted.

(10)This portfolio company is not domiciled in the United States. The principal place of business for Phaidon International is the United Kingdom. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

(11)Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

(12)Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information.

(13)The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2022, total non-qualifying assets at fair value represented 1.64% of the Fund's total assets calculated in accordance with the 1940 Act.

The accompanying notes are an integral part of these consolidated financial statements.

14

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

1. ORGANIZATION

Nuveen Churchill Private Capital Income Fund (“PCAP”, and together with its consolidated subsidiaries, the “Fund”) is a Delaware statutory trust formed on February 8, 2022. PCAP is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Fund is externally managed by its adviser, Churchill Asset Management LLC (the “Adviser” or “Churchill”). Churchill is an indirect subsidiary of Nuveen, LLC (“Nuveen”), the investment management division of TIAA (as defined below). Churchill has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or the “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (defined below) pursuant to an investment sub-advisory agreement between the Adviser and Nuveen Asset Management (as discussed further in Note 4). The Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Fund’s investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which the Fund defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Fund primarily focuses on investing in U.S. middle market companies with $10 to $100 million in EBITDA, which the Fund considers the core middle market. The Fund primarily invests in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. The portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of at least 50% in Senior Loan Investments, up to 30% in Junior Capital Investments and up to 20% in Equity Co-Investments. To support the Fund’s share repurchase program (as discussed further in Note 7), the Fund also will invest 5% to 10% of its assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”).

The Fund was established by Teachers Insurance and Annuity Association of America (“TIAA”), the ultimate parent of Churchill and Nuveen, and operated as a wholly owned subsidiary of TIAA until the Escrow Break Date (as defined below). On March 30, 2022, TIAA purchased 40 shares of the Fund’s Class I shares at $25.00 per share.

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In addition, on March 31, 2022, the Fund entered into a promissory note with TIAA (the “Note”) as the lender. The principal amount of the Note equaled (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500 (as discussed further in Note 4). In connection therewith, the Fund issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32,731 and $226 of principal and interest, respectively.

NCPIF SPV I LLC (“SPV I”), a Delaware limited liability company, formed on February 25, 2022. SPV I is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation. SPV I commenced operations on March 31, 2022, upon receipt of contribution of portfolio investments from TIAA to the Fund (as discussed further in Note 7).

NCPIF Equity Holdings LLC (“Equity Holdings”), a Delaware limited liability company, was formed on April 1, 2022. Equity Holdings commenced operations on February 6, 2023. Equity Holdings is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation.

15

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The Fund is offering on a continuous basis up to $2.5 billion of any combination of three classes of common shares of beneficial interest (“Common Shares”), Class S shares, Class D shares and Class I shares. On May 17, 2022, the Securities and Exchange Commission (the “SEC”) granted an exemptive order permitting the Fund to offer multiple classes of Common Shares and to impose varying sales loads, asset-based service and/or distribution fees and early withdrawal fees. The share classes have different ongoing shareholder servicing and/or distribution fees. None of the share classes being offered will have early withdrawal fees. The purchase price per share for each class of Common Shares will equal the Fund’s net asset value (“NAV”) per share as of the effective date of the monthly share purchase date. Nuveen Securities, LLC (the “Intermediary Manager”) will use its best efforts to sell Common Shares, but is not obligated to purchase or sell any specific amount of Common Shares in the offering. As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisfied the minimum offering requirement and the Fund’s Board of Trustees (the “Board of Trustees” or the “Board”) authorized the release of proceeds from escrow.

2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of September 30, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

16

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board of Trustees to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

17

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such value do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains and losses on investment transactions are determined on a specific identification basis and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of September 30, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $67,603 and $70,361, respectively, which represents approximately 15.17% and 20.13% of total investments at fair value, respectively. For the three and nine months ended September 30, 2023, the Company earned $573 and $1,647, respectively, in PIK income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company earned $211 and $450, respectively, in PIK income. As of September 30, 2023 and 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

18

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2023, the Company earned $17 and $115, respectively, in dividend income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2023, the Company earned other income of $100 and $131, respectively, primarily related to prepayment and amendment fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) to September 30, 2022, the Fund earned other income of $446 and $446, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of September 30, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 4 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the three and nine months ended September 30, 2023, offering costs of $326 and $660, respectively, were incurred, and $187 and $468, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, offering costs of $225 and $375, respectively, were incurred, and $78 and $118, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 4 for further details on the Expense Support Agreement.

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

19

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2023, the Company did not incur any excise tax expense. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Quarterly Report on Form 10-Q, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

Recent Accounting Standards Updates

The FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting in March 2020. This update provides temporary optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedge accounting, and other transactions subject to meeting certain criteria. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discounted because of reference rate reform, and was effective upon issuance through December 31, 2022. As of September 30, 2023, the Fund has amended substantially all of its agreements that have LIBOR as a reference rate to an alternate rate. Contract modifications may be required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”), which defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024. The Fund has adopted the accounting relief and noted no material impact on the consolidated financial statements, as relevant contract relationship modifications are made during the course of the reference rate reform transition period.

20

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

3. FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following table presents fair value measurements of investments, by major class as of September 30, 2023 and December 31, 2022, according to the fair value hierarchy:

As of September 30, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	31,383	$	310,315	$	341,698
Subordinated Debt (1)	—		—		94,751		94,751
Equity Investments	—		—		9,328		9,328
Cash Equivalents	5,417		—		—		5,417
Total	$	5,417	$	31,383	$	414,394	$	451,194

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2023	$	294,555	$	89,541	$	5,490	$	389,586
Purchase of investments	28,637		4,509		3,763		36,909
Proceeds from principal repayments and sales of investments	(11,251)		—		—		(11,251)
Payment-in-kind interest	—		447		—		447
Amortization of premium/accretion of discount, net	67		47		—		114
Net realized gain (loss) on investments	75		—		—		75
Net change in unrealized appreciation (depreciation) on investments	34		207		75		316
Transfers out of Level 3 (1)	(1,802)		—		—		(1,802)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	53	$	207	$	75	$	335

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

21

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,668	$	93,808	$	4,338	$	347,814
Purchase of investments	75,150		9,976		5,312		90,438
Proceeds from principal repayments and sales of investments	(14,041)		(10,212)		(392)		(24,645)
Payment-in-kind interest	—		1,521		—		1,521
Amortization of premium/accretion of discount, net	412		185		—		597
Net realized gain (loss) on investments	90		311		291		692
Net change in unrealized appreciation (depreciation) on investments	(964)		(838)		(221)		(2,023)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	(905)	$	(514)	$	(45)	$	(1,464)

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended September 30, 2022 and for the period February 28, 2022 (inception) through September 30, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2022	$	197,343	$	94,727	$	1,725	$	293,795
Purchase of investments	25,868		3,556		1,002		30,426
Proceeds from principal repayments and sales of investments	(1,102)		—		—		(1,102)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	82		52		—		134
Net realized gain (loss) on investments	3		—		—		3
Net change in unrealized appreciation (depreciation) on investments	(746)		(624)		113		(1,257)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(746)	$	(624)	$	113	$	(1,257)

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	231,983		117,526		2,383		351,892
Proceeds from principal repayments and sales of investments	(8,692)		(19,000)		—		(27,692)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	198		127		—		325
Net realized gain (loss) on investments	17		(281)		—		(264)
Net change in unrealized appreciation (depreciation) on investments	(2,058)		(661)		457		(2,262)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(2,058)	$	(661)	$	457	$	(2,262)

22

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, there were no transfers into or out of Level 3.

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at September 30, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	258,715	Yield Method	Discount Rate	6.13	%	19.50	%	11.72	%
First Lien Term Loans	51,600		Recent Transaction	Transaction Price	97.08		100.00		99.06
Subordinated Debt	92,577		Yield Method	Discount Rate	11.57	%	21.63	%	14.32	%
Subordinated Debt	2,174		Recent Transaction	Transaction Price	97.27		97.31		97.28
Equity Investments	5,530		Market Approach	EBITDA Multiple	3.50		19.50		10.18
Total	$	410,596

Equity investments in the amount of $3,798 at September 30, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

The significant unobservable input used in the yield method is a discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the performance multiple, which may include a revenue multiple, EBITDA multiple, or forward-looking metrics. The multiple is used to estimate the enterprise value of the underlying investment. An increase or decrease in the multiple would result in an increase or decrease, respectively, in the fair value. A recent transaction, if applicable, may also be factored into the valuation if the transaction price is believed to be an indicator of value.

Alternative valuation methodologies may be used as deemed appropriate for debt or equity investments, and may include, but are not limited to, a market analysis, income analysis, or liquidation (recovery) analysis.

Weighted average inputs are calculated based on the relative fair value of the investments.

4. RELATED PARTY TRANSACTIONS

Advisory Agreement

On March 31, 2022, the Fund entered into the Advisory Agreement. The Board of Trustees, including all of the trustees who are not “interested persons” (as defined under Section 2(a)(19) of the 1940 Act) of the Fund (the “Independent Trustees”), approved the Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. On August 3, 2022, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 1 to the Advisory Agreement (the “Advisory Agreement Amendment”), which became effective immediately. The Advisory Agreement Amendment was entered into solely to extend the notice requirement for the Adviser to terminate the Advisory Agreement from 60 days to 120 days (as described below).

23

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

On January 10, 2023, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 2 (the “Second Advisory Agreement Amendment”) to the Investment Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into the Second Advisory Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Second Advisory Agreement Amendment, among other things: (1) removed sunset provisions contingent upon recognition of the Common Shares as “covered securities”; (2) removed provisions entitling the Adviser to amounts owed under Sections 3 or Section 7 of the Advisory Agreement following a notice of termination of the Advisory Agreement; (3) specifies the conditions under which the Adviser may sell all or substantially all of the Fund’s assets; and (4) revised provisions to reflect conflicts of interest provisions set forth in the NASAA Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”).

On August 2, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 3 (the “Third Advisory Agreement Amendment”) to the Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into Second Advisory Agreement Amendment as a result of comments issued by state securities regulators in connection with their “blue sky” review of the Fund’s offering, and reflects specific language in the Omnibus Guidelines required by a state securities regulator.

Unless terminated earlier as described below, the Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by the Adviser without penalty upon not less than 120 days’ written notice to the Fund or by the Fund without penalty upon not less than 60 days’ written notice to the Adviser. The holders of a majority of the outstanding voting securities may also terminate either of the Advisory Agreement without penalty.

Base Management Fee

The management fee is payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured using the beginning net assets as of the Escrow Break Date. In addition, the Adviser has agreed to waive its management fee until the expiry of twelve months from the Escrow Break Date.

For the three and nine months ended September 30, 2023, base management fees earned were $547 and $712, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to management fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no management fees were earned.

Incentive Fee

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below.

Incentive Fee Based on Income

The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees).

Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns.

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized).

24

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows:

•No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized);

•100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and

•15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser.

These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter.

The Adviser has agreed to waive the incentive fee based on income until the expiry of twelve months from the Escrow Break Date. For the three and nine months ended September 30, 2023, income based incentive fees were $1,219 and $1,592, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to income based incentive fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no income based incentive fees were earned.

Incentive Fee Based on Capital Gains

The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal:

•15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP.

Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

The fees that are payable under the Advisory Agreement for any partial period will be appropriately prorated. For the three and nine months ended September 30, 2023, for the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Fund did not incur any incentive fee based on capital gains.

Sub-Advisory Agreement

On March 31, 2022, the Adviser entered into the Investment Sub-Advisory Agreement with the Sub-Adviser (the “Sub-Advisory Agreement”). The Board of Trustees, including all of the Independent Trustees, also approved the Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Investment Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement.

On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Sub-Advisory Agreement (the “Sub-Advisory Agreement Amendment”), which became effective immediately. The Sub-Advisory Agreement Amendment was entered into solely to extend the notice requirement applicable to both the Adviser and the Sub-Adviser to terminate the Sub-Advisory Agreement from 60 days to 120 days (as described below).

25

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Unless terminated earlier as described below, the Sub-Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Sub-Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by either the Adviser or the Sub-Adviser without penalty upon not less than 120 days’ written notice to the other.

Administration Agreement

On March 31, 2022, the Fund entered into an administration agreement with the Administrator (the “Administration Agreement”), which was approved by the Board of Trustees. Pursuant to the Administration Agreement, the Administrator furnishes the Fund with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Fund with the preparation of the financial records that the Fund is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or the Sub-Adviser, the Administrator also may provide significant managerial assistance on the Fund’s behalf to those portfolio companies that have accepted the Fund’s offer to provide such assistance. U.S. Bancorp Fund Services, LLC will provide the Fund with certain fund administration and bookkeeping services pursuant to a sub-administration agreement (the “Sub-Administration Agreement”) with the Administrator.

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 1 (the “Administration Agreement Amendment”) to the Administration Agreement, which became effective immediately. The Fund and the Administrator entered into the Administration Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Administration Agreement Amendment provides that the Indemnified Parties (as defined in the Administration Agreement) will not be entitled to indemnification for any loss or liability to the Fund or its shareholders by reason of the Indemnified Parties’ negligence or misconduct, in accordance with the Omnibus Guidelines.

For the three and nine months ended September 30, 2023, the Fund incurred $124 and $362, respectively, in fees under the Sub-Administrative Agreement, which are included in administration fees in the consolidated statement of operations. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company incurred $74 and $149, respectively, in fees under the Sub-Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $505 and $246, respectively, was unpaid and included in accounts payable and accrued expenses in the consolidated statement of assets and liabilities.

Intermediary Manager Agreement

On March 31, 2022, the Fund entered into an Intermediary Manager Agreement (the “Intermediary Manager Agreement”) with the Intermediary Manager, an affiliate of the Adviser. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager serves as the agent and principal distributor for the Fund’s public offering of its Common Shares. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.85% of the value of the Fund’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.25% of the value of the Fund’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholder servicing fees will be paid with respect to Class I shares.

The Fund will cease paying the distribution and/or shareholder servicing fees on any Class S share and Class D share in a shareholder’s account at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total brokerage commissions and distribution and/or shareholder servicing fees paid with respect to any such share held by such shareholder within such account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such share. At the end of such month, each such Class S share or Class D share will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such share. The total underwriting compensation and total organization and offering expenses will not exceed 10% and 15%, respectively, of the gross proceeds from the offering.

The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Independent Trustees and the trustees who have no direct or indirect financial interest in the operation of the Fund’s distribution plan or the Intermediary Manager Agreement or by vote a majority of the outstanding voting securities of the Fund, on not more than 60 days’ written notice to the Intermediary Manager or the Adviser. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act.

26

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Expense Support and Conditional Reimbursement Agreement

On March 31, 2022, the Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement provides that, Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such expense payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from the Fund to Nuveen Alternative Holdings.

Following any calendar quarter in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Fund’s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), the Fund will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings until such time as all Expense Payments made by the entity to the Fund within three years prior to the last business day of such calendar quarter have been reimbursed. Available Operating Funds means the sum of (i) the Fund’s net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) the Fund’s net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to the Fund on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to the Fund within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Fund to Nuveen Alternative Holdings.

No Reimbursement Payment for any month will be made if (1) the annualized rate of regular cash distributions declared by the Fund at the time of such Reimbursement Payment is less than the annualized rate of regular cash distributions declared by the Fund at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The Operating Expense Ratio is calculated by dividing the Fund’s operating costs and expenses incurred, less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets. The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Reimbursement Eligibility Expiration
March 31, 2022	$	983	$	—	$	983	March 31, 2025
June 30, 2022	677		—		677		June 30, 2025
September 30, 2022	379		—		379		September 30, 2025
December 31, 2022	176		—		176		December 31, 2025
March 31, 2023	198		—		198		March 31, 2026
June 30, 2023	113		—		113		June 30, 2026
September 30, 2023	327		—		327		September 30, 2026
Total	$	2,853	$	—	$	2,853

Board of Trustees’ Fees

The Board consists of seven members, four of whom are Independent Trustees. On March 30, 2022, the Board established an Audit Committee, a Nominating and Corporate Governance Committee and a Special Transactions Committee, each consisting solely of the Independent Trustees, and may establish additional committees in the future. For the three and nine months ended September 30, 2023, the Fund incurred $128 and $380, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, the Fund incurred $128 and $257, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $128 and $128, respectively, were unpaid and are included in Board of Trustees’ fees payable in the accompanying consolidated statements of assets and liabilities.

27

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

Other Related Party Transactions

From time to time, the Adviser may pay amounts owed by the Fund to third-party providers of goods or services and the Fund will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. As of September 30, 2023 and December 31, 2022, the Fund owed the Adviser $344 and $231, respectively, for reimbursements including the Fund’s allocable portion of overhead, which is included in accounts payable and accrued expenses in the accompanying consolidated statement of assets and liabilities.

Promissory Note

On March 31, 2022, the Fund entered into the Note with TIAA as the lender. The Note is issued under the purchase and sales agreement, dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund (as discussed further in Note 7). The principal amount of the Note equals (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note which was comprised of $32,731 and $226 of principal and interest, respectively.

5. SECURED BORROWINGS

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. As of September 30, 2023 and December 31, 2022, the Fund’s asset coverage was 350.22% and 267.94%, respectively.

On April 19, 2022, SPV I entered into a credit agreement with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”).

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200,000 to $250,000; and (ii) increased the rate to be paid from Daily SOFR +2.00% to Daily SOFR +2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR +2.15% to Daily SOFR +2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of September 30, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to entering into the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of September 30, 2023, approximates its carrying value. The carrying amounts of the Fund’s assets and liabilities, including the credit facilities, other than investments at fair value, approximate fair value due to their short maturities. The borrowing consisted of the following as of September 30, 2023 and December 31, 2022:

28

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

	September 30, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	120,750		120,750
Unused Portion (2)	129,250		129,250
Amount Available (3)	103,112		103,112

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022 and from February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022 (1)
Borrowing interest expense	$	2,469		$	1,189		$	7,238		$	1,654
Unused fees	124			117			351			203
Amortization of deferred financing costs (2)	44			19			122			35
Total interest and debt financing expenses	$	2,637		$	1,325		$	7,711		$	1,892
Average interest rate (3)	8.02		%	4.67		%	7.57		%	4.01		%
Average daily borrowings	$	128,192		$	110,788		$	133,903		$	102,442

_______________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

(2)For the three and nine months ended September 30, 2023, $0 and $2, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the three and nine months ended September 30, 2022, $373 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

6. COMMITMENTS AND CONTINGENCIES

In the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Fund. The Fund believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of September 30, 2023 for any such exposure.

29

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

As of September 30, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

Portfolio Company	September 30, 2023		December 31, 2022
Acclaim MidCo	$	891	$	—
ADPD Holdings, LLC	1,919		2,149
ASTP Holdings Co-Investment LP	26		—
Chroma Color Corporation	381		—
COP Exterminators	503		—
Evergreen Services Group, LLC	—		267
Health Management Associates	415		—
Heartland Veterinary Partners, LLC	2,210		5,000
Impact Parent Corporation	1,832		—
Infobase Acquisition, Inc.	122		122
INS Intermediate	1,139		—
ISG Merger Sub, LLC	766		1,282
ITSavvy, LLC	36		480
Kenco Group, Inc.	850		850
Keng Acquisition	2,041		—
KL Bronco Acquisition, Inc.	599		599
KRIV Acquisition	779		—
Legacy Service Partners	479		—
LMI Consulting, LLC	2		—
MEI Rigging & Crating	501		—
Omnia Partners	129		—
Orion Group	2,571		—
Ovation Holdings, Inc.	470		—
Palmetto AcquisitionCo	1,217		—
Patriot Growth Insurance Service	2,091		5,568
Perennial Services	1,319		—
Pinnacle Supply Partners	1,455		—
Randys Holdings, Inc	1,332		1,332
RTH	323		—
SCP Eye Care Holdco, LLC	386		735
Transit Buyer LLC	1,157		—
Trilon Group, LLC	—		363
Victors CCC Buyer LLC	560		560
Wellspring Pharmaceutical	—		1,895
WSB Engineering Holdings	1,096		—
Total unfunded commitments	$	29,597	$	21,202

The Fund believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of September 30, 2023, the Fund had cash and cash equivalents of $6,344 and available borrowings under the Bank of America Credit Facility of $103,112.

7. NET ASSETS

In connection with its formation, the Fund has the authority to issue an unlimited number of Common Shares.

On March 30, 2022, an affiliate of the Adviser, TIAA, purchased 40 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share.

30

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

On March 31, 2022, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In connection therewith, the Fund entered into the Note with TIAA as the lender (as described in Note 4), and issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. The Fund fully repaid the balance of the Note to TIAA on June 3, 2022.

On the Escrow Break Date, the Fund had satisfied the minimum offering requirement and the Board authorized the release of proceeds from escrow. During the nine months ending September 30, 2023, the Fund issued 1,735,030 Class I shares for total proceeds of $42,690. As of September 30, 2023, the Fund has not repurchased any Class I shares and has not issued any Class S or D shares. As of September 30, 2023, the Fund recorded $1,145 as a result of excess capital funding received in connection with its September capital contributions, this amount is included in due to transfer agent on the statement of assets and liabilities.

Distributions

The following table summarizes the Fund’s dividends declared for the period from February 8, 2022 (inception) through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Dividend per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain.

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board of Trustees on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board of Trustees authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

31

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Shares Issued
June 28, 2023	June 30, 2023	July 28, 2023	573
July 28, 2023	July 31, 2023	August 28, 2023	1,426
August 23, 2023	August 31, 2023	September 28, 2023	2,316

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board of Trustees, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board of Trustees, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board of Trustees will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board of Trustees, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the nine months ended September 30, 2023, no Common Shares were repurchased.

32

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

8. CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the nine months ended September 30, 2023 and for the period from February 8, 2022 (inception) through September 30, 2022:

	Nine Months Ended September 30,
	2023			2022*
Per share data:
Net asset value at beginning of period	$	24.70		$	—
Net investment income (loss)	2.18			0.99
Net realized gains (losses) (1)	0.06			(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.18)			(0.22)
Net increase (decrease) in net assets resulting from operations	2.06			0.75
Stockholder distributions from income (2)	(2.14)			(0.87)
Issuance of common shares	—			25.00
Other (3)	(0.01)			—
Net asset value at end of period	$	24.61		$	24.88
Supplemental Data:
Net assets at end of period	$	302,138		$	262,221
Shares outstanding at end of period (1)	12,279,386			10,540,040
Total return	8.63		%	2.93		%
Ratio to average net assets:
Ratio of net expenses to average net assets (4) (5)	4.73		%	1.82		%
Ratio of net investment income (loss) to average net assets (4)	11.75		%	6.17		%
Portfolio turnover rate (6)	6.36		%	9.10		%
Asset coverage ratio	350.22		%	309.78		%

_______________

*For the period February 8, 2022 (inception) through September 30, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 6.48% and 2.43% for the period ending September 30, 2023 and for the period September 30, 2022, respectively, on an annualized basis, excluding the effect of expense support which represented (0.27)% and (0.61)%, respectively, of average net assets, and excluding the effect of waived management fees and incentive fees which represented (0.45)% and (1.03)% of average net assets for the period ending September 30, 2023. There were no management fees or incentive fees incurred or waived for the period February 8, 2022 (inception) through September 30, 2022. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period ending September 30, 2023 and the period February 8, 2022 (inception) through September 30, 2022, was 3.78% and 1.11%%, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

9. SUBSEQUENT EVENTS

The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of September 30, 2023, except as discussed below.

On October 27, 2023, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023.

33

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(dollar amounts in thousands, except per share data)

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Through the date of issuance of the consolidated financial statements, the Fund has accepted approximately $342.4 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares. In connection with the October 2023 subscription closing, the net asset value for each of Class I shares, Class S shares, and Class D shares was $24.61 per share.

34

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The information in this section contains forward-looking statements, which relate to future events or the future performance or financial condition of Nuveen Churchill Private Capital Income Fund, including its wholly owned subsidiaries (collectively, "we", "us", "our", or the "Fund") and involves numerous risks and uncertainties, including, but not limited to, those set forth in “Risk Factors” in Part I, Item 1A of and elsewhere in this Quarterly Report on Form 10-Q. This discussion should be read in conjunction with the “Forward-Looking Statements” in this Quarterly Report on Form 10-Q. Actual results could differ materially from those implied or expressed in any forward-looking statements.

Overview

We were formed as a Delaware statutory trust on February 8, 2022. We are an externally managed, non-diversified closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). We are externally managed by Churchill Asset Management LLC (“Churchill” or the “Adviser”), which is responsible for sourcing potential investments, conducting due diligence on prospective investments, analyzing investment opportunities, structuring investments and monitoring our portfolio on an ongoing basis. The Adviser is registered as an investment adviser with the Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940, as amended (the “Advisers Act”). We have elected to be treated, and intend to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Our investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which we define as companies with $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). We primarily focus on investing in U.S. middle market companies with $10 million to $100 million of EBITDA, which we consider the core middle market.

We primarily invest in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. Our portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of at least 50% in Senior Loan Investments, up to 30% in Junior Capital Investments and up to 20% in Equity Co-Investments. To support our share repurchase program, we will also invest 5% to 10% of our assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”). While we seek to achieve the targets described above, the composition of the Fund’s investment portfolio may vary from time to time due to various factors, such as market conditions and the availability of attractive investment opportunities. For example, it is possible that the Fund will from time to time maintain a portfolio exclusively comprised of Senior Loan Investments, Junior Capital Investments or other fixed-income instruments, such as during its initial ramp-up phase.

NCPIF SPV I LLC (“SPV I”) and NCPIF Equity Holdings LLC (“Equity Holdings”) are wholly owned subsidiaries of the Fund and are consolidated in these consolidated financial statements.

On March 31, 2022, prior to our election to be regulated as a BDC under the 1940 Act, Teachers Insurance and Annuity Association of America (“TIAA”) contributed certain portfolio investments to the Fund and SPV I and, in connection therewith, the Fund entered into the Note (as described below) and issued Class I shares to TIAA.

35

Under our Investment Advisory Agreement with the Adviser (the “Advisory Agreement”), we have agreed to pay the Adviser an annual management fee as well as an incentive fee based on our investment performance. The Adviser has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (as defined below) pursuant to a sub-advisory agreement between the Adviser and Nuveen Asset Management (the “Sub-Advisory Agreement”). Under the administration agreement (the “Administration Agreement”) with Churchill BDC Administration LLC (f/k/a Nuveen Churchill Administration LLC), as our administrator (the “Administrator”), we have agreed to reimburse the Administrator for the allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including, but not limited to, our allocable portion of the costs of compensation and related expenses of our Chief Financial Officer and Chief Compliance Officer and their respective staffs. The Adviser, Nuveen Asset Management, and the Administrator are all affiliates and subsidiaries of Nuveen, LLC (“Nuveen”), the investment management division of TIAA.

Key Components of Our Results of Operations

Investments

Our level of investment activity varies substantially from period to period depending on many factors, including the amount we have available to invest as well as the amount of debt and equity capital available to middle-market companies, the level of merger and acquisition activity in the middle market, the general economic environment and the competitive environment for the types of investments we make, and other market conditions.

To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements. To the extent we qualify as a RIC, we generally will not be subject to U.S federal income tax on any income we timely distribute to our shareholders.

As a BDC, we are required to comply with certain regulatory requirements. For instance, we are generally required to invest at least 70% of our total assets in “qualifying assets,” including securities of private or thinly traded public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less.

As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” Under the 1940 Act, the term “eligible portfolio company” includes all private companies, companies whose securities are not listed on a national securities exchange, and certain public companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250.0 million. We also must be organized in the United States to qualify as a BDC.

Revenues

We generate revenue primarily in the form of interest income on our Senior Loan Investments, Junior Capital Investments and Liquid Investments, and capital gains and dividend income from our Equity Co-Investments in our portfolio companies. Our Senior Loan Investments typically bear interest at a floating rate usually determined on the basis of a benchmark, such as the Secured Overnight Financing Rate (“SOFR”). Our Junior Capital Investments generally include cash paying subordinated debt (including fixed-rate subordinated loans, which may have a portion of PIK income, and floating-rate second-lien term loans), subordinated PIK notes (with no current cash payments) and/or equity securities (with no current cash payments). Our Liquid Investments includes a portfolio of cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments. The principal amount of the debt securities and any accrued but unpaid PIK interest generally will become due at the maturity date. Original Issue discounts and market discounts or premiums will be capitalized, and we will accrete or amortize such amounts as interest income. We will record prepayment premiums on loans and debt securities as interest income.

Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amounts. In addition, we generate revenue in the form of commitment, loan origination, structuring or diligence fees, fees for providing managerial assistance to our portfolio companies, and possibly consulting fees.

Expenses

Churchill, Nuveen Asset Management and their affiliates are responsible for the compensation and routine overhead expenses allocable to personnel providing investment advisory and management services to the Fund. The Fund will bear all other out-of-pocket costs and expenses of its operations and transactions, including those costs and expenses incidental to the provision of investment advisory and management services to the Fund (such as items (iii) and (iv) listed below).

36

For the avoidance of doubt, unless the Adviser or Nuveen Asset Management elects to bear or waive any of the following costs, the Fund will bear the following costs:

(i)organization of the Fund;

(ii)calculating NAV (including the cost and expenses of any independent third-party valuation firm);

(iii)expenses, including travel, entertainment, lodging and meal expenses, incurred by the Adviser, Nuveen Asset Management, or members of its investment teams, or payable to third parties, in evaluating, developing, negotiating, structuring and performing due diligence on prospective portfolio companies, including such expenses related to potential investments that were not consummated, and, if necessary, enforcing the Fund’s rights;

(iv)fees and expenses incurred by the Adviser (and its affiliates), Nuveen Asset Management (and its affiliates), or the Administrator (or its affiliates) payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for the Fund and in conducting research and due diligence on prospective investments and equity sponsors, analyzing investment opportunities, structuring the Fund’s investments and monitoring investments and portfolio companies on an ongoing basis;

(v)any and all fees, costs and expenses incurred in connection with the incurrence of leverage and indebtedness of the Fund, including borrowings, dollar rolls, reverse purchase agreements, credit facilities, securitizations, margin financing and derivatives and swaps, and including any principal or interest on the Fund’s borrowings and indebtedness (including, without limitation, any fees, costs, and expenses incurred in obtaining lines of credit, loan commitments, and letters of credit for the account of the Fund and in making, carrying, funding and/or otherwise resolving investment guarantees);

(vi)offerings, sales, and repurchases of the Common Shares and other securities;

(vii)fees and expenses payable under the Intermediary Manager Agreement and selected dealer agreements, if any;

(viii)investment advisory fees payable under Section 7 of the Advisory Agreement;

(ix)administration fees and expenses, if any, payable under the Administration Agreement (including payments under the Administration Agreement between us and the Administrator, based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including the allocable portion of the cost of the Fund’s chief financial officer and chief compliance officer and their respective staffs);

(x)costs incurred in connection with investor relations and Board of Trustees relations;

(xi)any applicable administrative agent fees or loan arranging fees incurred with respect to portfolio investments by the Adviser, Nuveen Asset Management (and its affiliates), the Administrator or an affiliate thereof;

(xii)any and all fees, costs and expenses incurred in implementing or maintaining third-party or proprietary software tools, programs or other technology for the benefit of the Fund (including, without limitation, any and all fees, costs and expenses of any investment, books and records, portfolio compliance and reporting systems, general ledger or portfolio accounting systems and similar systems and services, including, without limitation, consultant, software licensing, data management and recovery services fees and expenses);

(xiii)transfer agent, dividend agent and custodial fees and expenses;

(xiv)federal and state registration fees;

(xv)all costs of registration and listing the Common Shares on any securities exchange;

(xvi)federal, state and local taxes;

(xvii)independent trustees’ fees and expenses, including reasonable travel, entertainment, lodging and meal expenses, and any legal counsel or other advisors retained by, or at the discretion or for the benefit of, the independent trustees;

37

(xviii)costs of preparing and filing reports or other documents required by the SEC, FINRA, U.S. Commodity Futures Trading Commission, or other regulators, and all fees, costs and expenses related to compliance-related matters (such as developing and implementing specific policies and procedures in order to comply with certain regulatory requirements) and regulatory filings related to the Fund’s activities and/or other regulatory filings, notices or disclosures of the Adviser, Nuveen Asset Management, and their respective affiliates relating to the Fund and its activities;

(xix)costs of any reports, proxy statements or other notices to shareholders, including printing costs;

(xx)fidelity bond, trustees’ and officers’/errors and omissions liability insurance, and any other insurance premiums;

(xxi)direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors, tax preparers and outside legal costs;

(xxii)proxy voting expenses;

(xxiii)all expenses relating to payments of dividends or interest or distributions in cash or any other form made or caused to be made by the Board of Trustees to or on account of holders of the securities of the Fund, including in connection with the distribution reinvestment plan or the share repurchase program;

(xxiv)costs incurred in connection with the formation or maintenance of entities or vehicles to hold the Fund’s assets for tax or other purposes;

(xxv)the allocated costs incurred by the Adviser, Nuveen Asset Management, and/or the Administrator in providing managerial assistance to those portfolio companies that request it;

(xxvi)allocable fees and expenses associated with marketing efforts on behalf of the Fund;

(xxvii)all fees, costs and expenses of any litigation involving the Fund or its portfolio companies and the amount of any judgments or settlements paid in connection therewith, Trustee and officers, liability or other insurance (including costs of title insurance) and indemnification (including advancement of any fees, costs or expenses to persons entitled to indemnification) or extraordinary expense or liability relating to Fund’s affairs;

(xxviii)fees, costs and expenses of winding up and liquidating the Fund’s assets; and

(xxix)all other expenses incurred by the Fund, the Adviser, Nuveen Asset Management, or the Administrator in connection with administering the Fund’s business.

With respect to (i) above, Nuveen Alternative Holdings LLC, an affiliate of the Adviser (“Nuveen Alternative Holdings”) agreed to advance (or cause one or more of its affiliates to advance) all of our organization and offering expenses on our behalf through the Escrow Break Date. Unless Nuveen Alternative Holdings elects to cover such expenses pursuant to the expense support and conditional reimbursement agreement with the Adviser (the “Expense Support Agreement”), we may be obligated to reimburse Nuveen Alternative Holdings under the terms of the Expense Support Agreement for such advanced expenses. Any reimbursements will not exceed actual expenses incurred by Nuveen Alternative Holdings.

From time to time, the Adviser, the Administrator or their affiliates may pay third-party providers of goods or services. We will reimburse the Adviser, the Administrator or such affiliates thereof for any such amounts paid on our behalf. From time to time, the Adviser or the Administrator may defer or waive fees and/or rights to be reimbursed for expenses. All of the foregoing expenses will ultimately be borne by our shareholders, subject to the cap on organization and offering expenses described above.

38

Portfolio and Investment Activity

Portfolio Composition

Our portfolio and investment activity for the three and nine months ended September 30, 2023 and for the period and from the period February 8, 2022 (inception) through September 30, 2022, is presented below (information presented herein is at amortized cost unless otherwise indicated) (dollar amounts in thousands):

	Three Months Ended September 30,
	2023		2022
Investments:
Total investments, beginning of period	$	395,305	$	294,800
Purchase of investments	66,756		30,426
Proceeds from principal repayments and sales of investments	(11,448)		(1,102)
Payment-in-kind interest	447		409
Amortization of premium/accretion of discount, net	117		134
Net realized gain (loss) on investments	67		3
Total investments, end of period	$	451,244	$	324,670
Portfolio companies at beginning of period	81		46
Number of new portfolio companies funded	65		11
Number of portfolio companies sold or repaid	(2)		—
Portfolio companies at end of period	144		57
Count of investments	220		83
Count of industries	27		18

	Nine Months Ended September 30,
	2023		2022 (1)
Investments:
Total investments, beginning of period	$	352,998	$	—
Purchase of investments	120,285		351,892
Proceeds from principal repayments and sales of investments	(24,852)		(27,692)
Payment-in-kind interest	1,521		409
Amortization of premium/accretion of discount, net	607		325
Net realized gain (loss) on investments	685		(264)
Total investments, end of period	$	451,244	$	324,670
Portfolio companies at beginning of period	64		—
Number of new portfolio companies funded	83		59
Number of portfolio companies sold or repaid	(3)		(2)
Portfolio companies at end of period	144		57
Count of investments	220		83
Count of industries	27		18

_______________

(1)For the period February 8, 2022 (inception) through September 30, 2022

As of September 30, 2023, our portfolio companies had a weighted average reported EBITDA (including all private debt investments and excluding quoted assets) of $65.1 million. Including the quoted assets, our portfolio companies had a weighted average reported EBITDA of $153.1 million. EBITDA amounts are derived from the most recently available portfolio company financial statements and are weighted based on the fair market value of each respective investment as of its most recent valuation.

39

As of September 30, 2023 and December 31, 2022, our investments consisted of the following (dollar amounts in thousands):

	September 30, 2023						December 31, 2022
	Amortized Cost		Fair Value		% of Fair Value		Amortized Cost		Fair Value		% of Fair Value
First-Lien Term Loans	$	345,197	$	341,698	76.65	%	$	253,940	$	251,371	71.92	%
Subordinated Debt (1)	97,260		94,751		21.26	%	95,481		93,809		26.84	%
Equity Investments	8,787		9,328		2.09	%	3,577		4,338		1.24	%
Total	$	451,244	$	445,777	100.00	%	$	352,998	$	349,518	100.00	%
Largest portfolio company investment	$	10,693	$	11,001	2.47	%	$	10,617	$	11,093	3.17	%
Average portfolio company investment	$	3,134	$	3,096	0.68	%	$	5,516	$	5,461	1.56	%

_______________

(1)Subordinated Debt is comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545 as of September 30, 2023, and $30,906 and $62,903 as of December 31, 2022, respectively.

The industry composition of our portfolio as a percentage of fair value as of September 30, 2023 and December 31, 2022 was as follows:

Industry	September 30, 2023		December 31, 2022
Aerospace & Defense	0.70	%	—	%
Automotive	1.10	%	1.11	%
Banking, Finance, Insurance, Real Estate	1.06	%	0.08	%
Beverage, Food & Tobacco	9.88	%	12.54	%
Capital Equipment	3.92	%	1.98	%
Chemicals, Plastics & Rubber	4.15	%	4.28	%
Construction & Building	4.84	%	4.52	%
Consumer Goods: Durable	4.23	%	4.48	%
Consumer Goods: Non-Durable	6.65	%	7.56	%
Containers, Packaging & Glass	3.81	%	4.89	%
Energy: Electricity	0.11	%	—	%
Energy: Oil & Gas	4.95	%	6.09	%
Environmental Industries	3.30	%	2.19	%
Healthcare & Pharmaceuticals	7.59	%	7.31	%
High Tech Industries	3.95	%	2.74	%
Hotel, Gaming & Leisure	0.28	%	—	%
Media: Advertising, Printing & Publishing	1.54	%	1.98	%
Media: Broadcasting & Subscription	0.69	%	—	%
Metals and Mining	0.11	%	—	%
Services: Business	17.10	%	16.98	%
Services: Consumer	7.49	%	6.65	%
Sovereign & Public Finance	0.87	%	1.08	%
Telecommunications	1.66	%	1.92	%
Transportation: Cargo	2.60	%	3.12	%
Transportation: Consumer	0.67	%	—	%
Utilities: Electric	0.58	%	—	%
Wholesale	6.17	%	8.50	%
Total	100.00	%	100.00	%

40

The weighted average yields of our investments as of September 30, 2023 and December 31, 2022 was as follows:

	September 30, 2023		December 31, 2022
Weighted average yield on debt and income producing investments, at cost	11.49	%	10.84	%
Weighted average yield on debt and income producing investments, at fair value	11.65	%	10.97	%
Percentage of debt investments bearing a floating rate	82.69	%	76.79	%
Percentage of debt investments bearing a fixed rate	17.31	%	23.21	%

As of September 30, 2023, 71.52% and 71.69% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that limit the minimum applicable interest rates on such loans. As of December 31, 2022, 74.64% and 74.79% of our debt and income producing investments at cost and at fair value, respectively, had interest rate floors that limit the minimum applicable interest rates on such loans.

The weighted average yield of our debt and income producing securities is not the same as a return on investment for our shareholders, but rather relates to our investment portfolio and is calculated before the payment of all of our and our subsidiary’s fees and expenses. The weighted average yield was computed using the effective interest rates as of each respective date, including accretion of original issue discount, but excluding investments on non-accrual status, if any. There can be no assurance that the weighted average yield will remain at its current level. Total weighted average yields of our debt and income producing investments, at cost, increased from 10.84% to 11.49% from December 31, 2022 to September 30, 2023. The increase in weighted average yields was primarily due to rising benchmark interest rates.

Based on current market conditions, the pace of our investment activities, including originations and repayments, may vary. Credit markets continued to be under pressure during the nine months ended September 30, 2023 amid a risk-off environment and sustained macro-economic uncertainty due to rising Treasury yields, record-high inflation, tighter financial conditions, financial market instability (including volatility in the banking system, particularly with small and regional banks), elements of geopolitical instability (including the ongoing war in Ukraine, the ongoing war in the Middle East, and U.S. and China relations) and growing recession risk. Central banks have remained focused on restoring price stability by raising interest rates and have signaled that growth may be hindered until inflation comes under control. There have been headwinds in the financing and merger and acquisition markets resulting from the foregoing factors. In the event that the U.S. economy enters into a protracted recession, it is possible that the performance of certain U.S. middle market companies could deteriorate. We are closely monitoring the effect of such market volatility may have on our portfolio companies and our investment activities, and we will continue to seek to invest in defensive businesses with low levels of cyclicality and strong levels of free cash flow generation. While we are not seeing signs of a broad-based deterioration in our performance or that of our portfolio companies at this time, there can be no assurance that the performance of certain of our portfolio companies will not be negatively impacted by economic conditions, which could have a negative impact on our future results.

Asset Quality

In addition to various risk management and monitoring tools, we use the Adviser’s investment rating system to characterize and monitor the credit profile and expected level of returns on each investment in our portfolio, with the exception of the Liquid Investments managed by the leveraged finance division of our Sub-Adviser. Each Investment Team intends to utilize a systematic, consistent approach to credit evaluation, with a particular focus on an acceptable level of debt repayment and deleveraging under a “base case” set of projections (the “Base Case”), which reflects a more conservative estimate than the set of projections provided by a prospective portfolio company, which the Advisers refer to as the “Management Case.” The following is a description of the conditions associated with each investment rating:

1.Performing - Superior: Borrower is performing significantly above Management Case.

2.Performing - High: Borrower is performing at or near the Management Case (i.e., in a range slightly below to slightly above).

3.Performing - Low Risk: Borrower is operating well ahead of the Base Case to slightly below the Management Case.

4.Performing - Stable Risk: Borrower is operating at or near the Base Case (i.e., in a range slightly below to slightly above). This is the initial rating assigned to all new borrowers.

5.Performing - Management Notice: Borrower is operating below the Base Case. Adverse trends in business conditions and/or industry outlook are viewed as temporary. There is no immediate risk of payment default and only a low to moderate risk of covenant default.

41

6.Watch List - Low Maintenance: Borrower is operating below the Base Case, with declining margin of protection. Adverse trends in business conditions and/or industry outlook are viewed as probably lasting for more than a year. Payment default is still considered unlikely, but there is a moderate to high risk of covenant default.

7.Watch List - Medium Maintenance: Borrower is operating well below the Base Case, but has adequate liquidity. Adverse trends are more pronounced than in Internal Risk Rating 6 above. There is a high risk of covenant default, or it may have already occurred. Payments are current, although subject to greater uncertainty, and there is a moderate to high risk of payment default.

8.Watch List - High Maintenance: Borrower is operating well below the Base Case. Liquidity may be strained. Covenant default is imminent or may have occurred. Payments are current, but there is a high risk of payment default. Negotiations to restructure or refinance debt on normal terms may have begun. Further significant deterioration appears unlikely and no loss of principal is currently anticipated.

9.Watch List - Possible Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Liquidity is strained. Payment default may have occurred or is very likely in the short term unless creditors grant some relief. Loss of principal is possible.

10.Watch List - Probable Loss: At the current level of operations and financial condition, the borrower does not have the ability to service and ultimately repay or refinance all outstanding debt on current terms. Payment default is very likely or may have already occurred. Liquidity is extremely limited. The prospects for improvement in the borrower’s situation are sufficiently negative that loss of some or all principal is probable.

The Adviser regularly monitors and, when appropriate, changes the investment rating assigned to each investment in our portfolio, excluding Liquid Investments managed by the leveraged finance division of our Sub-Adviser. Each investment team will review the investment ratings in connection with monthly or quarterly portfolio reviews. Based on a generally uncertain economic outlook in the United States (which includes a possible recession), we have increased oversight and analysis of credits in any vulnerable industries to mitigate any decline in loan performance and reduce credit risk.

The following table shows the investment ratings of the investments in our portfolio (dollar amounts in thousands):

	September 30, 2023					December 31, 2022
	Fair Value1		% of Portfolio		Number of Portfolio Companies1	Fair Value1		% of Portfolio		Number of Portfolio Companies1
1	$	—	—	%	—	$	—	—	%	—
2	—		—		—	—		—		—
3	33,133		7.96		5	13,698		3.92		2
4	311,661		74.88		74	318,565		91.15		60
5	63,111		15.16		11	9,797		2.80		1
6	—		—		—	7,458		2.13		1
7	8,306		2.00		1	—		—		—
8	—		—		—	—		—		—
9	—		—		—	—		—		—
10	—		—		—	—		—		—
Total	$	416,211	100.00	%	91	$	349,518	100.00	%	64

(1)Liquid Investments managed by the leveraged finance division of our Sub-Adviser are excluded from the investment ratings table. As of September 30, 2023, there were 53 portfolio companies in the Liquid Investments portfolio, which had a total fair value of $29,566 or 6.63% of the portfolio. There were no Liquid Investments managed by the leveraged finance division of our Sub-Advisor held as of December 31, 2022.

As of September 30, 2023 and December 31, 2022, the weighted average Internal Risk Rating of our investment portfolio was 4.1 and 4.0, respectively.

42

Results of Operations

Operating results for the three and nine months ended September 30, 2023 and for three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022 were as follows (dollar amounts in thousands):

	Three Months Ended September 30,
	2023		2022
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	11,496	$	6,555
Payment-in-kind interest income	573		211
Dividend income	17		—
Other income	100		446
Total investment income	12,186		7,212
Expenses:
Organizational expenses	—		148
Interest and debt financing expenses	2,637		1,325
Professional fees	250		291
Management fees	547		—
Income based incentive fees	1,219		—
Board of Trustees’ fees	128		128
Administration fees	124		74
Other general and administrative expenses	326		71
Offering costs	187		78
Total expenses	5,418		2,115
Expense support	(212)		(245)
Management fees waived	(547)		—
Incentive fees waived	(1,219)		—
Net expenses	3,440		1,870
Net investment income (loss)	$	8,746	$	5,342
Realized and unrealized gain (loss) on investments:
Net realized gains (losses)	$	67	$	3
Net change in unrealized gains (losses)	252		(1,257)
Total net realized and change in unrealized gains (losses)	319		(1,254)
Net increase (decrease) in net assets resulting from operations	$	9,065	$	4,088

43

	Nine Months Ended September 30,
	2023		2022(1)
Investment income:
Non-controlled/non-affiliated company investments:
Interest income	$	31,671	$	12,692
Payment-in-kind interest income	1,647		450
Dividend income	115		—
Other income	131		446
Total investment income	33,564		13,588
Expenses:
Organizational expenses	—		1,081
Interest and debt financing expenses	7,711		1,892
Interest expense on Note (See Note 4)	—		226
Professional fees	665		742
Management fees	712		—
Income based incentive fees	1,592		—
Board of Trustees’ fees	380		257
Administration fees	362		149
Other general and administrative expenses	588		129
Offering costs	468		118
Total expenses	12,478		4,594
Expense support	(541)		(1,422)
Management fees waived	(712)		—
Incentive fees waived	(1,592)		—
Net expenses	9,633		3,172
Net investment income (loss)	$	23,931	$	10,416
Realized and unrealized gain (loss) on investments:
Net realized gains (losses)	$	685	$	(264)
Net change in unrealized gains (losses)	(1,987)		(2,262)
Total net realized and change in unrealized gains (losses)	(1,302)		(2,526)
Net increase (decrease) in net assets resulting from operations	$	22,629	$	7,890

_______________

(1)For the period February 8, 2022 (inception) through September 30, 2022

A net increase (decrease) in net assets resulting from operations will vary from period to period as a result of various factors, including the level of new investment commitments, expenses, the recognition of realized gains and losses, and changes in unrealized appreciation and depreciation on the investment portfolio.

Investment Income

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund and SPV I. The Fund accrued investment income on this portfolio beginning April 1, 2022.

Investment income increased to $12.2 million and $33.6 million for the three and nine months ended September 30, 2023, respectively, from $7.2 million and $13.6 million for the comparable periods in the prior year, primarily due to increased investment activity and an increase in interest income from higher weighted average interest rates. As of September 30, 2023, the size of our portfolio increased to $451.2 million from $324.7 million, as of September 30, 2022, at cost. As of September 30, 2023, the weighted average yield of our debt and income producing investments increased to 11.49% from 9.88% as of September 30, 2022, at cost, primarily due to increases in base interest rates. We expect our portfolio will continue to grow as we raise and deploy capital through our offering and our investment income to grow commensurately. The shifting environment in base interest rates, such as SOFR and alternate rates, may affect our investment income over the long term.

44

Expenses

Total expenses before expense support increased to $5.4 million and $12.5 million for the three and nine months ended September 30, 2023, respectively, from $2.1 million and $4.6 million for the three months ended September 30, 2022 and for the period February 8, 2022 through September 30, 2022. Our Adviser has agreed to waive the management fee and the incentive fees until June 1, 2024, the expiry of twelve months from the Escrow Break Date.

Interest and debt financing expenses increased for the three and nine months ended September 30, 2023 compared to the three months ended September 30, 2022 and for the period February 8, 2022 through September 30, 2022 primarily due to higher average daily borrowings and higher average interest rates. The average daily borrowings for the three and nine months ended September 30, 2023 was $128.2 million and $133.9 million, compared to $110.8 million and $102.4 million for the three months ended September 30, 2022 and for the period February 8, 2022 through September 30, 2022. The average interest rate for the three and nine months ended September 30, 2023 was 8.02% and 7.57% compared to 4.67% and 4.01% for the three months ended September 30, 2022 and for the period February 8, 2022 through September 30, 2022. We anticipate certain operational expenses to decrease in relation to our income as we continue to ramp up our portfolio.

The expense support amount represents the amount of expenses paid by the Adviser on our behalf in accordance with the Expense Support Agreement. These expenses are subject to reimbursement by us in accordance with the terms of the Expense Support Agreement.

Net realized gain (loss) and Net change in unrealized gains (losses) on investments

We had a net realized gain on investments of $67 thousand for the three months ended September 30, 2023 primarily related to repayment activity of multiple portfolio companies compared to a net realized gain of $3 thousand for the three months ended September 30, 2022. For the nine months ended September 30, 2023, we had a net realized gain on investments of $685 thousand primarily related to a sale of a portfolio company compared to a net realized loss of $(264) thousand for the period February 8, 2022 through September 30, 2022.

We recorded a net change in unrealized gains of $0.3 million for the three months ended September 30, 2023, compared to a net unrealized losses of $(1.3) million for three months ended September 30, 2022, which reflects the net change in the fair value of our investment portfolio relative to its cost basis over the period. The unrealized gain for the three months ended September 30, 2023, resulted primarily due to the tightening of market spreads combined with an improvement in our portfolio companies' credit metrics.

We recorded a net change in unrealized loss of $(2.0) million for the the nine months ended September 30, 2023, compared to a net unrealized losses of $(2.3) million for the period February 8, 2022 though September 30, 2022, which reflects the net change in the fair value of our investment portfolio relative to its cost basis over the period. The increase in value for the three months ended September 30, 2023 was primarily due to the tightening of market spreads combined with an improvement in our portfolio companies' credit metrics.

Financial Condition, Liquidity and Capital Resources

We expect to generate cash primarily from (i) the net proceeds of our offering of Common Shares, (ii) cash flows from income earned from our investments and principal repayments, (iii) proceeds from net borrowings on our Bank of America Credit Facility and (iv) any future offerings of our equity or debt securities.

Our primary uses of cash will be for (i) investments in portfolio companies in accordance with investment objective and investment strategies and to comply with certain portfolio diversification requirements, (ii) the cost of operations (including paying the Adviser and the Administrator), (iii) cost of any borrowings under our Bank of America Credit Facility or other financing arrangements, and (iv) cash distributions to the holders of our Common Shares. Due to an uncertain economic outlook and current market volatility, we regularly evaluate our overall liquidity position and take proactive steps to maintain that position based on such circumstances.

Cash and cash equivalents as of September 30, 2023, taken together with our available debt, is expected to be sufficient for our investment activities and to conduct our operations in the near term. As of September 30, 2023, we had $103.1 million available borrowings under our Bank of America Credit Facility.

45

For the nine months ended September 30, 2023, our cash and cash equivalents balance decreased by $59.4 million. During that period, $44.3 million was used in operating activities, primarily due to investment purchases of $120.3 million, offset by $24.9 million in repayments and sales of investments in portfolio companies. During the same period, $15.1 million was used in financing activities, consisting primarily of proceeds from secured borrowings of $54.3 million, and repayments of secured borrowings of $88.5 million.

Net Worth of Sponsors

The North American Securities Administrators Association (“NASAA’), in its Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”), requires that our affiliates and Adviser, or our Sponsor, as defined under the Omnibus Guidelines, have an aggregate financial net worth, exclusive of home, automobiles and home furnishings, of the greater of either $100,000, or 5.0% of the first $20 million of both the gross amount of securities currently being offered in our offering and the gross amount of any originally issued direct participation program securities sold by our affiliates and sponsors within the past 12 months, plus 1.0% of all amounts in excess of the first $20 million. Based on these requirements, our Adviser and its affiliates, while not liable directly or indirectly for any indebtedness we may incur, have an aggregate financial net worth in excess of those amounts required by the Omnibus Guidelines Statement of Policy.

Equity

The Fund is authorized to issue an unlimited number of Common Shares at $0.01 per share par value. On March 30, 2022, we issued an initial 40 Class I shares to TIAA in connection with our formation. On March 31, 2022, TIAA contributed certain portfolio investments in the amount of $296.2 million (fair value as of March 31, 2022) and we entered into a promissory note with TIAA (the “Note”) as the lender. In connection therewith, we issued to TIAA 10,540,000 shares of our Class I shares of beneficial interest at $0.01 per share. We fully repaid the balance of the Note to TIAA on June 3, 2022.

As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisifed the minimum offering requirement and the Board authorized the release of proceeds from escrow. During the nine months ending September 30, 2023, the Fund issued 1,735,030 Class I shares for total proceeds of $42.7 million. As of September 30, 2023, we have not repurchased any Class I shares and has not issued any Class S or D shares.

Distributions

The following table summarizes the Fund’s dividend declared from inception to September 30, 2023:

			Class I
Declaration Date	Record Date	Payment Date	Dividend per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain, respectively.

46

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board of Trustees on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023:

			Class I
Declaration Date	Record Date	Payment Date	Shares Issued
June 28, 2023	June 30, 2023	July 28, 2023	573
July 28, 2023	July 31, 2023	August 28, 2023	1,426
August 23, 2023	August 31, 2023	September 28, 2023	2,316

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board of Trustees, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board of Trustees, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board of Trustees will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board of Trustees is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders. Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board of Trustees, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

47

For the nine months ended September 30, 2023, no Common Shares were repurchased.

Income Taxes

The Fund has elected to be regulated as a BDC under the 1940 Act. The Fund also intends to qualify annually to be treated, as a RIC under the Code. So long as the Fund maintains its RIC tax treatment, it generally will not be subject to U.S federal income tax on any ordinary income or capital gains that it timely distributes to its shareholders as dividends. Rather, any tax liability related to income earned and distributed by the Fund would represent obligations of the Fund’s investors and would not be reflected in the financial statements of the Fund.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.

To qualify for and maintain qualification as a RIC, the Fund must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Fund must distribute to its shareholders, for each taxable year, at least the sum of (i) 90% of its “investment company taxable income” for that year (without regard to the deduction for dividends paid), which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses and (ii) 90% of its net tax-exempt income.

In addition, based on the excise tax distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner in each taxable year an amount at least equal to the sum of (1) 98% of its ordinary income for the calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ending October 31 in that calendar year and (3) any income realized, but not distributed, in prior years. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to corporate income tax is considered to have been distributed.

48

Bank of America Credit Facility

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. The Fund’s asset coverage was 350.22% as of September 30, 2023.

On April 19, 2022, SPV I entered into a credit agreement (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”) with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian.

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200 million to $250 million; and (ii) increased the rate to be paid from Daily SOFR plus 2.00% to Daily SOFR plus 2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR plus 2.15% to Daily SOFR plus 2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of September 30, 2023, the Bank of America Credit Facility bears interest at a rate of SOFR, reset daily plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to the closing of the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of September 30, 2023 and as of December 31, 2022, approximates their carrying values. The following table presents outstanding borrowing as of September 30, 2023 and December 31, 2022:

	September 30, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	120,750		120,750
Unused Portion (2)	129,250		129,250
Amount Available (3)	103,112		103,112

_______________

(1)Borrowings outstanding on the consolidated statements of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

49

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

_______________

(1)Borrowings outstanding on the consolidated statements of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three months ended September 30, 2023 and September 30, 2022, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended September 30,
	2023			2022
Borrowing interest expense	$	2,469		$	1,189
Unused fees	124			117
Amortization of deferred financing costs (1)	44			19
Total interest and debt financing expenses	$	2,637		$	1,325
Average interest rate (2)	8.02		%	4.67		%
Average daily borrowings	$	128,192		$	110,788

_______________

(1)For the three months ended September 30, 2023 and September 30, 2022, $0 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(2)Average interest rate includes borrowing interest expense and unused fees.

For the nine months ended September 30, 2023 and for the period February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows:

	Nine Months Ended September 30,
	2023			2022(1)
Borrowing interest expense	$	7,238		$	1,654
Unused fees	351			203
Amortization of deferred financing costs (2)	122			35
Total interest and debt financing expenses	$	7,711		$	1,892
Average interest rate (3)	7.57		%	4.01		%
Average daily borrowings	$	133,903		$	102,442

_______________

(1) Period from February 8, 2022 (inception) through September 30, 2022.

(2) For the nine months ended September 30, 2023 and the period from February 8, 2022 (inception) to September 30, 2022, $2 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3) Average interest rate includes borrowing interest expense and unused fees.

We have entered into a number of business relationships with affiliated or related parties, including the following:

•the Advisory Agreement

•the Sub-Advisory Agreement

•the Administration Agreement; and

•the Expense Support Agreement

50

In addition to the aforementioned agreements, the SEC has granted an exemptive order (the “Order”) that permits us to participate in negotiated co-investment transactions with certain other funds and accounts sponsored or managed by either of the Adviser and/or their affiliates. Co-investment under the Order is subject to certain conditions therein, including the condition that, in the case of each co-investment transaction, the Board of Trustees determines that it would be in the Fund’s best interest to participate in the transaction. Neither we nor the affiliated funds are obligated to invest or co-invest when investment opportunities are referred to us or them.

In addition, pursuant to an exemptive order issued by the SEC on April 8, 2020 and applicable to all BDCs through December 31, 2020 (the “Temporary Relief”), BDCs were permitted, subject to the satisfaction of certain conditions, to complete follow-on investments in existing portfolio companies with certain affiliates that are private funds if such private funds did not hold an investment in such existing portfolio company. Without the Temporary Relief, such private funds would not be able to participate in such follow-on investments unless the private funds had previously acquired securities of the portfolio company in a co-investment transaction with the BDC. Although the Temporary Relief expired on December 31, 2020, the SEC’s Division of Investment Management had indicated that until March 31, 2022, it would not recommend enforcement action, to the extent that any BDC with an existing co-investment order continues to engage in certain transactions described in the Temporary Relief, pursuant to the same terms and conditions described therein. The conditional exemptive order is no longer effective; however, on October 14, 2022, the SEC granted the Fund’s request to amend the Order to make the Temporary Relief permanent for the Fund and permit the Fund to complete follow-on investments in its existing portfolio companies with certain affiliates that are private funds if such private funds do not hold an investment in such existing portfolio company.

Expense Support Agreement

We have entered into the Expense Support Agreement with the Adviser. The Expense Support Agreement provides that, at such times as it determines, Nuveen Alternative Holdings may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, including organization and offering expenses, provided that no portion of the payment will be used to pay any interest expense and/or shareholder servicing fees of the Fund (each, an “Expense Payment”). Such Expense Payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from us to Nuveen Alternative Holdings.

Following any calendar month in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to our shareholders based on distributions declared with respect to record dates occurring in such calendar month (such amount referred to as the “Excess Operating Funds”), we will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings that previously paid such expenses, until such time as all Expense Payments made by such entity within three years prior to the last business day of such calendar quarter have been reimbursed. “Available Operating Funds” means the sum of (i) net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to us on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar month will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to us within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by us to Nuveen Alternative Holdings.

The Expense Support Agreement provides additional restrictions on the amount of each Reimbursement Payment for any calendar quarter and no Reimbursement Payment will be made for any month if: (1) the annualized rate (based on a 365-day year) of regular cash distributions per share of common stock declared by our Board of Trustees exclusive of returns of capital, distribution rate reductions due to any fees (including to a transfer agent) payable in connection with distributions, and any declared special dividends or distributions (the “Effective Rate of Distributions Per Share”) declared by us at the time of such Reimbursement Payment is less than the Effective Rate of Distributions Per Share at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) our Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The “Operating Expense Ratio” is calculated by dividing Operating Expenses (as defined below), less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by our net assets. “Operating Expenses” means all of our operating costs and expenses incurred, as determined in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Adviser may waive its right to receive all or a portion of any Reimbursement Payment in any particular calendar quarter, so that such Reimbursement Payment may be reimbursable in a future calendar quarter within three years of the date of the applicable Expense Payment.

51

The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived the right to receive such payment for the applicable month.

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations (dollar amounts in thousands):

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Reimbursement Eligibility Expiration
March 31, 2022	$	983	$	—	$	983	March 31, 2025
June 30, 2022	677		—		677		June 30, 2025
September 30, 2022	379		—		379		September 30, 2025
December 31, 2022	176		—		176		December 31, 2025
March 31, 2023	198		—		198		March 31, 2026
June 30, 2023	113		—		113		June 30, 2026
September 30, 2023	327		—		327		September 30, 2026
Total	$	2,853	$	—	$	2,853

Off-Balance Sheet Arrangements

In the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur which may give rise to liabilities arising from these provisions against us. We believe that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of September 30, 2023 and December 31, 2022. We may in the future become obligated to fund commitments such as delayed draw commitments.

For more information on our off-balance sheet arrangements, commitments and contingencies see Note 6 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. Our critical accounting policies and estimates, including those relating to the valuation of our portfolio investments, are described below. We consider the most significant accounting policies to be those related to our Valuation of Portfolio Investments, Revenue Recognition, and U.S. Federal Income Taxes, which are described below. The valuation of investments is our most significant critical accounting estimate. The critical accounting policies and estimates should be read in connection with our risk factors as disclosed under the heading “Risk Factors” in our Quarterly Report on Form 10-Q for the period ended September 30, 2023.

Valuation of Portfolio investments

Consistent with U.S. GAAP and the 1940 Act, we conduct a valuation of our assets, pursuant to which our net asset value is determined.

Our assets are valued on a quarterly basis, or more frequently if required under the 1940 Act. Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, which became effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

Investments for which market quotations are readily available are typically valued at those market quotations. Market quotations are obtained from independent pricing services, where available. Generally investments marked in this manner will be marked at the mean of the bid and ask of the quotes obtained. To validate market quotations, we utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations.

52

With respect to investments for which market quotations are not readily available, we or an independent third-party valuation firm engaged by the Valuation Designee, will take into account relevant factors in determining the fair value of our investments, including and in combination of: comparison to publicly traded securities, including factors such as yield, maturity and measures of credit quality; the enterprise value of a portfolio company; the nature and realizable value of any collateral; the portfolio company's ability to make payments and its earnings and discounted cash flows; and the markets in which the portfolio company does business. Investment performance data utilized are the most recently available financial statements and compliance certificates received from the portfolio companies as of the measurement date which in many cases may reflect a lag in information. The independent third-party valuation firm provides a fair valuation report, a description of the methodology used to determine the fair value and their analysis and calculations to support their conclusion.

When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, we use the pricing indicated by the external event to corroborate our valuation.

U.S. GAAP establishes a hierarchical disclosure framework which ranks the level of observability of market price inputs used in measuring investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment and the characteristics specific to the investment and state of the marketplace, including the existence and transparency of transactions between market participants. Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets generally have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value. We review pricing and methodologies in order to determine if observable market information is being used, versus unobservable inputs.

Our accounting policy on the fair value of our investments is critical because the determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of these valuations, and any change in these valuations, on the consolidated financial statements.

For more information on the fair value hierarchy, our framework for determining fair value and the composition of our portfolio see Note 3 to the consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Revenue Recognition

Our revenue recognition policies are as follows:

Net realized gains (losses) on investments: Investment transactions are recorded on the trade date. Realized gains or losses are measured by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment using the specific identification method

Investment Income: Interest income, including amortization of premium and accretion of discount on loans are recorded on the accrual basis. We accrue interest income based on the effective yield if we expect that, ultimately, we will be able to collect such income. We may have loans in our portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with our investment activities as well as any fees for managerial assistance services rendered by us to our portfolio companies. Such fees are recognized as income when earned or the services are rendered.

Non-accrual: Generally, if a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments, the Sub-Adviser will place the loan on non-accrual status and we will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible even though we remain contractually entitled to this interest. We may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated.

53

U.S. Federal Income Taxes

We have elected to be regulated as a BDC under the 1940 Act. We have elected, and intend to qualify annually, to be treated as a RIC under the Code. So long as we maintain our qualification as a RIC, we generally will not be subject to U.S. federal income tax on any ordinary income or capital gains that we timely distribute at least annually to our shareholders as dividends. As a result, any tax liability related to income earned and distributed by us represents obligations of our shareholders and will not be reflected in our consolidated financial statements.

We evaluate tax positions taken or expected to be taken in the course of preparing our financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reversed and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof.

Our accounting policy on income taxes is critical because if we are unable to maintain our status as a RIC, we would be required to record a provision for U.S. federal income taxes which may be significant to our financial results.

Contractual Obligations

We have entered into the Advisory Agreement with the Adviser to provide us with investment advisory services and the Administration Agreement with the Administrator to provide us with administrative services. Payments for investment advisory services under the Advisory Agreement and reimbursements under the Administration Agreement.

We entered into the Bank of America Credit Facility and intend to establish additional credit facilities or enter into other financing arrangements in the future to facilitate investments and the timely payment of our expenses. It is anticipated that any such credit facilities will bear interest at floating rates at to-be-determined spreads, such as SOFR. We cannot assure shareholders that we will be able to enter into a credit facility on favorable terms or at all. In connection with a credit facility or other borrowings, lenders may require us to pledge assets, commitments and/or drawdowns (and the ability to enforce the payment thereof) and may ask to comply with positive or negative covenants that could have an effect on our operations.

Promissory Note

On March 31, 2022, we entered into a promissory note (the “Note”) with TIAA as the lender. The Note is issued under the Purchase and Sales Agreement dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund and SPV I. The principal amount of the Note equals (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263.5 million. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32.7 million and $0.2 million of principal and interest, respectively.

Recent Developments

On October 27, 2023, we declared regular distributions for each class of our common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Through the date of issuance of the consolidated financial statements, we accepted approximately $342.4 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares. In connection with the October 2023 subscription closing, the net asset value for each of Class I shares, Class S shares, and Class D shares was $24.61 per share.

54

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk

Uncertainty with respect to, among other things, the rising interest rates, inflationary pressures, risks relating to a failure to increase the U.S. debt ceiling, and the failure of major financial institutions introduced significant volatility in the financial markets, and the effects of this volatility has materially impacted and could continue to materially impact our market risks, including those listed below

Valuation Risk

We have invested, and plan to continue to invest, primarily in illiquid debt and equity securities of private companies. Most of our investments do not have a readily available market price, and we value these investments at fair value as determined in good faith by the Adviser, as the valuation designee, in accordance with our valuation policy subject to the oversight of the Board and, based on, among other things, the input of the independent third-party valuation firms engaged at the direction of the valuation designee. There is no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment while employing a consistently applied valuation process for the types of investments we make. If we were required to liquidate a portfolio investment in a forced or liquidation sale, we may realize amounts that are different from the amounts presented and such differences could be material.

Interest Rate Risk

We are subject to interest rate risk. Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, variability of spread relationships, the difference in re-pricing internals between our assets and liabilities and the effect that interest rates may have on our cash flows. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. Our net investment income is also affected by fluctuations in various interest rates, including the replacement of LIBOR with alternate rates and prime rates, to the extent our debt investments include floating interest rates. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income.

Since March 2022, the Federal Reserve has been rapidly raising interest rates and has indicated that it may consider additional rate hikes in response to ongoing inflation concerns. In a rising interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve's tightening cycle could result in leading the United States into a recession, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR or other alternate rates, are not offset by corresponding increases in the spread over such base rate that we earn on any portfolio investments, a decrease in our operating expenses, or a decrease in the interest rate associated with our borrowings.

As of September 30, 2023, on a fair value basis, approximately 17.31% of our debt investments bear interest at a fixed rate and approximately 82.69% of our debt investments bear interest at a floating rate. As of September 30, 2023, 86.71% of our floating rate debt investments are subject to interest rate floors. Additionally, the Bank of America Credit Facility is also subject to floating interest rates and are currently paid based on floating SOFR rates.

The following table estimates the potential changes in net cash flow generated from interest income and expenses, should interest rates increase by 100, 200 or 300 basis points, or decrease by 100, 200 or 300 basis points. Interest income is calculated as revenue from interest generated from our portfolio of investments held on September 30, 2023. Interest expense is calculated based on the terms of the Bank of America Credit Facility, using the outstanding balance as of September 30, 2023. Interest expense on the Bank of America Credit Facility is calculated using the interest rate as of September 30, 2023, adjusted for the impact of hypothetical changes in rates, as shown below. The base interest rate case assumes the rates on our portfolio investments remain unchanged from the actual effective interest rates as of September 30, 2023. These hypothetical calculations are based on a model of the investments in our portfolio, held as of September 30, 2023, and are only adjusted for assumed changes in the underlying base interest rates.

55

Actual results could differ significantly from those estimated in the table (dollars amounts in thousands).

Changes in Interest Rates	Interest Income		Interest Expense		Net Income
- 300 Basis Points	$	(8,248)	$	(2,709)	$	(5,539)
- 200 Basis Points	(5,501)		(1,806)		(3,695)
- 100 Basis Points	(2,750)		(903)		(1,847)
+100 Basis Points	2,750		903		1,847
+200 Basis Points	5,501		1,806		3,695
+300 Basis Points	8,251		2,709		5,542

56

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

In accordance with Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on that evaluation, we, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of September 30, 2023 and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.

(b) Management’s Quarterly Report on Internal Control Over Financial Reporting

This quarterly report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the company’s registered public accounting firm due to a transition period established by rules of the Securities and Exchange Commission for newly public companies.

(c) Changes in Internal Controls Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

57

Part II - Other Information

Item 1. Legal Proceedings

We, and our consolidated subsidiaries, the Adviser and the Sub-Adviser are not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal proceedings threatened against us or them. From time to time, we, our consolidated subsidiaries and/or the Adviser and Sub-Adviser may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. Our business is subject to extensive regulation, which may result in regulatory proceedings against us.

Item 1A. Risk Factors

Except for the risk factor set forth below, there have been no material changes to the risk factors previously disclosed under Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2022. For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on March 9, 2023, which is accessible on the SEC’s website at sec.gov.

The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.

LIBOR is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.

The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom's Financial Conduct Authority (“FCA"), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBOR, including USD LIBOR, except in very limited circumstances.

In the United States, SOFR is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.

As of the filing date of this Quarterly Report on Form 10-Q, substantially all of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on the secured overnight financing rate (“CME Term SOFR”). CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed, one-month and three-month CME Group traded SOFR futures contracts and, in some cases, over-the-counter SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Because CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used.

There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.

58

Our business is dependent on bank relationships and recent strain on the banking system may adversely impact us.

The financial markets recently have encountered volatility associated with concerns about the balance sheets of banks, especially small and regional banks that may have significant losses associated with investments that make it difficult to fund demands to withdraw deposits and other liquidity needs. Although the federal government has announced measures to assist these banks and protect depositors, some banks have already been impacted and others may be materially and adversely impacted. Our business is dependent on bank relationships, including small and regional banks, and we are proactively monitoring the financial health of banks with which we (or our portfolio companies) do or may in the future do business. To the extent that our portfolio companies work with banks that are negatively impacted by the foregoing, such portfolio companies’ ability to access their own cash, cash equivalents and investments may be threatened. In addition, such affected portfolio companies may not be able to enter into new banking arrangements or credit facilities, or receive the benefits of their existing banking arrangements or credit facilities. Any such developments could harm our business, financial condition, and operating results, and prevent us from fully implementing our investment plan. Continued strain on the banking system may adversely impact our business, financial condition and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

We did not sell any securities during the period covered by this Quarterly Report on Form 10-Q that were not registered under the Securities Act of 1933, as amended.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

(a)None.

(b)None.

(c)For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Fund has entered into any (i) contract, instruction or written plan for the purchase or sale of securities of the Fund intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

The Fund has adopted insider trading policies and procedures governing the purchase, sale, and disposition of the Fund’s securities by officers and directors of the Fund that are reasonably designed to promote compliance with insider trading laws, rules and regulations.

59

Item 6. Exhibits

3.1	Fifth Amended and Restated Declaration of Trust of the Registrant(2)
3.2	Third Amended and Restated Bylaws of the Registrant(3)
4.1	Form of Subscription Agreement(4)
4.2	Distribution Reinvestment Plan(1)
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended*
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as amended*
101.INS	Inline XBRL Instance Document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

__________________

*Filed herewith

(1)Incorporated by reference to Post-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2 (File No. 333-262771) filed on September 6, 2022.

(2)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on March 3, 2023.

(3)Incorporated by reference to the Registrant’s Current Report on Form 8-K filed on May 1, 2023.

(4)Incorporated by reference to the Registrant’s Post-Effective Amendment No. 5 to the Registration Statement on Form N-2 (File No. 333-262771) filed on July 31, 2023.

60

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND
By:	/s/ Kenneth Kencel
Name:	Kenneth Kencel
Title:	Chief Executive Officer, President, Trustee and Chairman

By:	/s/ Shai Vichness
Name:	Shai Vichness
Title:	Chief Financial Officer and Treasurer

Date: November 1, 2023

61

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kenneth Kencel, Chief Executive Officer of Nuveen Churchill Private Capital Income Fund, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nuveen Churchill Private Capital Income Fund;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 1, 2023	By:	/s/ Kenneth Kencel
			Name: Kenneth Kencel
			Title: President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Shai Vichness, Chief Financial Officer of Nuveen Churchill Private Capital Income Fund, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Nuveen Churchill Private Capital Income Fund;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	November 1, 2023	By:	/s/ Shai Vichness
			Name: Shai Vichness
			Title: Chief Financial Officer and Treasurer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the quarterly report of Nuveen Churchill Private Capital Income Fund on Form 10-Q for the period ended September 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of Nuveen Churchill Private Capital Income Fund does hereby certify, to the best of such officer's knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Nuveen Churchill Private Capital Income Fund.

Date:	November 1, 2023
	/s/ Kenneth Kencel
	Name: Kenneth Kencel
	Title: President and Chief Executive Officer

Date:	November 1, 2023
	/s/ Shai Vichness
	Name: Shai Vichness
	Title: Chief Financial Officer and Treasurer

XML

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 01, 2023
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Securities Act File Number	001-04321
Entity Registrant Name	NUVEEN CHURCHILL PRIVATE CAPITAL INCOME FUND
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-6187397
Entity Address, Address Line One	375 Park Avenue, 9th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10152
City Area Code	212
Local Phone Number	478-9200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001911066
Amendment Flag	false
Class I Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		12,975,926
Class D Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		7,111
Class S Common Shares
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		40,634
Former Address
Class of Stock [Line Items]
Entity Address, Address Line One	430 Park Avenue, 14th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $451,244 and $352,998, respectively)	$ 451,194	$ 349,518
Cash and cash equivalents	6,344	65,785
Due from affiliate expense support (See Note 4)	2,853	2,215
Interest receivable	5,594	4,282
Receivable for investments sold	1,011	196
Prepaid expenses	71	29
Total assets	461,650	422,025
Liabilities
Secured borrowings (net of $551 and $647 deferred financing costs, respectively) (See Note 5)	120,199	154,353
Distributions payable	3,070	3,109
Payable for investments purchased	29,747	0
Interest payable	446	533
Due to affiliate expense support (See Note 4)	2,853	2,215
Board of Trustees' fees payable	128	128
Accounts payable and accrued expenses	1,924	1,386
Due to transfer agent	1,145	0
Total liabilities	159,512	161,724
Commitments and contingencies (See Note 6)
Net Assets: (See Note 7)
Common shares of beneficial interest, par value $0.01 per share, unlimited shares authorized, 12,279,387 and 10,540,040 Class I shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	123	105
Paid-in-capital in excess of par value	306,173	263,396
Total distributable earnings (loss)	(4,158)	(3,200)
Total net assets	302,138	260,301
Total liabilities and net assets	$ 461,650	$ 422,025
Net asset value per Class I share (in dollars per share)	$ 24.61	$ 24.70
Non-controlled/Non-affiliated
Investments
Non-controlled/non-affiliate company investments, at fair value (amortized cost of $451,244 and $352,998, respectively)	$ 445,777	$ 349,518

XML

CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Amortized cost	$ 456,661	$ 352,998
Deferred financing costs	$ 551	$ 647
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common shares, shares outstanding (in shares)	12,279,386
Class I Common Shares
Common shares, shares issued (in shares)	12,279,387	10,540,040
Common shares, shares outstanding (in shares)	12,279,387	10,540,040
Non-controlled/Non-affiliated
Amortized cost	$ 451,244	$ 352,998

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Investment income:
Payment-in-kind interest income	$ 573,000	$ 211,000	$ 450,000		$ 1,647,000
Dividend income	17,000	0	0		115,000
Other income	100,000	446,000	446,000		131,000
Expenses:
Organizational expenses	0	148,000	1,081,000	[1]	0
Interest and debt financing expenses	2,637,000	1,325,000	1,892,000	[1]	7,711,000
Interest expense on Note (See Note 4)	0	0	226,000	[1]	0
Professional fees	250,000	291,000	742,000	[1]	665,000
Management fees	547,000	0	0	[1]	712,000
Income based incentive fees	1,219,000	0	0	[1]	1,592,000
Board of Trustees’ fees	128,000	128,000	257,000	[1]	380,000
Administration fees	124,000	74,000	149,000	[1]	362,000
Other general and administrative expenses	326,000	71,000	129,000	[1]	588,000
Offering costs	187,000	78,000	118,000	[1]	468,000
Total expenses	5,418,000	2,115,000	4,594,000	[1]	12,478,000
Expense support	(212,000)	(245,000)	(1,422,000)	[1]	(541,000)
Management fees waived (Note 4)	(547,000)	0	0	[1]	(712,000)
Incentive fees waived (Note 4)	(1,219,000)	0	0	[1]	(1,592,000)
Net expenses	3,440,000	1,870,000	3,172,000	[1]	9,633,000
Net investment income (loss)	8,746,000	5,342,000	10,416,000	[2]	23,931,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments			(264,000)	[3]	685,000
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments			(2,262,000)	[3]	(1,987,000)
Net increase (decrease) in net assets resulting from operations	$ 9,065,000	$ 4,088,000	$ 7,890,000	[2]	$ 22,629,000
Per share data:
Net investment income per share - basic (in dollars per share)	$ 0.75	$ 0.51	$ 0.99	[1]	$ 2.18
Net investment income per share - diluted (in dollars per share)	0.75	0.51	0.99	[1]	2.18
Net increase (decrease) in net assets resulting from operations per share (in dollars per share)	$ 0.78	$ 0.39	$ 0.75	[1]	$ 2.06
Weighted average common shares outstanding - basic (in shares)	11,758,707	10,540,040	10,483,067	[1]	10,985,133
Weighted average common shares outstanding - diluted (in shares)	11,758,707	10,540,040	10,483,067	[1]	10,985,133
Non-controlled/Non-affiliated
Investment income:
Interest income	$ 11,496,000	$ 6,555,000	$ 12,692,000	[1]	$ 31,671,000
Payment-in-kind interest income	573,000	211,000	450,000	[1]	1,647,000
Dividend income	17,000	0	0	[1]	115,000
Other income	100,000	446,000	446,000	[1]	131,000
Total investment income	12,186,000	7,212,000	13,588,000	[1]	33,564,000
Realized and unrealized gain (loss) on investments:
Net realized gain (loss) on non-controlled/non-affiliated company investments	67,000	3,000	(264,000)	[1]	685,000
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments	252,000	(1,257,000)	(2,262,000)	[1]	(1,987,000)
Total net realized and unrealized gain (loss) on investments	$ 319,000	$ (1,254,000)	$ (2,526,000)	[1]	$ (1,302,000)

[1] Period from February 8, 2022 (inception) through September 30, 2022.

[2] Period from February 8, 2022 (inception) through September 30, 2022.

[3] Period from February 8, 2022 (inception) through September 30, 2022.

XML

CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended			8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022		Sep. 30, 2022		Sep. 30, 2023	Sep. 30, 2022	[1]
Increase (decrease) in net assets resulting from operations:
Net investment income (loss)	$ 8,746	$ 5,342		$ 10,416	[1]	$ 23,931
Net realized gain (loss) on investments	67	3		(264)	[1]	685
Net change in unrealized appreciation (depreciation) on investments	252	(1,257)		(2,262)	[1]	(1,987)
Net increase (decrease) in net assets resulting from operations	9,065	4,088		7,890	[1]	22,629
Shareholder Distributions:
Distribution declared from net investment income	(8,823)	(9,170)		(9,170)	[1]	(23,128)
Distribution declared from realized gains	(460)	0		0		(460)
Net increase (decrease) in net assets resulting from shareholder distributions	(9,283)	(9,170)		(9,170)	[1]	(23,588)
Capital share transactions:
Issuance of common shares, net	34,970	0		263,501	[1]	42,690
Reinvestment of shareholder distributions	106	0				106	$ 0
Net increase (decrease) in net assets resulting from capital share transactions - Class I	35,076	0		263,501	[1]	42,796
Total increase (decrease) in net assets	34,858	(5,082)		262,221	[1]	41,837
Net assets, at beginning of period	267,280	267,303		0	[1]	260,301
Net assets, at end of period	$ 302,138	$ 262,221	[1]	$ 262,221	[1]	$ 302,138	$ 262,221

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	8 Months Ended		9 Months Ended
	Sep. 30, 2022		Sep. 30, 2023
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 7,890	[1]	$ 22,629
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities
Purchase of investments	(55,661)	[2]	(120,285)
Proceeds from principal repayments and sales of investments	27,692	[2]	24,852
Payment-in-kind interest	(450)	[2]	(1,647)
Amortization of premium/accretion of discount, net	(325)	[2]	(607)
Net realized (gain) loss on investments	264	[2]	(685)
Net change in unrealized (appreciation) depreciation on investments	2,262	[2]	1,987
Amortization of deferred financing costs	0	[2]	122
Changes in operating assets and liabilities:
Due from affiliate expense support	(2,039)	[2]	(638)
Receivable for investments sold	(209)	[2]	(815)
Interest receivable	(4,640)	[2]	(1,186)
Prepaid expenses	(50)	[2]	(42)
Payable for investments purchased	0	[2]	29,747
Interest payable	287	[2]	(87)
Due to affiliate expense support	2,039	[2]	638
Board of Trustees' fees payable	128	[2]	0
Accounts payable and accrued expenses	720	[2]	538
Due to transfer agent	0	[2]	1,145
Net cash provided by (used in) operating activities	(22,092)	[2]	(44,334)
Cash flows from financing activities:
Proceeds from issuance of common shares	1	[2]	42,690
Proceeds from secured borrowings	125,000	[2]	54,250
Repayments of secured borrowings	(32,731)	[2]	(88,500)
Distributions paid	0	[2]	(23,521)
Payments of deferred financing costs	0	[2]	(26)
Net cash provided by (used in) financing activities	92,270	[2]	(15,107)
Net increase (decrease) in cash and cash equivalents	70,178	[2]	(59,441)
Cash and cash equivalents, beginning of period	0	[2]	65,785
Cash and cash equivalents, end of period	70,178	[2]	6,344
Supplemental information and non-cash activities:
Purchases of investments	(296,231)	[2]	0
Cash paid during the period for interest	1,796	[2]	7,676
Financing costs paid through expense support	373	[2]	0
Cash paid during the period for excise taxes	0	[2]	2
Issuance of Class I common shares, net	263,500	[2]	0
Reinvestment of Shareholder Distributions	$ 0	[2]	$ 106

[1] Period from February 8, 2022 (inception) through September 30, 2022.

[2] Period from February 8, 2022 (inception) through September 30, 2022.

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands		Sep. 30, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Cost		$ 456,661		$ 352,998
Fair Value		$ 451,194		$ 349,518
% of Net Assets		149.33%	[1]	134.27%	[2]
Debt Securities
Schedule of Investments [Line Items]
Cost		$ 442,457		$ 349,421
Fair Value		$ 436,449		$ 345,180
% of Net Assets		144.45%	[1]	132.60%	[2]
Equity Investments
Schedule of Investments [Line Items]
Cost		$ 8,787		$ 3,577
Fair Value		$ 9,328		$ 4,338
% of Net Assets		3.09%	[1]	1.67%	[2]
Cash Equivalents
Schedule of Investments [Line Items]
Cost	[3]	$ 5,417
Fair Value	[3]	$ 5,417
% of Net Assets	[1],[3]	1.79%
Aerospace & Defense | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 1,928
Fair Value		$ 1,929
% of Net Assets	[1]	0.64%
Aerospace & Defense | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,180
Fair Value		$ 1,180
% of Net Assets	[1]	0.39%
Automotive | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 4,899		$ 3,918
Fair Value		$ 4,897		$ 3,893
% of Net Assets		1.62%	[1]	1.50%	[2]
Banking, Finance, Insurance, Real Estate | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 4,839		$ 375
Fair Value		$ 4,725		$ 266
% of Net Assets		1.56%	[1]	0.10%	[2]
Beverage, Food & Tobacco | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 43,217		$ 43,357
Fair Value		$ 42,844		$ 43,015
% of Net Assets		14.18%	[1]	16.53%	[2]
Beverage, Food & Tobacco | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 980		$ 681
Fair Value		$ 1,194		$ 831
% of Net Assets		0.40%	[1]	0.32%	[2]
Capital Equipment | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 17,298		$ 6,891
Fair Value		$ 17,282		$ 6,937
% of Net Assets		5.72%	[1]	2.66%	[2]
Capital Equipment | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 160
Fair Value		$ 181
% of Net Assets	[1]	0.06%
Chemicals, Plastics, & Rubber | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 18,329		$ 14,083
Fair Value		$ 17,698		$ 13,976
% of Net Assets		5.86%	[1]	5.37%	[2]
Chemicals, Plastics, & Rubber | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 504		$ 504
Fair Value		$ 812		$ 980
% of Net Assets		0.27%	[1]	0.38%	[2]
Construction & Building | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 21,332		$ 15,713
Fair Value		$ 21,251		$ 15,568
% of Net Assets		7.03%	[1]	5.98%	[2]
Construction & Building | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 330		$ 212
Fair Value		$ 337		$ 219
% of Net Assets		0.11%	[1]	0.08%	[2]
Consumer Goods: Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 19,105		$ 15,875
Fair Value		$ 18,837		$ 15,653
% of Net Assets		6.23%	[1]	6.01%	[2]
Consumer Goods: Non-Durable | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 28,953		$ 26,344
Fair Value		$ 28,801		$ 26,157
% of Net Assets		9.53%	[1]	10.05%	[2]
Consumer Goods: Non-Durable | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 763		$ 228
Fair Value		$ 823		$ 263
% of Net Assets		0.27%	[1]	0.10%	[2]
Containers, Packaging & Glass | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 16,373		$ 16,335
Fair Value		$ 16,343		$ 16,303
% of Net Assets		5.41%	[1]	6.26%	[2]
Containers, Packaging & Glass | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 780		$ 719
Fair Value		$ 663		$ 774
% of Net Assets		0.22%	[1]	0.30%	[2]
Energy: Electricity | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 499
Fair Value		$ 497
% of Net Assets	[1]	0.16%
Energy: Oil & Gas | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 22,822		$ 21,951
Fair Value		$ 22,053		$ 21,275
% of Net Assets		7.30%	[1]	8.17%	[2]
Environmental Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 14,857		$ 7,734
Fair Value		$ 14,713		$ 7,661
% of Net Assets		4.87%	[1]	2.94%	[2]
Healthcare & Pharmaceuticals | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 34,080		$ 25,919
Fair Value		$ 33,664		$ 25,541
% of Net Assets		11.14%	[1]	9.81%	[2]
Healthcare & Pharmaceuticals | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 162
Fair Value		$ 179
% of Net Assets	[1]	0.06%
High Tech Industries | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 17,353		$ 9,449
Fair Value		$ 17,351		$ 9,414
% of Net Assets		5.74%	[1]	3.62%	[2]
High Tech Industries | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 119		$ 119
Fair Value		$ 237		$ 158
% of Net Assets		0.08%	[1]	0.06%	[2]
Hotel, Gaming & Leisure | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 1,249
Fair Value		$ 1,250
% of Net Assets	[1]	0.41%
Media: Advertising, Printing & Publishing | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 6,860		$ 6,906
Fair Value		$ 6,867		$ 6,916
% of Net Assets		2.27%	[1]	2.66%	[2]
Media: Broadcasting & Subscription | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,110
Fair Value		$ 3,095
% of Net Assets	[1]	1.02%
Metals and Mining | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 503
Fair Value		$ 500
% of Net Assets	[1]	0.17%
Services: Business | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 76,024		$ 59,479
Fair Value		$ 74,338		$ 58,583
% of Net Assets		24.60%	[1]	22.51%	[2]
Services: Business | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 2,057		$ 865
Fair Value		$ 1,889		$ 782
% of Net Assets		0.63%	[1]	0.30%	[2]
Services: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 32,736		$ 23,623
Fair Value		$ 32,037		$ 23,088
% of Net Assets		10.60%	[1]	8.87%	[2]
Services: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 1,396		$ 142
Fair Value		$ 1,352		$ 151
% of Net Assets		0.45%	[1]	0.06%	[2]
Sovereign & Public Finance | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 3,602		$ 3,617
Fair Value		$ 3,671		$ 3,607
% of Net Assets		1.22%	[1]	1.39%	[2]
Sovereign & Public Finance | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 107		$ 107
Fair Value		$ 217		$ 180
% of Net Assets		0.07%	[1]	0.07%	[2]
Telecommunications | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 7,844		$ 6,894
Fair Value		$ 7,403		$ 6,720
% of Net Assets		2.45%	[1]	2.58%	[2]
Transportation: Cargo | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 11,599		$ 10,902
Fair Value		$ 11,620		$ 10,901
% of Net Assets		3.85%	[1]	4.18%	[2]
Transportation: Consumer | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,816
Fair Value		$ 2,812
% of Net Assets	[1]	0.94%
Transportation: Consumer | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 137
Fair Value		$ 161
% of Net Assets	[1]	0.05%
Utilities: Electric | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 2,477
Fair Value		$ 2,465
% of Net Assets	[1]	0.82%
Utilities: Electric | Equity Investments
Schedule of Investments [Line Items]
Cost		$ 112
Fair Value		$ 103
% of Net Assets	[1]	0.03%
Wholesale | Debt Securities
Schedule of Investments [Line Items]
Cost		$ 27,753		$ 30,056
Fair Value		$ 27,506		$ 29,706
% of Net Assets		9.11%	[1]	11.41%	[2]
Investment, Identifier [Axis]: A Place for Mom, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	4.50%	[7],[8],[9],[10]
Interest Rate		9.82%	[4],[5],[6]	9.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,872	[4],[5]	$ 6,936	[7],[8],[9]
Cost		6,872	[4],[5]	6,936	[7],[8],[9]
Fair Value		$ 6,748	[4],[5]	$ 6,657	[7],[8],[9]
% of Net Assets		2.23%	[1],[4],[5]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[4],[5],[6],[11]	6.00%	[7],[8],[9],[10]
Interest Rate		11.47%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 4,953	[4],[5],[11]	$ 4,848	[7],[8],[9]
Cost		4,915	[4],[5],[11]	4,807	[7],[8],[9]
Fair Value		$ 4,634	[4],[5],[11]	$ 4,800	[7],[8],[9]
% of Net Assets		1.53%	[1],[4],[5],[11]	1.84%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[4],[5],[6],[11],[12]	6.00%	[7],[8],[9],[10],[13]
Interest Rate		11.47%	[4],[5],[6],[11],[12]	10.59%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 1,000	[4],[5],[11],[12]	$ 1,000	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (64)	[4],[5],[11],[12]	$ (10)	[7],[8],[9],[13]
% of Net Assets		(0.02%)	[1],[4],[5],[11],[12]	0.00%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[4],[5],[6],[11],[12]	6.00%	[7],[8],[9],[10],[13]
Interest Rate		11.47%	[4],[5],[6],[11],[12]	10.59%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 920	[4],[5],[11],[12]	$ 150	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (59)	[4],[5],[11],[12]	$ (1)	[7],[8],[9],[13]
% of Net Assets		(0.02%)	[1],[4],[5],[11],[12]	0.00%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) (Delayed Draw) 3
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[9],[10],[13]			6.00%
Interest Rate	[7],[8],[9],[10],[13]			10.59%
Par Amount / Unit	[7],[8],[9],[13]			$ 1,000
Cost	[7],[8],[9],[13]			0
Fair Value	[7],[8],[9],[13]			$ (10)
% of Net Assets	[2],[7],[8],[9],[13]			0.00%
Investment, Identifier [Axis]: ADPD Holdings, LLC (a/k/a NearU) 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 142	[5],[16],[17]	$ 142	[8],[14],[15]
Fair Value		$ 91	[5],[16],[17]	$ 151	[8],[14],[15]
% of Net Assets		0.03%	[1],[5],[16],[17]	0.06%	[2],[8],[14],[15]
Share / Unit		1,419	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: ALKU Intermediate Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.57%
Par Amount / Unit	[4],[5]	$ 2,718
Cost	[4],[5]	2,665
Fair Value	[4],[5]	$ 2,667
% of Net Assets	[1],[4],[5]	0.88%
Investment, Identifier [Axis]: AMC Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[10]			5.50%
Interest Rate	[7],[8],[10]			10.09%
Par Amount / Unit	[7],[8]			$ 6,947
Cost	[7],[8]			6,919
Fair Value	[7],[8]			$ 6,947
% of Net Assets	[2],[7],[8]			2.67%
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 137
Fair Value	[5],[16],[17]	$ 161
% of Net Assets	[1],[5],[16],[17]	0.05%
Share / Unit	[5],[16],[17]	160,609
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 2,221
Cost	[4],[5]	2,178
Fair Value	[4],[5]	$ 2,179
% of Net Assets	[1],[4],[5]	0.72%
Investment, Identifier [Axis]: Acclaim MidCo, LLC (dba ClaimLogiQ) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 891
Cost	[4],[5],[12]	(4)
Fair Value	[4],[5],[12]	$ (17)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Accupac, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.00%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		11.40%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,893	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,876	[4],[5],[11]	6,923	[7],[8],[9]
Fair Value		$ 6,666	[4],[5],[11]	$ 6,815	[7],[8],[9]
% of Net Assets		2.21%	[1],[4],[5],[11]	2.62%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Adient US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.25%
Interest Rate	[4],[6],[18],[19]	8.65%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	503
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Air Canada
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: AmSpec Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.15%	[4],[5],[6],[11]	10.52%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,891	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,891	[4],[5],[11]	6,946	[7],[8],[9]
Fair Value		$ 6,891	[4],[5],[11]	$ 6,945	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.67%	[2],[7],[8],[9]
Investment, Identifier [Axis]: American Student Transportaton Partners, Inc
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	10.00%
Interest Rate, PIK	[5],[6]	3.50%
Par Amount / Unit	[5]	$ 1,606
Cost	[5]	1,562
Fair Value	[5]	$ 1,562
% of Net Assets	[1],[5]	0.52%
Investment, Identifier [Axis]: Apex Services Partners, LLC (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 2,978	[4],[5],[11]	$ 3,000	[7],[8],[9]
Cost		2,968	[4],[5],[11]	2,987	[7],[8],[9]
Fair Value		$ 2,977	[4],[5],[11]	$ 2,981	[7],[8],[9]
% of Net Assets		0.99%	[1],[4],[5],[11]	1.14%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Apex Services Partners, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 2,978	[4],[5],[11]	$ 3,000	[7],[8],[9]
Cost		2,958	[4],[5],[11]	2,973	[7],[8],[9]
Fair Value		$ 2,977	[4],[5],[11]	$ 2,981	[7],[8],[9]
% of Net Assets		0.99%	[1],[4],[5],[11]	1.14%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Arise Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.25%	[4],[5],[6]	4.25%	[7],[8],[10]
Interest Rate		9.72%	[4],[5],[6]	8.84%	[7],[8],[10]
Par Amount / Unit		$ 6,893	[4],[5]	$ 6,946	[7],[8]
Cost		6,853	[4],[5]	6,894	[7],[8]
Fair Value		$ 6,414	[4],[5]	$ 6,720	[7],[8]
% of Net Assets		2.12%	[1],[4],[5]	2.58%	[2],[7],[8]
Investment, Identifier [Axis]: Arsenal AIC Parent LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	4.50%
Interest Rate	[4],[6],[18]	9.90%
Par Amount / Unit	[4],[18]	$ 500
Cost	[4],[18]	503
Fair Value	[4],[18]	$ 500
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: BPC Kodiak LLC (Turbine Engine Specialist, Inc) LLC Intrest
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[20]	$ 1,180
Fair Value	[5],[16],[17],[20]	$ 1,180
% of Net Assets	[1],[5],[16],[17],[20]	0.39%
Share / Unit	[5],[16],[17],[20]	1,180,000
Investment, Identifier [Axis]: Bakeovations Intermediate, LLC (d/b/a Commercial Bakeries)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[19],[21]	6.25%
Interest Rate	[4],[5],[6],[19],[21]	11.65%
Par Amount / Unit	[4],[5],[19],[21]	$ 4,246
Cost	[4],[5],[19],[21]	4,162
Fair Value	[4],[5],[19],[21]	$ 4,162
% of Net Assets	[1],[4],[5],[19],[21]	1.38%
Investment, Identifier [Axis]: Belron Finance US LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.43%
Interest Rate	[4],[6],[18],[19]	7.82%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10.00%
Interest Rate, PIK	[8],[10]			3.75%
Par Amount / Unit		$ 2,673	[5]	$ 2,649	[8]
Cost		2,627	[5]	2,597	[8]
Fair Value		$ 2,580	[5]	$ 2,598	[8]
% of Net Assets		0.85%	[1],[5]	1.00%	[2],[8]
Investment, Identifier [Axis]: BroadcastMed Holdco, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 655	[5],[16],[17]	$ 655	[8],[14],[15]
Fair Value		$ 600	[5],[16],[17]	$ 655	[8],[14],[15]
% of Net Assets		0.20%	[1],[5],[16],[17]	0.25%	[2],[8],[14],[15]
Share / Unit		43,679	[5],[16],[17]	44	[8],[14],[15]
Investment, Identifier [Axis]: Brown & Joseph, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		10.82%	[4],[5],[6]	10.34%	[7],[8],[10]
Par Amount / Unit		$ 6,639	[4],[5]	$ 6,945	[7],[8]
Cost		6,602	[4],[5]	6,896	[7],[8]
Fair Value		$ 6,639	[4],[5]	$ 6,920	[7],[8]
% of Net Assets	[2]	2.20%	[4],[5]	2.66%	[7],[8]
Investment, Identifier [Axis]: CDI AcquisitionCo, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.00%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		9.47%	[4],[5],[6]	9.28%	[7],[8],[10]
Par Amount / Unit		$ 6,729	[4],[5]	$ 6,865	[7],[8]
Cost		6,714	[4],[5]	6,840	[7],[8]
Fair Value		$ 6,729	[4],[5]	$ 6,827	[7],[8]
% of Net Assets		2.22%	[1],[4],[5]	2.62%	[2],[7],[8]
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc.
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	9.00%
Interest Rate, PIK	[5],[6]	4.00%
Par Amount / Unit	[5]	$ 642
Cost	[5]	625
Fair Value	[5]	$ 625
% of Net Assets	[1],[5]	0.21%
Investment, Identifier [Axis]: COP Exterminators Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Interest Rate	[5],[6],[12]	9.00%
Interest Rate, PIK	[5],[6],[12]	4.00%
Par Amount / Unit	[5],[12]	$ 503
Cost	[5],[12]	(7)
Fair Value	[5],[12]	$ (14)
% of Net Assets	[1],[5],[12]	0.00%
Investment, Identifier [Axis]: COP Exterminators Investment, LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 862
Fair Value	[5],[16],[17]	$ 862
% of Net Assets	[1],[5],[16],[17]	0.29%
Share / Unit	[5],[16],[17]	770,000
Investment, Identifier [Axis]: CV Holdco, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost	[8],[14],[15]			$ 102
Fair Value	[8],[14],[15]			$ 49
% of Net Assets	[2],[8],[14],[15]			0.02%
Share / Unit	[8],[14],[15]			1
Investment, Identifier [Axis]: CV Intermediate Holdco Corp.
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6]	11.00%	[8],[10]
Par Amount / Unit		$ 10,000	[5]	$ 10,000	[8]
Cost		9,875	[5]	9,848	[8]
Fair Value		$ 9,123	[5]	$ 9,333	[8]
% of Net Assets		3.02%	[1],[5]	3.59%	[2],[8]
Investment, Identifier [Axis]: Chroma Color Corporation (dba "Chroma Color)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 1,749
Cost	[4],[5]	1,715
Fair Value	[4],[5]	$ 1,716
% of Net Assets	[1],[4],[5]	0.57%
Investment, Identifier [Axis]: Chroma Color Corporation (dba "Chroma Color) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	5.75%
Interest Rate	[4],[5],[6],[12]	11.15%
Par Amount / Unit	[4],[5],[12]	$ 381
Cost	[4],[5],[12]	(4)
Fair Value	[4],[5],[12]	$ (7)
% of Net Assets	[1],[4],[5],[12]	0.00%
Investment, Identifier [Axis]: Cinemark USA Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 499
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Clarios Global LP (f/k/a Johnson Controls Inc)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.75%
Interest Rate	[4],[6],[18],[19],[21]	9.15%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	502
Fair Value	[4],[18],[19],[21]	$ 500
% of Net Assets	[1],[4],[18],[19],[21]	0.17%
Investment, Identifier [Axis]: Class Valuation
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6]	11.00%	[8],[10]
Par Amount / Unit		$ 444	[5]	$ 444	[8]
Cost		437	[5]	436	[8]
Fair Value		$ 405	[5]	$ 415	[8]
% of Net Assets		0.13%	[1],[5]	0.16%	[2],[8]
Investment, Identifier [Axis]: Class Valuation 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 105
Fair Value	[5],[16],[17]	$ 28
% of Net Assets	[1],[5],[16],[17]	0.01%
Share / Unit	[5],[16],[17]	1,038
Investment, Identifier [Axis]: Cold Spring Brewing Company
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.07%	[4],[5],[6]	9.11%	[7],[8],[10]
Par Amount / Unit		$ 6,288	[4],[5]	$ 6,805	[7],[8]
Cost		6,287	[4],[5]	6,805	[7],[8]
Fair Value		$ 6,287	[4],[5]	$ 6,804	[7],[8]
% of Net Assets		2.08%	[1],[4],[5]	2.61%	[2],[7],[8]
Investment, Identifier [Axis]: Copeland (Emerson Climate Technologies)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	3.00%
Interest Rate	[4],[6],[18]	8.32%
Par Amount / Unit	[4],[18]	$ 750
Cost	[4],[18]	753
Fair Value	[4],[18]	$ 750
% of Net Assets	[1],[4],[18]	0.25%
Investment, Identifier [Axis]: Covanta Holding Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 35
Cost	[4],[18],[19]	35
Fair Value	[4],[18],[19]	$ 35
% of Net Assets	[1],[4],[18],[19]	0.01%
Investment, Identifier [Axis]: Covanta Holding Corp 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 464
Cost	[4],[18],[19]	464
Fair Value	[4],[18],[19]	$ 462
% of Net Assets	[1],[4],[18],[19]	0.15%
Investment, Identifier [Axis]: CrossCountry Consulting
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.07%	[4],[5],[6],[11]	10.34%	[7],[8],[9],[10]
Par Amount / Unit		$ 1,383	[4],[5],[11]	$ 1,393	[7],[8],[9]
Cost		1,359	[4],[5],[11]	1,367	[7],[8],[9]
Fair Value		$ 1,383	[4],[5],[11]	$ 1,376	[7],[8],[9]
% of Net Assets		0.45%	[1],[4],[5],[11]	0.53%	[2],[7],[8],[9]
Investment, Identifier [Axis]: CrossCountry Consulting (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6],[11],[12]	5.75%	[8],[9],[10],[13]
Interest Rate		11.07%	[5],[6],[11],[12]	10.34%	[8],[9],[10],[13]
Par Amount / Unit		$ 560	[5],[11],[12]	$ 560	[8],[9],[13]
Cost		(5)	[5],[11],[12]	(5)	[8],[9],[13]
Fair Value		$ 0	[5],[11],[12]	$ (7)	[8],[9],[13]
% of Net Assets		0.00%	[1],[5],[11],[12]	0.00%	[2],[8],[9],[13]
Investment, Identifier [Axis]: DIRECTV (AKA DIRECTV Financing LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	5.00%
Interest Rate	[4],[6],[18],[19]	10.40%
Par Amount / Unit	[4],[18],[19]	$ 389
Cost	[4],[18],[19]	386
Fair Value	[4],[18],[19]	$ 381
% of Net Assets	[1],[4],[18],[19]	0.13%
Investment, Identifier [Axis]: Delta 2 (Lux) (Formula One) T/L B (09/23)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.25%
Interest Rate	[4],[6],[18],[19],[21]	8.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 750
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 751
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	4.25%	[7],[8],[10]
Interest Rate		10.57%	[4],[5],[6]	8.64%	[7],[8],[10]
Par Amount / Unit		$ 3,447	[4],[5]	$ 3,473	[7],[8]
Cost		3,447	[4],[5]	3,473	[7],[8]
Fair Value		$ 3,447	[4],[5]	$ 3,473	[7],[8]
% of Net Assets		1.14%	[1],[4],[5]	1.33%	[2],[7],[8]
Investment, Identifier [Axis]: Dresser Utility Solutions, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.57%	[4],[5],[6]	9.64%	[7],[8],[10]
Par Amount / Unit		$ 3,446	[4],[5]	$ 3,473	[7],[8]
Cost		3,413	[4],[5]	3,429	[7],[8]
Fair Value		$ 3,409	[4],[5]	$ 3,399	[7],[8]
% of Net Assets		1.13%	[1],[4],[5]	1.30%	[2],[7],[8]
Investment, Identifier [Axis]: EFC Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[5],[6]	11.00%
Interest Rate, PIK	[5],[6]	2.50%
Par Amount / Unit	[5],[12]	$ 2,420
Cost	[5],[12]	2,354
Fair Value	[5],[12]	$ 2,375
% of Net Assets	[1],[5],[12]	0.79%
Investment, Identifier [Axis]: EFC Holdings, LLC 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 114
Fair Value	[5],[16],[17],[19]	$ 119
% of Net Assets	[1],[5],[16],[17],[19]	0.04%
Share / Unit	[5],[16],[17],[19]	114
Investment, Identifier [Axis]: EFC Holdings, LLC 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 46
Fair Value	[5],[16],[17],[19]	$ 62
% of Net Assets	[1],[5],[16],[17],[19]	0.02%
Share / Unit	[5],[16],[17],[19]	114
Investment, Identifier [Axis]: Elevation Labs
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.15%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 1,305	[4],[5]	$ 1,315	[7],[8]
Cost		1,294	[4],[5]	1,303	[7],[8]
Fair Value		$ 1,260	[4],[5]	$ 1,301	[7],[8]
% of Net Assets		0.42%	[1],[4],[5]	0.50%	[2],[7],[8]
Investment, Identifier [Axis]: Elevation Labs (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[12]	5.25%	[7],[8],[10],[13]
Interest Rate		11.15%	[4],[5],[6],[12]	9.84%	[7],[8],[10],[13]
Par Amount / Unit		$ 599	[4],[5],[12]	$ 599	[7],[8],[13]
Cost		(2)	[4],[5],[12]	(3)	[7],[8],[13]
Fair Value		$ (21)	[4],[5],[12]	$ (6)	[7],[8],[13]
% of Net Assets		(0.01%)	[1],[4],[5],[12]	0.00%	[2],[7],[8],[13]
Investment, Identifier [Axis]: Evergreen Services Group
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6.00%	[7],[8],[9],[10]
Interest Rate		11.65%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 4,037	[4],[5],[11]	$ 4,068	[7],[8],[9]
Cost		3,967	[4],[5],[11]	3,991	[7],[8],[9]
Fair Value		$ 3,921	[4],[5],[11]	$ 3,971	[7],[8],[9]
% of Net Assets		1.30%	[1],[4],[5],[11]	1.52%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Evergreen Services Group (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6.00%	[7],[8],[9],[10],[13]
Interest Rate		11.65%	[4],[5],[6],[11]	10.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 966	[4],[5],[11]	$ 970	[7],[8],[9]
Cost		957	[4],[5],[11]	694	[7],[8],[9]
Fair Value		$ 938	[4],[5],[11]	$ 680	[7],[8],[9]
% of Net Assets		0.31%	[1],[4],[5],[11]	0.26%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Excel Fitness
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 5,940	[4],[5]	$ 5,985	[7],[8]
Cost		5,880	[4],[5]	5,920	[7],[8]
Fair Value		$ 5,735	[4],[5]	$ 5,690	[7],[8]
% of Net Assets		1.90%	[1],[4],[5]	2.19%	[2],[7],[8]
Investment, Identifier [Axis]: FCP-Cranium Holdings P/S A
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 0
Fair Value	[5],[16],[17],[19],[21]	$ 0
% of Net Assets	[1],[5],[16],[17],[19],[21]	0.00%
Share / Unit	[5],[16],[17],[19],[21]	375
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs)
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 389
Fair Value	[5],[16],[17],[19],[21]	$ 400
% of Net Assets	[1],[5],[16],[17],[19],[21]	0.13%
Share / Unit	[5],[16],[17],[19],[21]	1,026
Investment, Identifier [Axis]: FCP-Cranium Holdings, LLC (Brain labs) 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19],[21]	$ 600
Fair Value	[5],[16],[17],[19],[21]	$ 600
% of Net Assets	[1],[5],[16],[17],[19],[21]	0.20%
Share / Unit	[5],[16],[17],[19],[21]	375
Investment, Identifier [Axis]: FSK Pallet Holding Corp. (DBA Kamps Pallets)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.00%	[7],[8],[10]
Interest Rate		10.90%	[4],[5],[6]	9.77%	[7],[8],[10]
Par Amount / Unit		$ 5,940	[4],[5]	$ 5,985	[7],[8]
Cost		5,843	[4],[5]	5,870	[7],[8]
Fair Value		$ 5,774	[4],[5]	$ 5,869	[7],[8]
% of Net Assets		1.91%	[1],[4],[5]	2.25%	[2],[7],[8]
Investment, Identifier [Axis]: Fortune International, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.15%	[4],[5],[6]	9.52%	[7],[8],[10]
Par Amount / Unit		$ 6,896	[4],[5]	$ 6,948	[7],[8]
Cost		6,853	[4],[5]	6,891	[7],[8]
Fair Value		$ 6,805	[4],[5]	$ 6,802	[7],[8]
% of Net Assets		2.25%	[1],[4],[5]	2.61%	[2],[7],[8]
Investment, Identifier [Axis]: Freedom U.S. Acquisition Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		9.90%	[4],[5],[6]	9.27%	[7],[8],[10]
Par Amount / Unit		$ 7,000	[4],[5]	$ 7,000	[7],[8]
Cost		7,000	[4],[5]	7,000	[7],[8]
Fair Value		$ 6,974	[4],[5]	$ 6,955	[7],[8]
% of Net Assets		2.31%	[1],[4],[5]	2.67%	[2],[7],[8]
Investment, Identifier [Axis]: Fresh Edge
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.50%	[4],[5],[6]	9.00%	[8],[10]
Interest Rate		15.09%	[4],[5],[6]	13.36%	[8],[10]
Interest Rate, PIK	[4],[5],[6]	5.125%
Par Amount / Unit		$ 2,916	[4],[5]	$ 2,890	[8]
Cost		2,848	[4],[5]	2,820	[8]
Fair Value		$ 2,833	[4],[5]	$ 2,820	[8]
% of Net Assets		0.94%	[1],[4],[5]	1.08%	[2],[8]
Investment, Identifier [Axis]: Fresh Edge - Common
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 0
Fair Value	[5],[16],[17]	$ 0
% of Net Assets	[1],[5],[16],[17]	0.00%
Share / Unit	[5],[16],[17]	454
Investment, Identifier [Axis]: Fresh Edge - Preferred
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 454
Fair Value	[5],[16],[17]	$ 413
% of Net Assets	[1],[5],[16],[17]	0.14%
Share / Unit	[5],[16],[17]	454
Investment, Identifier [Axis]: Fresh Edge 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost	[8],[14],[15]			$ 454
Fair Value	[8],[14],[15]			$ 454
% of Net Assets	[2],[8],[14],[15]			0.17%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: Fresh Edge 2
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost	[8],[14],[15]			$ 0
Fair Value	[8],[14],[15]			$ 0
% of Net Assets	[2],[8],[14],[15]			0.00%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: GFL Environmental T/L (1/23)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: GTCR W Merger Sub LLC (Worldpay)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 340
Cost	[4],[18],[19]	338
Fair Value	[4],[18],[19]	$ 340
% of Net Assets	[1],[4],[18],[19]	0.11%
Investment, Identifier [Axis]: Gannett Fleming
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.60%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		12.00%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 1,985	[4],[5]	$ 2,000	[7],[8]
Cost		1,949	[4],[5]	1,960	[7],[8]
Fair Value		$ 1,970	[4],[5]	$ 1,960	[7],[8]
% of Net Assets		0.65%	[1],[4],[5]	0.76%	[2],[7],[8]
Investment, Identifier [Axis]: Gannett Fleming 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 85	[5],[16],[17],[20]	$ 85	[8],[14],[15]
Fair Value		$ 99	[5],[16],[17],[20]	$ 85	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17],[20]	0.03%	[2],[8],[14],[15]
Share / Unit		84,949	[5],[16],[17],[20]	85	[8],[14],[15]
Investment, Identifier [Axis]: Gannett Fleming 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 118
Fair Value	[5],[16],[17]	$ 133
% of Net Assets	[1],[5],[16],[17]	0.04%
Share / Unit	[5],[16],[17]	113,901
Investment, Identifier [Axis]: GenServe LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11]	5.25%	[7],[8],[9],[10]
Interest Rate		11.22%	[4],[5],[6],[11]	9.84%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,873	[4],[5],[11]	6,891	[7],[8],[9]
Fair Value		$ 6,800	[4],[5],[11]	$ 6,937	[7],[8],[9]
% of Net Assets		2.25%	[1],[4],[5],[11]	2.66%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Getty Images Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	4.50%
Interest Rate	[4],[6],[18]	9.90%
Par Amount / Unit	[4],[18]	$ 498
Cost	[4],[18]	500
Fair Value	[4],[18]	$ 500
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: Gray Television, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	498
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Grifols Worldwide Operations LTD
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.00%
Interest Rate	[4],[6],[18],[19],[21]	7.40%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	496
Fair Value	[4],[18],[19],[21]	$ 492
% of Net Assets	[1],[4],[18],[19],[21]	0.16%
Investment, Identifier [Axis]: Harvest Hill Beverage Company
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	9.00%
Interest Rate	[5],[6]	14.32%
Par Amount / Unit	[5]	$ 2,800
Cost	[5]	2,721
Fair Value	[5]	$ 2,748
% of Net Assets	[1],[5]	0.91%
Investment, Identifier [Axis]: Hayward Industries, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	495
Fair Value	[4],[18],[19]	$ 496
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Health Management Associates
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 3,430
Cost	[4],[5]	3,365
Fair Value	[4],[5]	$ 3,399
% of Net Assets	[1],[4],[5]	1.12%
Investment, Identifier [Axis]: Health Management Associates (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 611
Cost	[4],[5],[12]	183
Fair Value	[4],[5],[12]	$ 190
% of Net Assets	[1],[4],[5],[12]	0.06%
Investment, Identifier [Axis]: Health Management Associates 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 162
Fair Value	[5],[16],[17]	$ 179
% of Net Assets	[1],[5],[16],[17]	0.06%
Share / Unit	[5],[16],[17]	161,953
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[5],[6]	7.50%	[8],[10]
Interest Rate		12.82%	[5],[6]	12.09%	[8],[10]
Par Amount / Unit		$ 1,000	[5]	$ 1,000	[8]
Cost		984	[5]	982	[8]
Fair Value		$ 978	[5]	$ 980	[8]
% of Net Assets		0.33%	[1],[5]	0.38%	[2],[8]
Investment, Identifier [Axis]: Heartland Veterinary Partners LLC (Incremental) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		7.50%	[5],[6],[12]	7.50%	[8],[10],[13]
Interest Rate		12.82%	[5],[6],[12]	12.09%	[8],[10],[13]
Par Amount / Unit		$ 5,000	[5],[12]	$ 5,000	[8],[13]
Cost		2,790	[5],[12]	0	[8],[13]
Fair Value		$ 2,680	[5],[12]	$ (100)	[8],[13]
% of Net Assets		0.89%	[1],[5],[12]	(0.04%)	[2],[8],[13]
Investment, Identifier [Axis]: Hyphen Solutions, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	9.89%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,855	[4],[5],[11]	6,898	[7],[8],[9]
Fair Value		$ 6,688	[4],[5],[11]	$ 6,804	[7],[8],[9]
% of Net Assets		2.21%	[1],[4],[5],[11]	2.61%	[2],[7],[8],[9]
Investment, Identifier [Axis]: ICON Publishing Ltd
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 92
Cost	[4],[18],[19]	92
Fair Value	[4],[18],[19]	$ 92
% of Net Assets	[1],[4],[18],[19]	0.03%
Investment, Identifier [Axis]: ICON Publishing Ltd 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.25%
Interest Rate	[4],[6],[18],[19],[21]	7.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 369
Cost	[4],[18],[19],[21]	370
Fair Value	[4],[18],[19],[21]	$ 369
% of Net Assets	[1],[4],[18],[19],[21]	0.12%
Investment, Identifier [Axis]: II-VI Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: INEOS US Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: INEOS US Petrochem LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 4,595
Cost	[4],[5]	4,513
Fair Value	[4],[5]	$ 4,557
% of Net Assets	[1],[4],[5]	1.51%
Investment, Identifier [Axis]: INS Intermediate II, LLC (Ergotech Controls, Inc. – d/b/a INS) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 1,139
Cost	[4],[5],[12]	(20)
Fair Value	[4],[5],[12]	$ (9)
% of Net Assets	[1],[4],[5],[12]	0.00%
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	10.61%	[7],[8],[10]
Par Amount / Unit		$ 2,460	[4],[5]	$ 2,479	[7],[8]
Cost		2,415	[4],[5]	2,429	[7],[8]
Fair Value		$ 2,440	[4],[5]	$ 2,429	[7],[8]
% of Net Assets		0.81%	[1],[4],[5]	0.93%	[2],[7],[8]
Investment, Identifier [Axis]: ISG Merger Sub, LLC (dba Industrial Service Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[12]	6.25%	[7],[8],[10],[13]
Interest Rate		11.65%	[4],[5],[6],[12]	10.61%	[7],[8],[10],[13]
Par Amount / Unit		$ 1,281	[4],[5],[12]	$ 1,282	[7],[8],[13]
Cost		509	[4],[5],[12]	(6)	[7],[8],[13]
Fair Value		$ 505	[4],[5],[12]	$ (25)	[7],[8],[13]
% of Net Assets		0.17%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: ITSavvy LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 1,780	[4],[5]	$ 1,793	[7],[8]
Cost		1,765	[4],[5]	1,776	[7],[8]
Fair Value		$ 1,780	[4],[5]	$ 1,793	[7],[8]
% of Net Assets		0.59%	[1],[4],[5]	0.69%	[2],[7],[8]
Investment, Identifier [Axis]: ITSavvy LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12]	5.25%	[8],[10],[13]
Interest Rate		10.90%	[5],[6],[12]	9.84%	[8],[10],[13]
Par Amount / Unit		$ 335	[5],[12]	$ 480	[8],[13]
Cost		296	[5],[12]	(5)	[8],[13]
Fair Value		$ 299	[5],[12]	$ 0	[8],[13]
% of Net Assets		0.10%	[1],[5],[12]	0.00%	[2],[8],[13]
Investment, Identifier [Axis]: ITSavvy LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 119	[5],[16],[17]	$ 119	[8],[14],[15]
Fair Value		$ 237	[5],[16],[17]	$ 158	[8],[14],[15]
% of Net Assets		0.08%	[1],[5],[16],[17]	0.06%	[2],[8],[14],[15]
Share / Unit		119	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: Image International Intermediate Holdco II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	10.27%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,992	[4],[5],[11]	$ 6,992	[7],[8],[9]
Cost		6,958	[4],[5],[11]	6,950	[7],[8],[9]
Fair Value		$ 6,868	[4],[5],[11]	$ 6,873	[7],[8],[9]
% of Net Assets		2.27%	[1],[4],[5],[11]	2.64%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.00%
Interest Rate	[4],[5],[6]	11.47%
Par Amount / Unit	[4],[5]	$ 2,081
Cost	[4],[5]	2,040
Fair Value	[4],[5]	$ 2,043
% of Net Assets	[1],[4],[5]	0.68%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.00%
Interest Rate	[4],[5],[6],[12]	11.47%
Par Amount / Unit	[4],[5],[12]	$ 972
Cost	[4],[5],[12]	851
Fair Value	[4],[5],[12]	$ 838
% of Net Assets	[1],[4],[5],[12]	0.28%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.00%
Interest Rate	[4],[5],[6]	11.47%
Par Amount / Unit	[4],[5]	$ 427
Cost	[4],[5]	418
Fair Value	[4],[5]	$ 419
% of Net Assets	[1],[4],[5]	0.13%
Investment, Identifier [Axis]: Impact Parent Corporation (d/b/a Impact Environmental Group) (Second Amendment Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.00%
Interest Rate	[4],[5],[6],[12]	11.47%
Par Amount / Unit	[4],[5],[12]	$ 1,716
Cost	[4],[5],[12]	(8)
Fair Value	[4],[5],[12]	$ (31)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Infinite Bidco LLC (Infinite Electronics) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	6.25%
Interest Rate	[4],[5],[6],[11]	11.72%
Par Amount / Unit	[4],[5],[11]	$ 1,972
Cost	[4],[5],[11]	1,919
Fair Value	[4],[5],[11]	$ 1,920
% of Net Assets	[1],[4],[5],[11]	0.64%
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.50%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	10.09%	[7],[8],[10]
Par Amount / Unit		$ 733	[4],[5]	$ 738	[7],[8]
Cost		727	[4],[5]	731	[7],[8]
Fair Value		$ 725	[4],[5]	$ 729	[7],[8]
% of Net Assets		0.24%	[1],[4],[5]	0.28%	[2],[7],[8]
Investment, Identifier [Axis]: Infobase Acquisition, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[5],[6],[12]	5.50%	[8],[10],[13]
Interest Rate		10.97%	[5],[6],[12]	10.09%	[8],[10],[13]
Par Amount / Unit		$ 122	[5],[12]	$ 122	[8],[13]
Cost		0	[5],[12]	0	[8],[13]
Fair Value		$ (1)	[5],[12]	$ (2)	[8],[13]
% of Net Assets		0.00%	[1],[5],[12]	0.00%	[2],[8],[13]
Investment, Identifier [Axis]: Informatica LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	752
Fair Value	[4],[18],[19]	$ 747
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Ingram Micro T/L (09/23) TARGET FACILITY
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Instructure Holdings Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Intelsat Jackson Holdings S.A.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	4.25%
Interest Rate	[4],[6],[18],[19],[21]	9.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 488
Cost	[4],[18],[19],[21]	489
Fair Value	[4],[18],[19],[21]	$ 488
% of Net Assets	[1],[4],[18],[19],[21]	0.16%
Investment, Identifier [Axis]: Iridium Satellite LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Jazz Pharmaceuticals plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.50%
Interest Rate	[4],[6],[18],[19],[21]	8.90%
Par Amount / Unit	[4],[18],[19],[21]	$ 748
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 748
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: KRIV Acquisition, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 5,221
Cost	[4],[5]	5,078
Fair Value	[4],[5]	$ 5,068
% of Net Assets	[1],[4],[5]	1.68%
Investment, Identifier [Axis]: KRIV Acquisition, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 779
Cost	[4],[5],[12]	(10)
Fair Value	[4],[5],[12]	$ (23)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: KRIV Acquisition, Inc 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 200
Fair Value	[5],[16],[17]	$ 200
% of Net Assets	[1],[5],[16],[17]	0.07%
Share / Unit	[5],[16],[17]	200
Investment, Identifier [Axis]: Kenco Group, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6]	5.50%	[7],[8],[10]
Interest Rate		10.40%	[4],[5],[6]	10.09%	[7],[8],[10]
Par Amount / Unit		$ 5,112	[4],[5]	$ 5,150	[7],[8]
Cost		5,020	[4],[5]	5,049	[7],[8]
Fair Value		$ 5,099	[4],[5]	$ 5,049	[7],[8]
% of Net Assets		1.69%	[1],[4],[5]	1.94%	[2],[7],[8]
Investment, Identifier [Axis]: Kenco Group, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6],[12]	5.50%	[7],[8],[10],[13]
Interest Rate		10.40%	[4],[5],[6],[12]	10.09%	[7],[8],[10],[13]
Par Amount / Unit		$ 850	[4],[5],[12]	$ 850	[7],[8],[13]
Cost		(15)	[4],[5],[12]	(17)	[7],[8],[13]
Fair Value		$ (2)	[4],[5],[12]	$ (17)	[7],[8],[13]
% of Net Assets		0.00%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	6.25%
Interest Rate	[4],[5],[6],[11]	11.65%
Par Amount / Unit	[4],[5],[11]	$ 2,431
Cost	[4],[5],[11]	2,395
Fair Value	[4],[5],[11]	$ 2,396
% of Net Assets	[1],[4],[5],[11]	0.79%
Investment, Identifier [Axis]: Keng Acquisition, Inc. (Engage Group Holdings, LLC) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11],[12]	6.25%
Interest Rate	[4],[5],[6],[11],[12]	11.65%
Par Amount / Unit	[4],[5],[11],[12]	$ 2,342
Cost	[4],[5],[11],[12]	296
Fair Value	[4],[5],[11],[12]	$ 269
% of Net Assets	[1],[4],[5],[11],[12]	0.09%
Investment, Identifier [Axis]: Kofile, Inc.
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6]	10.00%	[8],[10]
Interest Rate, PIK		1.75%	[5],[6]	1.75%	[8],[10]
Par Amount / Unit		$ 10,263	[5]	$ 10,128	[8]
Cost		10,263	[5]	10,128	[8]
Fair Value		$ 9,629	[5]	$ 9,987	[8]
% of Net Assets		3.19%	[1],[5]	3.84%	[2],[8]
Investment, Identifier [Axis]: Kofile, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost	[8],[14],[15]			$ 108
Fair Value	[8],[14],[15]			$ 78
% of Net Assets	[2],[8],[14],[15]			0.03%
Share / Unit	[8],[14],[15]			0
Investment, Identifier [Axis]: Kofile, Inc. 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 108
Fair Value	[5],[16],[17]	$ 61
% of Net Assets	[1],[5],[16],[17]	0.02%
Share / Unit	[5],[16],[17]	100
Investment, Identifier [Axis]: Kraton Polymers LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.25%
Interest Rate	[4],[6],[18],[19]	8.65%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	493
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		11.90%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 736	[4],[5]	$ 742	[7],[8]
Cost		724	[4],[5]	728	[7],[8]
Fair Value		$ 731	[4],[5]	$ 718	[7],[8]
% of Net Assets		0.24%	[1],[4],[5]	0.28%	[2],[7],[8]
Investment, Identifier [Axis]: LMI Consulting, LLC (LMI) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6]	6.50%	[7],[8],[10]
Interest Rate		11.90%	[4],[5],[6]	11.09%	[7],[8],[10]
Par Amount / Unit		$ 2,963	[4],[5]	$ 2,985	[7],[8]
Cost		2,878	[4],[5]	2,889	[7],[8]
Fair Value		$ 2,940	[4],[5]	$ 2,889	[7],[8]
% of Net Assets		0.98%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: LMI Renaissance
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 107	[5],[16],[17]	$ 107	[8],[14],[15]
Fair Value		$ 217	[5],[16],[17]	$ 180	[8],[14],[15]
% of Net Assets		0.07%	[1],[5],[16],[17]	0.07%	[2],[8],[14],[15]
Share / Unit		106,984	[5],[16],[17]	107	[8],[14],[15]
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.90%
Par Amount / Unit	[4],[5]	$ 4,075
Cost	[4],[5]	4,001
Fair Value	[4],[5]	$ 4,001
% of Net Assets	[1],[4],[5]	1.32%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.90%
Par Amount / Unit	[4],[5],[12]	$ 1,898
Cost	[4],[5],[12]	1,410
Fair Value	[4],[5],[12]	$ 1,384
% of Net Assets	[1],[4],[5],[12]	0.46%
Investment, Identifier [Axis]: Legacy Service Partners, LLC (“LSP”) 1
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 196
Fair Value	[5],[16],[17]	$ 203
% of Net Assets	[1],[5],[16],[17]	0.07%
Share / Unit	[5],[16],[17]	1,963
Investment, Identifier [Axis]: MEI Rigging & Crating
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.50%
Interest Rate	[4],[5],[6]	11.82%
Par Amount / Unit	[4],[5]	$ 3,166
Cost	[4],[5]	3,103
Fair Value	[4],[5]	$ 3,105
% of Net Assets	[1],[4],[5]	1.03%
Investment, Identifier [Axis]: MEI Rigging & Crating (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.50%
Interest Rate	[4],[5],[6],[12]	11.82%
Par Amount / Unit	[4],[5],[12]	$ 501
Cost	[4],[5],[12]	(2)
Fair Value	[4],[5],[12]	$ (10)
% of Net Assets	[1],[4],[5],[12]	0.00%
Investment, Identifier [Axis]: MKS Instruments Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 499
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Marco APE Opco Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10.50%
Interest Rate, PIK	[8],[10]	15.00%		4.25%
Par Amount / Unit		$ 9,523	[5]	$ 8,633	[8]
Cost		9,071	[5]	8,103	[8]
Fair Value		$ 8,306	[5]	$ 7,458	[8]
% of Net Assets		2.75%	[1],[5]	2.87%	[2],[8]
Investment, Identifier [Axis]: Marlin Coinvest LP
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 200
Fair Value	[5],[16],[17]	$ 456
% of Net Assets	[1],[5],[16],[17]	0.15%
Share / Unit	[5],[16],[17]	200,000
Investment, Identifier [Axis]: Messer Industries GmbH
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 498
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Mr. Greens
Schedule of Investments [Line Items]
Interest Rate	[8],[10]			10.00%
Interest Rate, PIK	[8],[10]			2.00%
Par Amount / Unit	[8]			$ 10,153
Cost	[8]			9,807
Fair Value	[8]			$ 10,153
% of Net Assets	[2],[8]			3.90%
Investment, Identifier [Axis]: Mr. Greens 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost	[8],[14],[15]			$ 101
Fair Value	[8],[14],[15]			$ 276
% of Net Assets	[2],[8],[14],[15]			0.11%
Share / Unit	[8],[14],[15]			1
Investment, Identifier [Axis]: NCR Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	501
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: NMC Skincare Intermediate Holdings II, LLC (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6],[11]	5.00%	[7],[8],[9],[10]
Interest Rate		10.32%	[4],[5],[6],[11]	9.77%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,892	[4],[5],[11]	$ 6,946	[7],[8],[9]
Cost		6,834	[4],[5],[11]	6,849	[7],[8],[9]
Fair Value		$ 6,606	[4],[5],[11]	$ 6,672	[7],[8],[9]
% of Net Assets		2.19%	[1],[4],[5],[11]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New Era Technology, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6],[11]	6.25%	[7],[8],[9],[10]
Interest Rate		11.65%	[4],[5],[6],[11]	11.02%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,741	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,720	[4],[5],[11]	6,919	[7],[8],[9]
Fair Value		$ 6,553	[4],[5],[11]	$ 6,650	[7],[8],[9]
% of Net Assets		2.17%	[1],[4],[5],[11]	2.56%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New ILC Dover, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6],[11]	5.00%	[7],[8],[9],[10]
Interest Rate		10.40%	[4],[5],[6],[11]	9.77%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,893	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,885	[4],[5],[11]	6,935	[7],[8],[9]
Fair Value		$ 6,893	[4],[5],[11]	$ 6,946	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.67%	[2],[7],[8],[9]
Investment, Identifier [Axis]: New You Bariatric Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 6,892	[4],[5]	$ 6,946	[7],[8]
Cost		6,892	[4],[5]	6,946	[7],[8]
Fair Value		$ 6,641	[4],[5]	$ 6,838	[7],[8]
% of Net Assets		2.20%	[1],[4],[5]	2.63%	[2],[7],[8]
Investment, Identifier [Axis]: Nexstar Media Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Nonni's Foods, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6]	5.00%	[7],[8],[10]
Interest Rate		10.97%	[4],[5],[6]	9.39%	[7],[8],[10]
Par Amount / Unit		$ 6,909	[4],[5]	$ 6,963	[7],[8]
Cost		6,908	[4],[5]	6,958	[7],[8]
Fair Value		$ 6,838	[4],[5]	$ 6,915	[7],[8]
% of Net Assets		2.26%	[1],[4],[5]	2.66%	[2],[7],[8]
Investment, Identifier [Axis]: North Haven Stack Buyer, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[11]	5.50%	[7],[8],[9],[10]
Interest Rate		10.90%	[4],[5],[6],[11]	9.86%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,894	[4],[5],[11]	$ 6,947	[7],[8],[9]
Cost		6,871	[4],[5],[11]	6,918	[7],[8],[9]
Fair Value		$ 6,793	[4],[5],[11]	$ 6,845	[7],[8],[9]
% of Net Assets		2.25%	[1],[4],[5],[11]	2.63%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Norton Lifelock Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.00%
Interest Rate	[4],[6],[18],[19]	7.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Nouryon Finance B.V.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	4.00%
Interest Rate	[4],[6],[18],[19]	9.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Nutrition 101 Buyer LLC (a/k/a 101, Inc.)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		10.65%	[4],[5],[6]	9.61%	[7],[8],[10]
Par Amount / Unit		$ 818	[4],[5]	$ 824	[7],[8]
Cost		811	[4],[5]	816	[7],[8]
Fair Value		$ 806	[4],[5]	$ 816	[7],[8]
% of Net Assets		0.27%	[1],[4],[5]	0.31%	[2],[7],[8]
Investment, Identifier [Axis]: OMNIA Partners, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11]	4.25%
Interest Rate	[4],[5],[6],[11]	9.65%
Par Amount / Unit	[4],[5],[11]	$ 1,371
Cost	[4],[5],[11]	1,358
Fair Value	[4],[5],[11]	$ 1,358
% of Net Assets	[1],[4],[5],[11]	0.45%
Investment, Identifier [Axis]: OMNIA Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[11],[12]	4.25%
Interest Rate	[4],[5],[6],[11],[12]	9.65%
Par Amount / Unit	[4],[5],[11],[12]	$ 129
Cost	[4],[5],[11],[12]	(1)
Fair Value	[4],[5],[11],[12]	$ (1)
% of Net Assets	[1],[4],[5],[11],[12]	0.00%
Investment, Identifier [Axis]: Oliver Packaging
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6]	10.00%	[8],[10]
Interest Rate, PIK	[8],[10]			1.00%
Par Amount / Unit		$ 1,326	[5]	$ 1,332	[8]
Cost		1,304	[5]	1,308	[8]
Fair Value		$ 1,266	[5]	$ 1,265	[8]
% of Net Assets		0.42%	[1],[5]	0.48%	[2],[8]
Investment, Identifier [Axis]: Oliver Packaging 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 671	[5],[16],[17]	$ 610	[8],[14],[15]
Fair Value		$ 523	[5],[16],[17]	$ 639	[8],[14],[15]
% of Net Assets		0.17%	[1],[5],[16],[17]	0.25%	[2],[8],[14],[15]
Share / Unit		6,710	[5],[16],[17]	6	[8],[14],[15]
Investment, Identifier [Axis]: Open Text Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.75%
Interest Rate	[4],[6],[18],[19],[21]	8.15%
Par Amount / Unit	[4],[18],[19],[21]	$ 748
Cost	[4],[18],[19],[21]	750
Fair Value	[4],[18],[19],[21]	$ 749
% of Net Assets	[1],[4],[18],[19],[21]	0.25%
Investment, Identifier [Axis]: Organon & Co
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 750
Cost	[4],[18],[19]	754
Fair Value	[4],[18],[19]	$ 750
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 3,429
Cost	[4],[5]	3,378
Fair Value	[4],[5]	$ 3,380
% of Net Assets	[1],[4],[5]	1.12%
Investment, Identifier [Axis]: Orion Group FM Holdings, LLC (dba Leo Facilities Maintenance) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 2,571
Cost	[4],[5],[12]	(6)
Fair Value	[4],[5],[12]	$ (36)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.65%
Par Amount / Unit	[4],[5]	$ 2,980
Cost	[4],[5]	2,920
Fair Value	[4],[5]	$ 2,934
% of Net Assets	[1],[4],[5]	0.97%
Investment, Identifier [Axis]: Ovation Holdings, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.65%
Par Amount / Unit	[4],[5],[12]	$ 704
Cost	[4],[5],[12]	226
Fair Value	[4],[5],[12]	$ 223
% of Net Assets	[1],[4],[5],[12]	0.07%
Investment, Identifier [Axis]: PG Aggregator, LLC
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 109	[5],[16],[17]	$ 109	[8],[14],[15]
Fair Value		$ 140	[5],[16],[17]	$ 135	[8],[14],[15]
% of Net Assets		0.05%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		100	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: PG Buyer, LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[4],[5],[6]	10.00%
Interest Rate, PIK		1.50%	[4],[5],[6]	1.50%
Par Amount / Unit		$ 8,184	[4],[5]	$ 8,092	[8]
Cost		8,184	[4],[5]	8,092	[8]
Fair Value		$ 8,184	[4],[5]	$ 8,092	[8]
% of Net Assets		2.71%	[1],[4],[5]	3.11%	[2],[8]
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 3,348
Cost	[4],[5]	3,290
Fair Value	[4],[5]	$ 3,290
% of Net Assets	[1],[4],[5]	1.09%
Investment, Identifier [Axis]: Palmetto Acquisitionco, Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	5.75%
Interest Rate	[4],[5],[6],[12]	11.15%
Par Amount / Unit	[4],[5],[12]	$ 1,217
Cost	[4],[5],[12]	(5)
Fair Value	[4],[5],[12]	$ (21)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Patriot Growth Insurance Service (Delayed Draw) (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[11],[12]	5.75%	[7],[8],[9],[10],[13]
Interest Rate		11.15%	[4],[5],[6],[11],[12]	10.52%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 5,980	[4],[5],[11],[12]	$ 5,999	[7],[8],[9],[13]
Cost		3,839	[4],[5],[11],[12]	375	[7],[8],[9],[13]
Fair Value		$ 3,726	[4],[5],[11],[12]	$ 266	[7],[8],[9],[13]
% of Net Assets		1.23%	[1],[4],[5],[11],[12]	0.10%	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: Perennial Services Investors LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 196
Fair Value	[5],[16],[17],[19]	$ 196
% of Net Assets	[1],[5],[16],[17],[19]	0.06%
Share / Unit	[5],[16],[17],[19]	1,957
Investment, Identifier [Axis]: Perennial Services, Group, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.00%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 1,697
Cost	[4],[5]	1,672
Fair Value	[4],[5]	$ 1,672
% of Net Assets	[1],[4],[5]	0.55%
Investment, Identifier [Axis]: Perennial Services, Group, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.00%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,516
Cost	[4],[5],[12]	193
Fair Value	[4],[5],[12]	$ 175
% of Net Assets	[1],[4],[5],[12]	0.05%
Investment, Identifier [Axis]: Perrigo Company plc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	499
Fair Value	[4],[18],[19]	$ 498
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Phaidon International
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.50%	[4],[5],[6],[19],[21]	5.50%	[7],[8],[10]
Interest Rate		10.82%	[4],[5],[6],[19],[21]	9.86%	[7],[8],[10],[22],[23]
Par Amount / Unit		$ 6,626	[4],[5],[19],[21]	$ 7,000	[7],[8],[22],[23]
Cost		6,568	[4],[5],[19],[21]	6,932	[7],[8],[22],[23]
Fair Value		$ 6,521	[4],[5],[19],[21]	$ 6,916	[7],[8],[22],[23]
% of Net Assets		2.16%	[1],[4],[5],[19],[21]	2.66%	[2],[7],[8],[22],[23]
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.00%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,455
Cost	[4],[5],[12]	(13)
Fair Value	[4],[5],[12]	$ (27)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.00%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 2,539
Cost	[4],[5]	2,490
Fair Value	[4],[5]	$ 2,492
% of Net Assets	[1],[4],[5]	0.83%
Investment, Identifier [Axis]: Pinnacle Supply Partners, LLC 2
Schedule of Investments [Line Items]
Cost	[5],[16],[17]	$ 112
Fair Value	[5],[16],[17]	$ 103
% of Net Assets	[1],[5],[16],[17]	0.03%
Share / Unit	[5],[16],[17]	111,875
Investment, Identifier [Axis]: Prime Security Services Borrower LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	750
Fair Value	[4],[18],[19]	$ 748
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Protective Industrial Products (“PIP”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.00%
Interest Rate	[4],[5],[6]	10.32%
Par Amount / Unit	[4],[5]	$ 1,346
Cost	[4],[5]	1,295
Fair Value	[4],[5]	$ 1,346
% of Net Assets	[1],[4],[5]	0.45%
Investment, Identifier [Axis]: Quikrete Holdings, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	2.75%
Interest Rate	[4],[6],[18]	8.15%
Par Amount / Unit	[4],[18]	$ 499
Cost	[4],[18]	500
Fair Value	[4],[18]	$ 499
% of Net Assets	[1],[4],[18]	0.17%
Investment, Identifier [Axis]: RTH Buyer LLC (dba "Rhino Tool House)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[4],[5],[6]	11.72%
Par Amount / Unit	[4],[5]	$ 2,680
Cost	[4],[5]	2,628
Fair Value	[4],[5]	$ 2,657
% of Net Assets	[1],[4],[5]	0.88%
Investment, Identifier [Axis]: RTH Buyer LLC (dba "Rhino Tool House) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.72%
Par Amount / Unit	[4],[5],[12]	$ 627
Cost	[4],[5],[12]	300
Fair Value	[4],[5],[12]	$ 298
% of Net Assets	[1],[4],[5],[12]	0.10%
Investment, Identifier [Axis]: RVGD Aggregator LP (Revision Skincare)
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 98	[5],[16],[17]	$ 98	[8],[14],[15]
Fair Value		$ 108	[5],[16],[17]	$ 133	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		100	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: Randys Holdings, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11]	6.50%	[7],[8],[9],[10]
Interest Rate		11.90%	[4],[5],[6],[11]	11.09%	[7],[8],[9],[10]
Par Amount / Unit		$ 3,967	[4],[5],[11]	$ 3,996	[7],[8],[9]
Cost		3,895	[4],[5],[11]	3,918	[7],[8],[9]
Fair Value		$ 3,915	[4],[5],[11]	$ 3,919	[7],[8],[9]
% of Net Assets		1.30%	[1],[4],[5],[11]	1.51%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Randys Holdings, Inc (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11],[12]	6.50%	[7],[8],[9],[10],[13]
Interest Rate		11.90%	[4],[5],[6],[11],[12]	11.09%	[7],[8],[9],[10],[13]
Par Amount / Unit		$ 1,332	[4],[5],[11],[12]	$ 1,332	[7],[8],[9],[13]
Cost		0	[4],[5],[11],[12]	0	[7],[8],[9],[13]
Fair Value		$ (17)	[4],[5],[11],[12]	$ (26)	[7],[8],[9],[13]
% of Net Assets		(0.01%)	[1],[4],[5],[11],[12]	(0.01%)	[2],[7],[8],[9],[13]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.25%	[5],[6]	8.25%	[8],[10]
Interest Rate		13.65%	[5],[6]	13.02%	[8],[10]
Par Amount / Unit		$ 6,650	[5]	$ 6,650	[8]
Cost		6,650	[5]	6,650	[8]
Fair Value		$ 6,601	[5]	$ 6,650	[8]
% of Net Assets		2.18%	[1],[5]	2.54%	[2],[8]
Investment, Identifier [Axis]: Red Dawn SEI Buyer, Inc. (Incremental)
Schedule of Investments [Line Items]
Spread Above Reference Rate		8.50%	[5],[6]	8.50%	[8],[10]
Interest Rate		13.90%	[5],[6]	13.27%	[8],[10]
Par Amount / Unit		$ 3,350	[5]	$ 3,350	[8]
Cost		3,350	[5]	3,350	[8]
Fair Value		$ 3,347	[5]	$ 3,350	[8]
% of Net Assets		1.11%	[1],[5]	1.29%	[2],[8]
Investment, Identifier [Axis]: Red Ventures LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	3.00%
Interest Rate	[4],[6],[18]	8.40%
Par Amount / Unit	[4],[18]	$ 499
Cost	[4],[18]	499
Fair Value	[4],[18]	$ 496
% of Net Assets	[1],[4],[18]	0.16%
Investment, Identifier [Axis]: Revision Buyer LLC
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6]	10.00%	[8],[10]
Interest Rate, PIK		1.00%	[5],[6]	1.00%	[8],[10]
Par Amount / Unit		$ 10,151	[5]	$ 10,075	[8]
Cost		9,982	[5]	9,889	[8]
Fair Value		$ 10,151	[5]	$ 9,896	[8]
% of Net Assets		3.36%	[1],[5]	3.80%	[2],[8]
Investment, Identifier [Axis]: Ryan Specialty Group LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 500
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		11.07%	[4],[5],[6]	10.34%	[7],[8],[10]
Par Amount / Unit		$ 2,248	[4],[5]	$ 2,265	[7],[8]
Cost		2,204	[4],[5]	2,217	[7],[8]
Fair Value		$ 2,220	[4],[5]	$ 2,221	[7],[8]
% of Net Assets		0.73%	[1],[4],[5]	0.85%	[2],[7],[8]
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC (DBA EyeSouth Partners) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6],[12]	5.75%	[7],[8],[10],[13]
Interest Rate		11.07%	[4],[5],[6],[12]	10.34%	[7],[8],[10],[13]
Par Amount / Unit		$ 734	[4],[5],[12]	$ 735	[7],[8],[13]
Cost		348	[4],[5],[12]	0	[7],[8],[13]
Fair Value		$ 339	[4],[5],[12]	$ (14)	[7],[8],[13]
% of Net Assets		0.11%	[1],[4],[5],[12]	(0.01%)	[2],[7],[8],[13]
Investment, Identifier [Axis]: SPI LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6],[11]	5.00%	[7],[8],[9],[10]
Interest Rate		10.32%	[4],[5],[6],[11]	9.59%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,895	[4],[5],[11]	$ 6,948	[7],[8],[9]
Cost		6,814	[4],[5],[11]	6,855	[7],[8],[9]
Fair Value		$ 6,895	[4],[5],[11]	$ 6,804	[7],[8],[9]
% of Net Assets		2.28%	[1],[4],[5],[11]	2.61%	[2],[7],[8],[9]
Investment, Identifier [Axis]: SRAM LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18]	2.75%
Interest Rate	[4],[6],[18]	8.15%
Par Amount / Unit	[4],[18]	$ 500
Cost	[4],[18]	501
Fair Value	[4],[18]	$ 499
% of Net Assets	[1],[4],[18]	0.16%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.25%
Interest Rate	[4],[6],[18],[19]	7.65%
Par Amount / Unit	[4],[18],[19]	$ 199
Cost	[4],[18],[19]	199
Fair Value	[4],[18],[19]	$ 199
% of Net Assets	[1],[4],[18],[19]	0.07%
Investment, Identifier [Axis]: SS&C Technology Holdings Inc 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.25%
Interest Rate	[4],[6],[18],[19]	7.65%
Par Amount / Unit	[4],[18],[19]	$ 300
Cost	[4],[18],[19]	301
Fair Value	[4],[18],[19]	$ 300
% of Net Assets	[1],[4],[18],[19]	0.10%
Investment, Identifier [Axis]: SW Ingredients Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		10.50%	[5],[6]	10.50%	[8],[10]
Interest Rate, PIK		1.00%	[5],[6]	1.00%	[8],[10]
Par Amount / Unit		$ 10,153	[5]	$ 10,076	[8]
Cost		10,153	[5]	10,076	[8]
Fair Value		$ 9,902	[5]	$ 9,521	[8]
% of Net Assets		3.28%	[1],[5]	3.67%	[2],[8]
Investment, Identifier [Axis]: Select Medical Corporation
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	752
Fair Value	[4],[18],[19]	$ 747
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Solaray, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.50%	[4],[5],[6],[11]	5.75%	[7],[8],[9],[10]
Interest Rate		11.90%	[4],[5],[6],[11]	10.34%	[7],[8],[9],[10]
Par Amount / Unit		$ 6,907	[4],[5],[11]	$ 6,963	[7],[8],[9]
Cost		6,902	[4],[5],[11]	6,955	[7],[8],[9]
Fair Value		$ 6,731	[4],[5],[11]	$ 6,878	[7],[8],[9]
% of Net Assets		2.23%	[1],[4],[5],[11]	2.64%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Southern Veterinary Partners
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[9],[10]			5.50%
Interest Rate	[7],[8],[9],[10]			9.86%
Par Amount / Unit	[7],[8],[9]			$ 3,085
Cost	[7],[8],[9]			3,026
Fair Value	[7],[8],[9]			$ 3,022
% of Net Assets	[2],[7],[8],[9]			1.16%
Investment, Identifier [Axis]: Spartech
Schedule of Investments [Line Items]
Spread Above Reference Rate		4.75%	[4],[5],[6],[11]	4.75%	[7],[8],[9],[10]
Interest Rate		10.15%	[4],[5],[6],[11]	9.52%	[7],[8],[9],[10]
Par Amount / Unit		$ 3,940	[4],[5],[11]	$ 3,970	[7],[8],[9]
Cost		3,940	[4],[5],[11]	3,970	[7],[8],[9]
Fair Value		$ 3,320	[4],[5],[11]	$ 3,863	[7],[8],[9]
% of Net Assets		1.10%	[1],[4],[5],[11]	1.48%	[2],[7],[8],[9]
Investment, Identifier [Axis]: Specialist Resources Global Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6]	4.50%	[7],[8],[10]
Interest Rate		10.32%	[4],[5],[6]	8.89%	[7],[8],[10]
Par Amount / Unit		$ 6,894	[4],[5]	$ 6,947	[7],[8]
Cost		6,894	[4],[5]	6,947	[7],[8]
Fair Value		$ 6,894	[4],[5]	$ 6,894	[7],[8]
% of Net Assets		2.28%	[1],[4],[5]	2.65%	[2],[7],[8]
Investment, Identifier [Axis]: Spice World
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 126	[5],[16],[17],[19]	$ 126	[8],[14],[15]
Fair Value		$ 125	[5],[16],[17],[19]	$ 101	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17],[19]	0.04%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17],[19]	1	[8],[14],[15]
Investment, Identifier [Axis]: Sugar PPC Holdings LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 200
Fair Value	[5],[16],[17],[19]	$ 200
% of Net Assets	[1],[5],[16],[17],[19]	0.07%
Share / Unit	[5],[16],[17],[19]	2,000
Investment, Identifier [Axis]: Summit Materials, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: SupplyOne, Inc.
Schedule of Investments [Line Items]
Interest Rate		10.00%	[5],[6]	10.00%	[8],[10]
Interest Rate, PIK		1.50%	[5],[6]	1.50%	[8],[10]
Par Amount / Unit		$ 10,189	[5]	$ 10,113	[8]
Cost		10,189	[5]	10,113	[8]
Fair Value		$ 10,189	[5]	$ 10,113	[8]
% of Net Assets		3.37%	[1],[5]	3.89%	[2],[8]
Investment, Identifier [Axis]: SupplyOne, Inc. 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 504	[5],[16],[17]	$ 504	[8],[14],[15]
Fair Value		$ 812	[5],[16],[17]	$ 980	[8],[14],[15]
% of Net Assets		0.27%	[1],[5],[16],[17]	0.38%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: Tempo Acquisition LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	502
Fair Value	[4],[18],[19]	$ 501
% of Net Assets	[1],[4],[18],[19]	0.17%
Investment, Identifier [Axis]: Topgolf Callaway Brands Corp
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	500
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.25%
Interest Rate	[5],[6]	11.72%
Par Amount / Unit	[5]	$ 2,532
Cost	[5]	2,487
Fair Value	[5]	$ 2,511
% of Net Assets	[1],[5]	0.83%
Investment, Identifier [Axis]: Transit Buyer LLC (dba“Propark”) (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.25%
Interest Rate	[4],[5],[6],[12]	11.72%
Par Amount / Unit	[4],[5],[12]	$ 1,157
Cost	[4],[5],[12]	(21)
Fair Value	[4],[5],[12]	$ (10)
% of Net Assets	[1],[4],[5],[12]	0.00%
Investment, Identifier [Axis]: Trench Plate Rental Co.
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 127	[5],[16],[17]	$ 127	[8],[14],[15]
Fair Value		$ 105	[5],[16],[17]	$ 134	[8],[14],[15]
% of Net Assets		0.03%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		1,000	[5],[16],[17]	1	[8],[14],[15]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10],[13]
Interest Rate		11.65%	[4],[5],[6]	10.84%	[7],[8],[10],[13]
Par Amount / Unit		$ 2,978	[4],[5]	$ 400	[7],[8],[13]
Cost		2,978	[4],[5]	37	[7],[8],[13]
Fair Value		$ 2,919	[4],[5]	$ 32	[7],[8],[13]
% of Net Assets		0.97%	[1],[4],[5]	0.01%	[2],[7],[8],[13]
Investment, Identifier [Axis]: Trilon Group, LLC (Delayed Draw) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 398	[4],[5]	$ 3,000	[7],[8]
Cost		398	[4],[5]	3,000	[7],[8]
Fair Value		$ 390	[4],[5]	$ 2,888	[7],[8]
% of Net Assets		0.13%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 1
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	5.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	9.84%	[7],[8],[10]
Par Amount / Unit		$ 597	[4],[5]	$ 2,993	[7],[8]
Cost		593	[4],[5]	2,964	[7],[8]
Fair Value		$ 585	[4],[5]	$ 2,881	[7],[8]
% of Net Assets		0.19%	[1],[4],[5]	1.11%	[2],[7],[8]
Investment, Identifier [Axis]: Trilon Group, LLC 2
Schedule of Investments [Line Items]
Spread Above Reference Rate		6.25%	[4],[5],[6]	6.25%	[7],[8],[10]
Interest Rate		11.65%	[4],[5],[6]	10.84%	[7],[8],[10]
Par Amount / Unit		$ 2,970	[4],[5]	$ 600	[7],[8]
Cost		2,944	[4],[5]	594	[7],[8]
Fair Value		$ 2,911	[4],[5]	$ 593	[7],[8]
% of Net Assets		0.96%	[1],[4],[5]	0.23%	[2],[7],[8]
Investment, Identifier [Axis]: Tronox Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.50%
Interest Rate	[4],[6],[18],[19]	8.90%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	498
Fair Value	[4],[18],[19]	$ 497
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Turbine Engine Specialist, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[5],[6]	950.00%
Interest Rate	[5],[6]	14.82%
Par Amount / Unit	[5]	$ 1,978
Cost	[5]	1,928
Fair Value	[5]	$ 1,929
% of Net Assets	[1],[5]	0.64%
Investment, Identifier [Axis]: UPC Finance Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 500
Cost	[4],[18],[19]	486
Fair Value	[4],[18],[19]	$ 494
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: US Foods, Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.50%
Interest Rate	[4],[6],[18],[19]	7.90%
Par Amount / Unit	[4],[18],[19]	$ 750
Cost	[4],[18],[19]	753
Fair Value	[4],[18],[19]	$ 752
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: US Radiology Specialists, Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[6],[11],[18]	5.25%	[7],[9],[10],[24]
Interest Rate		10.65%	[4],[6],[11],[18]	10.02%	[7],[9],[10],[24]
Par Amount / Unit		$ 1,868	[4],[11],[18]	$ 1,882	[7],[9],[24]
Cost		1,794	[4],[11],[18]	1,798	[7],[9],[24]
Fair Value		$ 1,817	[4],[11],[18]	$ 1,704	[7],[9],[24]
% of Net Assets		0.60%	[1],[4],[11],[18]	0.66%	[2],[7],[9],[24]
Investment, Identifier [Axis]: Uber Technologies Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	2.75%
Interest Rate	[4],[6],[18],[19]	8.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	751
Fair Value	[4],[18],[19]	$ 749
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Ultima Health Holdings, LLC
Schedule of Investments [Line Items]
Interest Rate		11.00%	[5],[6]	11.00%	[8],[10]
Interest Rate, PIK		1.50%	[5],[6]	1.50%	[8],[10]
Par Amount / Unit		$ 1,321	[5]	$ 1,306	[8]
Cost		1,298	[5]	1,282	[8]
Fair Value		$ 1,281	[5]	$ 1,278	[8]
% of Net Assets		0.42%	[1],[5]	0.49%	[2],[8]
Investment, Identifier [Axis]: Ultima Health Holdings, LLC 1
Schedule of Investments [Line Items]
Interest Rate	[8],[10],[14],[15]			0.00%
Cost		$ 130	[5],[16],[17]	$ 130	[8],[14],[15]
Fair Value		$ 126	[5],[16],[17]	$ 130	[8],[14],[15]
% of Net Assets		0.04%	[1],[5],[16],[17]	0.05%	[2],[8],[14],[15]
Share / Unit		11	[5],[16],[17]	0	[8],[14],[15]
Investment, Identifier [Axis]: United Airlines Inc
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.75%
Interest Rate	[4],[6],[18],[19]	9.15%
Par Amount / Unit	[4],[18],[19]	$ 748
Cost	[4],[18],[19]	753
Fair Value	[4],[18],[19]	$ 750
% of Net Assets	[1],[4],[18],[19]	0.25%
Investment, Identifier [Axis]: Viking Target, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.00%	[4],[5],[6]	5.00%	[7],[8],[10]
Interest Rate		10.32%	[4],[5],[6]	9.77%	[7],[8],[10]
Par Amount / Unit		$ 6,379	[4],[5]	$ 6,945	[7],[8]
Cost		6,360	[4],[5]	6,906	[7],[8]
Fair Value		$ 6,367	[4],[5]	$ 6,916	[7],[8]
% of Net Assets		2.10%	[1],[4],[5]	2.66%	[2],[7],[8]
Investment, Identifier [Axis]: Virgin Media Bristol LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	3.25%
Interest Rate	[4],[6],[18],[19],[21]	8.65%
Par Amount / Unit	[4],[18],[19],[21]	$ 750
Cost	[4],[18],[19],[21]	743
Fair Value	[4],[18],[19],[21]	$ 734
% of Net Assets	[1],[4],[18],[19],[21]	0.24%
Investment, Identifier [Axis]: W2O Holdings, LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.25%	[4],[5],[6]	4.75%	[7],[8],[10]
Interest Rate		10.72%	[4],[5],[6]	9.52%	[7],[8],[10]
Par Amount / Unit		$ 6,895	[4],[5]	$ 6,947	[7],[8]
Cost		6,895	[4],[5]	6,947	[7],[8]
Fair Value		$ 6,895	[4],[5]	$ 6,905	[7],[8]
% of Net Assets		2.28%	[1],[4],[5]	2.65%	[2],[7],[8]
Investment, Identifier [Axis]: WCI Holdings LLC
Schedule of Investments [Line Items]
Cost	[5],[16],[17],[19]	$ 535
Fair Value	[5],[16],[17],[19]	$ 589
% of Net Assets	[1],[5],[16],[17],[19]	0.19%
Share / Unit	[5],[16],[17],[19]	534,934
Investment, Identifier [Axis]: WSB Engineering Holdings Inc.
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	6.00%
Interest Rate	[4],[5],[6]	11.40%
Par Amount / Unit	[4],[5]	$ 1,644
Cost	[4],[5]	1,619
Fair Value	[4],[5]	$ 1,619
% of Net Assets	[1],[4],[5]	0.54%
Investment, Identifier [Axis]: WSB Engineering Holdings Inc. (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6],[12]	6.00%
Interest Rate	[4],[5],[6],[12]	11.40%
Par Amount / Unit	[4],[5],[12]	$ 1,096
Cost	[4],[5],[12]	(8)
Fair Value	[4],[5],[12]	$ (16)
% of Net Assets	[1],[4],[5],[12]	(0.01%)
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[4],[5],[6]	5.75%	[7],[8],[10]
Interest Rate		11.47%	[4],[5],[6]	10.53%	[7],[8],[10]
Par Amount / Unit		$ 4,064	[4],[5]	$ 4,095	[7],[8]
Cost		3,995	[4],[5]	4,017	[7],[8]
Fair Value		$ 3,937	[4],[5]	$ 4,020	[7],[8]
% of Net Assets		1.30%	[1],[4],[5]	1.54%	[2],[7],[8]
Investment, Identifier [Axis]: Wellspring Pharmaceutical (Delayed Draw)
Schedule of Investments [Line Items]
Spread Above Reference Rate		5.75%	[5],[6]	5.75%	[8],[10],[13]
Interest Rate		11.22%	[5],[6]	10.53%	[8],[10],[13]
Par Amount / Unit		$ 1,890	[5]	$ 1,895	[8],[13]
Cost		1,878	[5]	(14)	[8],[13]
Fair Value		$ 1,831	[5]	$ (35)	[8],[13]
% of Net Assets		0.61%	[1],[5]	(0.01%)	[2],[8],[13]
Investment, Identifier [Axis]: WideOpenWest Finance LLC
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19]	3.00%
Interest Rate	[4],[6],[18],[19]	8.40%
Par Amount / Unit	[4],[18],[19]	$ 499
Cost	[4],[18],[19]	494
Fair Value	[4],[18],[19]	$ 493
% of Net Assets	[1],[4],[18],[19]	0.16%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign)
Schedule of Investments [Line Items]
Spread Above Reference Rate	[7],[8],[10]			5.00%
Interest Rate	[7],[8],[10]			9.59%
Par Amount / Unit	[7],[8]			$ 2,045
Cost	[7],[8]			2,026
Fair Value	[7],[8]			$ 2,026
% of Net Assets	[2],[7],[8]			0.78%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 1
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.75%
Interest Rate	[4],[5],[6]	11.15%
Par Amount / Unit	[4],[5]	$ 1,535
Cost	[4],[5]	1,505
Fair Value	[4],[5]	$ 1,520
% of Net Assets	[1],[4],[5]	0.50%
Investment, Identifier [Axis]: Xpressmyself.com LLC (a/k/a SmartSign) 2
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[5],[6]	5.50%
Interest Rate	[4],[5],[6]	10.90%
Par Amount / Unit	[4],[5]	$ 2,030
Cost	[4],[5]	2,012
Fair Value	[4],[5]	$ 1,991
% of Net Assets	[1],[4],[5]	0.66%
Investment, Identifier [Axis]: Ziggo Financing Partnership
Schedule of Investments [Line Items]
Spread Above Reference Rate	[4],[6],[18],[19],[21]	2.50%
Interest Rate	[4],[6],[18],[19],[21]	7.90%
Par Amount / Unit	[4],[18],[19],[21]	$ 500
Cost	[4],[18],[19],[21]	489
Fair Value	[4],[18],[19],[21]	$ 489
% of Net Assets	[1],[4],[18],[19],[21]	0.16%

[1] Percentage is based on net assets of $302,138 as of September 30, 2023.

[2] Percentage is based on net assets of $260,301 as of December 31, 2022.

[3] Cash equivalents balance represents amounts held in interest-bearing money market funds issued by U.S. Bank National Association and First American.

[4] Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings” for more information.

[5] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

[6] The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over SOFR and the current contractual interest rate in effect at September 30, 2023. As of September 30, 2023, effective rates for 1M S, 3M S, 6M S and 12M S are 5.32%, 5.40%, 5.47% and 5.47%, respectively. Certain investments are subject to a SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[7] Denotes that all or a portion of the assets are owned by SPV I (as defined in Note 1 “Organization”). SPV I entered into a senior secured revolving credit facility (the “Bank of America Credit Facility”) on April 19, 2022. The lenders of the Bank of America Credit Facility have a first lien security interest in substantially all of the assets of SPV I. Accordingly, such assets are not available to creditors of the Fund. See Note 5 “Secured Borrowings”.

[8] Investment valued using unobservable inputs (Level 3). See Note 2 “Significant Accounting Policies - Valuation of Portfolio Investments” for more information.

[9] Investment is a unitranche position.

[10] The majority of the investments bear interest at rates that may be determined by reference to London Interbank Offered Rate (“LIBOR” or "L"), as well as Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Fund has provided the spread over LIBOR and SOFR and the current contractual interest rate in effect at December 31, 2022. As of December 31, 2022, effective rates for 1M L and 3M L are 4.39% and 4.77%, respectively. As of December 31, 2022, effective rates for 1M S, 3M S and 6M S are 4.36%, 4.59% and 4.78%, respectively. For portfolio companies with multiple interest rate contracts, the interest rate shown is a weighted average current interest rate in effect as of December 31, 2022. Certain investments are subject to a LIBOR or SOFR floor. For fixed rate loans, a spread above a reference rate is not applicable.

[11] Investment is a unitranche position.

[12] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[13] Position or portion thereof is an unfunded loan commitment, and no interest is being earned on the unfunded portion. See Note 6 "Commitments and Contingencies". The investment may be subject to unused commitment fees.

[14] Equity investments are non-income producing securities unless otherwise noted.

[15] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of December 31, 2022, the Fund held seventeen restricted securities with an aggregate fair value of $4,338, or 1.7% of the Fund’s net assets. The acquisition dates of these securities were as follows: CV Holdco, LLC - March 31, 2022, Kofile, Inc. - March 31, 2022, Mr. Greens - March 31, 2022, PG Aggregator, LLC - March 31, 2022, RVGD Aggregator LP (Revision Skincare) - March 31, 2022. Spice World - March 31, 2022, Supply One - March 31, 2022, Trench Plate Rental Co. - March 31, 2022, LMI Renaissance - June 30, 2022, Oliver Packaging - July 6, 2022, ITSavvy LLC- August 8, 2022, ADPD Holdings, LLC (a/k/a NearU) - August 11, 2022 and Ultima Health Holdings, LLC - September 12, 2022, Fresh Edge Class A and Fresh Edge Class B - October 3, 2022, BroadcastMed Holdco, LLC - October 4, 2022 and Gannett Fleming - December 20, 2022.

[16] Equity investments are non-income producing securities unless otherwise noted.

[17] Security acquired in transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), and may be deemed to be a “restricted security” under the Securities Act. As of September 30, 2023, the Fund held thirty-three restricted securities with an aggregate fair value of $9,328, or 3.09% of the Fund’s net assets.

[18] Investments valued using observable inputs (Level 2), if applicable. See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information.

[19] The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of September 30, 2023, total non-qualifying assets at fair value represented 8.62% of the Fund's total assets calculated in accordance with the 1940 Act.

[20] Represents an investment held through an aggregator vehicle organized as a pooled investment vehicle.

[21] This portfolio company is not domiciled in the United States. As of September 30, 2023, the total fair value of investments domiciled in Canada, Ireland, Luxembourg, Netherland and United Kingdom are $5,411, $1,240, $1,239, $489, and $8,624 respectively, representing 1.79%, 0.41%, 0.41%, 0.16%, and 2.86% of the Fund’s net assets, respectively. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

[22] The investment is considered as a non-qualifying asset under Section 55(a) of the 1940 Act. Under the 1940 Act, the Company cannot acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Fund's total assets. As of December 31, 2022, total non-qualifying assets at fair value represented 1.64% of the Fund's total assets calculated in accordance with the 1940 Act.

[23] This portfolio company is not domiciled in the United States. The principal place of business for Phaidon International is the United Kingdom. A portfolio company that is not domiciled in the United States is considered a non-qualifying asset under Section 55(a) of the 1940 Act.

[24] Investments valued using observable inputs (Level 2). See Note 2 “Significant Accounting Policies – Valuation of Portfolio Investments” and Note 3 "Fair Value Measurements" for more information.

XML

CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED) (Parenthetical) $ in Thousands	Sep. 30, 2023 USD ($) investment		Dec. 31, 2022 USD ($) investment
Schedule of Investments [Line Items]
Net assets	$ 302,138		$ 260,301
Aggregate fair value	$ 9,328		$ 4,338
Percent of net assets	149.33%	[1]	134.27%	[2]
Canada
Schedule of Investments [Line Items]
Percent of net assets	1.79%
Fair value of investments	$ 5,411
Ireland
Schedule of Investments [Line Items]
Percent of net assets	0.41%
Fair value of investments	$ 1,240
Luxembourg
Schedule of Investments [Line Items]
Percent of net assets	0.41%
Fair value of investments	$ 1,239
Netherlands
Schedule of Investments [Line Items]
Percent of net assets	0.16%
Fair value of investments	$ 489
United Kingdom
Schedule of Investments [Line Items]
Percent of net assets	2.86%
Fair value of investments	$ 8,624
Restricted Security
Schedule of Investments [Line Items]
Number of investments | investment	33		17
Percent of net assets	3.09%		1.70%
Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	70.00%		70.00%
Non Qualifying Assets
Schedule of Investments [Line Items]
Percent of net assets	8.62%		1.64%
One Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.39%
Three Month Libor
Schedule of Investments [Line Items]
Effective interest rate			4.77%
One Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.32%		4.36%
Three Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.40%		4.59%
Six Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.47%		4.78%
Twelve Month SOFR
Schedule of Investments [Line Items]
Effective interest rate	5.47%

[1] Percentage is based on net assets of $302,138 as of September 30, 2023.

[2] Percentage is based on net assets of $260,301 as of December 31, 2022.

XML

ORGANIZATION

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

ORGANIZATION

ORGANIZATION

Nuveen Churchill Private Capital Income Fund (“PCAP”, and together with its consolidated subsidiaries, the “Fund”) is a Delaware statutory trust formed on February 8, 2022. PCAP is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Fund is externally managed by its adviser, Churchill Asset Management LLC (the “Adviser” or “Churchill”). Churchill is an indirect subsidiary of Nuveen, LLC (“Nuveen”), the investment management division of TIAA (as defined below). Churchill has engaged its affiliate, Nuveen Asset Management, LLC (“Nuveen Asset Management” or the “Sub-Adviser”), acting through its leveraged finance division, to manage certain of its Liquid Investments (defined below) pursuant to an investment sub-advisory agreement between the Adviser and Nuveen Asset Management (as discussed further in Note 4). The Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) as defined under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

The Fund’s investment objective is to generate attractive risk-adjusted returns primarily through current income and, secondarily, long-term capital appreciation, by investing in a diversified portfolio of private debt and equity investments in U.S. middle market companies owned by leading private equity firms, which the Fund defines as companies with approximately $10 million to $250 million of earnings before interest, taxes, depreciation and amortization (“EBITDA”). The Fund primarily focuses on investing in U.S. middle market companies with $10 to $100 million in EBITDA, which the Fund considers the core middle market. The Fund primarily invests in first-lien senior secured debt and first-out positions in unitranche loans (collectively “Senior Loan Investments”), as well as junior debt investments, such as second-lien loans, unsecured debt, subordinated debt and last-out positions in unitranche loans (including fixed- and floating-rate instruments and instruments with payment-in-kind income) (“Junior Capital Investments”). Senior Loan Investments and Junior Capital Investments may be originated alongside smaller related common equity positions to the same portfolio companies. The portfolio also will include larger, stand-alone direct equity co-investments in private-equity backed companies that may or may not be originated alongside or separately from Senior Loan Investments and/or Junior Capital Investments to the applicable portfolio company (“Equity Co-Investments”). We target an investment portfolio consisting, directly or indirectly, of at least 50% in Senior Loan Investments, up to 30% in Junior Capital Investments and up to 20% in Equity Co-Investments. To support the Fund’s share repurchase program (as discussed further in Note 7), the Fund also will invest 5% to 10% of its assets in cash and cash equivalents, liquid fixed-income securities (including broadly syndicated loans) and other liquid credit instruments (“Liquid Investments”).

The Fund was established by Teachers Insurance and Annuity Association of America (“TIAA”), the ultimate parent of Churchill and Nuveen, and operated as a wholly owned subsidiary of TIAA until the Escrow Break Date (as defined below). On March 30, 2022, TIAA purchased 40 shares of the Fund’s Class I shares at $25.00 per share.

On March 31, 2022, prior to the Fund’s election to be regulated as a BDC under the 1940 Act, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In addition, on March 31, 2022, the Fund entered into a promissory note with TIAA (the “Note”) as the lender. The principal amount of the Note equaled (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500 (as discussed further in Note 4). In connection therewith, the Fund issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. On June 3, 2022, the Fund fully repaid the balance on the Note to TIAA which was comprised of $32,731 and $226 of principal and interest, respectively.

NCPIF SPV I LLC (“SPV I”), a Delaware limited liability company, formed on February 25, 2022. SPV I is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation. SPV I commenced operations on March 31, 2022, upon receipt of contribution of portfolio investments from TIAA to the Fund (as discussed further in Note 7).

NCPIF Equity Holdings LLC (“Equity Holdings”), a Delaware limited liability company, was formed on April 1, 2022. Equity Holdings commenced operations on February 6, 2023. Equity Holdings is a wholly owned subsidiary of the Fund and is consolidated in these consolidated financial statements commencing from the date of its formation.

The Fund is offering on a continuous basis up to $2.5 billion of any combination of three classes of common shares of beneficial interest (“Common Shares”), Class S shares, Class D shares and Class I shares. On May 17, 2022, the Securities and Exchange Commission (the “SEC”) granted an exemptive order permitting the Fund to offer multiple classes of Common Shares and to impose varying sales loads, asset-based service and/or distribution fees and early withdrawal fees. The share classes have different ongoing shareholder servicing and/or distribution fees. None of the share classes being offered will have early withdrawal fees. The purchase price per share for each class of Common Shares will equal the Fund’s net asset value (“NAV”) per share as of the effective date of the monthly share purchase date. Nuveen Securities, LLC (the “Intermediary Manager”) will use its best efforts to sell Common Shares, but is not obligated to purchase or sell any specific amount of Common Shares in the offering. As of June 1, 2023 (the “Escrow Break Date”), the Fund had satisfied the minimum offering requirement and the Fund’s Board of Trustees (the “Board of Trustees” or the “Board”) authorized the release of proceeds from escrow.

XML

SIGNIFICANT ACCOUNTING POLICIES

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of September 30, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board of Trustees to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such value do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions and Revenue Recognition

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains and losses on investment transactions are determined on a specific identification basis and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments.

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of September 30, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $67,603 and $70,361, respectively, which represents approximately 15.17% and 20.13% of total investments at fair value, respectively. For the three and nine months ended September 30, 2023, the Company earned $573 and $1,647, respectively, in PIK income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company earned $211 and $450, respectively, in PIK income. As of September 30, 2023 and 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2023, the Company earned $17 and $115, respectively, in dividend income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2023, the Company earned other income of $100 and $131, respectively, primarily related to prepayment and amendment fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) to September 30, 2022, the Fund earned other income of $446 and $446, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of September 30, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 4 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the three and nine months ended September 30, 2023, offering costs of $326 and $660, respectively, were incurred, and $187 and $468, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, offering costs of $225 and $375, respectively, were incurred, and $78 and $118, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 4 for further details on the Expense Support Agreement.

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2023, the Company did not incur any excise tax expense. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Quarterly Report on Form 10-Q, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

Recent Accounting Standards Updates

The FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting in March 2020. This update provides temporary optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedge accounting, and other transactions subject to meeting certain criteria. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discounted because of reference rate reform, and was effective upon issuance through December 31, 2022. As of September 30, 2023, the Fund has amended substantially all of its agreements that have LIBOR as a reference rate to an alternate rate. Contract modifications may be required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”), which defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024. The Fund has adopted the accounting relief and noted no material impact on the consolidated financial statements, as relevant contract relationship modifications are made during the course of the reference rate reform transition period.

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair Value Disclosures

The following table presents fair value measurements of investments, by major class as of September 30, 2023 and December 31, 2022, according to the fair value hierarchy:

As of September 30, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	31,383	$	310,315	$	341,698
Subordinated Debt (1)	—		—		94,751		94,751
Equity Investments	—		—		9,328		9,328
Cash Equivalents	5,417		—		—		5,417
Total	$	5,417	$	31,383	$	414,394	$	451,194

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2023	$	294,555	$	89,541	$	5,490	$	389,586
Purchase of investments	28,637		4,509		3,763		36,909
Proceeds from principal repayments and sales of investments	(11,251)		—		—		(11,251)
Payment-in-kind interest	—		447		—		447
Amortization of premium/accretion of discount, net	67		47		—		114
Net realized gain (loss) on investments	75		—		—		75
Net change in unrealized appreciation (depreciation) on investments	34		207		75		316
Transfers out of Level 3 (1)	(1,802)		—		—		(1,802)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	53	$	207	$	75	$	335

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,668	$	93,808	$	4,338	$	347,814
Purchase of investments	75,150		9,976		5,312		90,438
Proceeds from principal repayments and sales of investments	(14,041)		(10,212)		(392)		(24,645)
Payment-in-kind interest	—		1,521		—		1,521
Amortization of premium/accretion of discount, net	412		185		—		597
Net realized gain (loss) on investments	90		311		291		692
Net change in unrealized appreciation (depreciation) on investments	(964)		(838)		(221)		(2,023)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	(905)	$	(514)	$	(45)	$	(1,464)

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended September 30, 2022 and for the period February 28, 2022 (inception) through September 30, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2022	$	197,343	$	94,727	$	1,725	$	293,795
Purchase of investments	25,868		3,556		1,002		30,426
Proceeds from principal repayments and sales of investments	(1,102)		—		—		(1,102)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	82		52		—		134
Net realized gain (loss) on investments	3		—		—		3
Net change in unrealized appreciation (depreciation) on investments	(746)		(624)		113		(1,257)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(746)	$	(624)	$	113	$	(1,257)

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	231,983		117,526		2,383		351,892
Proceeds from principal repayments and sales of investments	(8,692)		(19,000)		—		(27,692)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	198		127		—		325
Net realized gain (loss) on investments	17		(281)		—		(264)
Net change in unrealized appreciation (depreciation) on investments	(2,058)		(661)		457		(2,262)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(2,058)	$	(661)	$	457	$	(2,262)

Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, there were no transfers into or out of Level 3.

Significant Unobservable Inputs

ASC Topic 820 requires disclosure of quantitative information about the significant unobservable inputs used in the valuation of assets and liabilities classified as Level 3 within the fair value hierarchy. The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at September 30, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	258,715	Yield Method	Discount Rate	6.13	%	19.50	%	11.72	%
First Lien Term Loans	51,600		Recent Transaction	Transaction Price	97.08		100.00		99.06
Subordinated Debt	92,577		Yield Method	Discount Rate	11.57	%	21.63	%	14.32	%
Subordinated Debt	2,174		Recent Transaction	Transaction Price	97.27		97.31		97.28
Equity Investments	5,530		Market Approach	EBITDA Multiple	3.50		19.50		10.18
Total	$	410,596

Equity investments in the amount of $3,798 at September 30, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

XML

RELATED PARTY TRANSACTIONS

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Advisory Agreement

On March 31, 2022, the Fund entered into the Advisory Agreement. The Board of Trustees, including all of the trustees who are not “interested persons” (as defined under Section 2(a)(19) of the 1940 Act) of the Fund (the “Independent Trustees”), approved the Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. On August 3, 2022, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 1 to the Advisory Agreement (the “Advisory Agreement Amendment”), which became effective immediately. The Advisory Agreement Amendment was entered into solely to extend the notice requirement for the Adviser to terminate the Advisory Agreement from 60 days to 120 days (as described below).

On January 10, 2023, the Board of Trustees, including all of the Independent Trustees, approved Amendment No. 2 (the “Second Advisory Agreement Amendment”) to the Investment Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into the Second Advisory Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Second Advisory Agreement Amendment, among other things: (1) removed sunset provisions contingent upon recognition of the Common Shares as “covered securities”; (2) removed provisions entitling the Adviser to amounts owed under Sections 3 or Section 7 of the Advisory Agreement following a notice of termination of the Advisory Agreement; (3) specifies the conditions under which the Adviser may sell all or substantially all of the Fund’s assets; and (4) revised provisions to reflect conflicts of interest provisions set forth in the NASAA Omnibus Guidelines Statement of Policy adopted on March 29, 1992 and as amended on May 7, 2007 and from time to time (the “Omnibus Guidelines”).

On August 2, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 3 (the “Third Advisory Agreement Amendment”) to the Advisory Agreement, which became effective immediately. The Fund and the Adviser entered into Second Advisory Agreement Amendment as a result of comments issued by state securities regulators in connection with their “blue sky” review of the Fund’s offering, and reflects specific language in the Omnibus Guidelines required by a state securities regulator.

Unless terminated earlier as described below, the Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by the Adviser without penalty upon not less than 120 days’ written notice to the Fund or by the Fund without penalty upon not less than 60 days’ written notice to the Adviser. The holders of a majority of the outstanding voting securities may also terminate either of the Advisory Agreement without penalty.

Base Management Fee

The management fee is payable monthly in arrears at an annual rate of 0.75% of the value of the Fund’s net assets as of the beginning of the first calendar day of the applicable month. For the first calendar month in which the Fund has operations, net assets will be measured using the beginning net assets as of the Escrow Break Date. In addition, the Adviser has agreed to waive its management fee until the expiry of twelve months from the Escrow Break Date.

For the three and nine months ended September 30, 2023, base management fees earned were $547 and $712, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to management fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no management fees were earned.

Incentive Fee

The incentive fee consists of two components that are independent of each other, with the result that one component may be payable even if the other is not: (i) incentive fee on income and (ii) an incentive fee on capital gains. Each part of the incentive fee is outlined below.

Incentive Fee Based on Income

The portion based on income is based on Pre-Incentive Fee Net Investment Income Returns. “Pre-Incentive Fee Net Investment Income Returns” means, as the context requires, either the dollar value of, or percentage rate of return on the value of net assets at the end of the immediate preceding quarter from, interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that the Fund receives from portfolio companies) accrued during the calendar quarter, minus our operating expenses accrued for the quarter (including the management fee, expenses payable under the Administration Agreement, and any interest expense or fees on any credit facilities or outstanding debt and dividends paid on any issued and outstanding preferred shares, but excluding the incentive fee and any shareholder servicing and/or distribution fees).

Pre-Incentive Fee Net Investment Income Returns include, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that has not yet been received in cash. Pre-Incentive Fee Net Investment Income Returns do not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. The impact of expense support payments and recoupments (as discussed further below) are also excluded from Pre-Incentive Fee Net Investment Income Returns.

Pre-Incentive Fee Net Investment Income Returns, expressed as a rate of return on the value of the Fund’s net assets at the end of the immediate preceding quarter, is compared to a “hurdle rate” of return of 1.50% per quarter (6% annualized).

The Fund will pay the Adviser an incentive fee quarterly in arrears with respect to Pre-Incentive Fee Net Investment Income Returns in each calendar quarter as follows:

•No incentive fee based on Pre-Incentive Fee Net Investment Income Returns in any calendar quarter in which our Pre-Incentive Fee Net Investment Income Returns do not exceed the hurdle rate of 1.50% per quarter (6% annualized);

•100% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns with respect to that portion of such Pre-Incentive Fee Net Investment Income Returns, if any, that exceeds the hurdle rate but is less than a rate of return of 1.76% (7.06% annualized). The Fund refers to this portion of Pre-Incentive Fee Net Investment Income Returns (which exceeds the hurdle rate but is less than 1.76%) as the “catch-up.” The “catch-up” is meant to provide the Adviser with approximately 15% of our Pre-Incentive Fee Net Investment Income Returns as if a hurdle rate did not apply if this net investment income exceeds 1.76% in any calendar quarter; and

•15% of the dollar amount of our Pre-Incentive Fee Net Investment Income Returns, if any, that exceed a rate of return of 1.76% (7.06% annualized). This reflects that once the hurdle rate is reached and the catch-up is achieved, 15% of all Pre-Incentive Fee Net Investment Income Returns thereafter are allocated to the Adviser.

These calculations will be pro-rated for any period of less than three months and adjusted for any share issuances or repurchases during the relevant quarter.

The Adviser has agreed to waive the incentive fee based on income until the expiry of twelve months from the Escrow Break Date. For the three and nine months ended September 30, 2023, income based incentive fees were $1,219 and $1,592, respectively, all of which were voluntarily waived by the Adviser. As of September 30, 2023, no amounts were payable to the Adviser related to income based incentive fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, no income based incentive fees were earned.

Incentive Fee Based on Capital Gains

The second component of the incentive fee, the capital gains incentive fee, will be payable at the end of each calendar year in arrears. The amount payable will equal:

•15% of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fee on capital gains as calculated in accordance with U.S. GAAP.

Each year, the fee paid for the capital gains incentive fee will be net of the aggregate amount of any previously paid capital gains incentive fee for all prior periods. The Fund will accrue, but will not pay, a capital gains incentive fee with respect to unrealized appreciation because a capital gains incentive fee would be owed to the Adviser if the Fund was to sell the relevant investment and realize a capital gain. In no event will the capital gains incentive fee payable pursuant to the Advisory Agreement be in excess of the amount permitted by the Advisers Act, including Section 205 thereof.

The fees that are payable under the Advisory Agreement for any partial period will be appropriately prorated. For the three and nine months ended September 30, 2023, for the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Fund did not incur any incentive fee based on capital gains.

Sub-Advisory Agreement

On March 31, 2022, the Adviser entered into the Investment Sub-Advisory Agreement with the Sub-Adviser (the “Sub-Advisory Agreement”). The Board of Trustees, including all of the Independent Trustees, also approved the Sub-Advisory Agreement in accordance with, and on the basis of an evaluation satisfactory to such trustees as required by the 1940 Act. The Sub-Adviser manages certain of the Liquid Investments pursuant to the Sub-Advisory Agreement. The Adviser has general oversight over the investment process on behalf of the Fund and manages the capital structure of the Fund, including, but not limited to, asset and liability management. The Adviser also has ultimate responsibility for the Fund’s performance under the terms of the Investment Advisory Agreement. The Adviser will pay the Sub-Adviser monthly in arrears, 0.375% of the daily weighted average principal amount of the Liquid Investments managed by the Sub-Adviser pursuant to the Sub-Advisory Agreement.

On August 3, 2022, the Board, including all of the Independent Trustees, approved Amendment No. 1 to the Sub-Advisory Agreement (the “Sub-Advisory Agreement Amendment”), which became effective immediately. The Sub-Advisory Agreement Amendment was entered into solely to extend the notice requirement applicable to both the Adviser and the Sub-Adviser to terminate the Sub-Advisory Agreement from 60 days to 120 days (as described below).

Unless terminated earlier as described below, the Sub-Advisory Agreement will remain in effect for a period of two years from March 31, 2022 and will remain in effect from year-to-year thereafter if approved annually by the Board of Trustees or by the affirmative vote of the holders of a majority of our outstanding voting securities and, in each case, a majority of the Independent Trustees. The Sub-Advisory Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act, by the Adviser and may be terminated by either the Adviser or the Sub-Adviser without penalty upon not less than 120 days’ written notice to the other.

Administration Agreement

On March 31, 2022, the Fund entered into an administration agreement with the Administrator (the “Administration Agreement”), which was approved by the Board of Trustees. Pursuant to the Administration Agreement, the Administrator furnishes the Fund with office facilities and equipment and provides clerical, bookkeeping and record keeping and other administrative services at such facilities. The Administrator performs, or oversees the performance of, the required administrative services, which include, among other things, assisting the Fund with the preparation of the financial records that the Fund is required to maintain and with the preparation of reports to shareholders and reports filed with the SEC. At the request of the Adviser or the Sub-Adviser, the Administrator also may provide significant managerial assistance on the Fund’s behalf to those portfolio companies that have accepted the Fund’s offer to provide such assistance. U.S. Bancorp Fund Services, LLC will provide the Fund with certain fund administration and bookkeeping services pursuant to a sub-administration agreement (the “Sub-Administration Agreement”) with the Administrator.

On January 10, 2023, the Board, including all of the Independent Trustees, approved Amendment No. 1 (the “Administration Agreement Amendment”) to the Administration Agreement, which became effective immediately. The Fund and the Administrator entered into the Administration Agreement Amendment as a result of comments issued by securities regulators from various states in connection with their “blue sky” review of the Fund’s offering. The Administration Agreement Amendment provides that the Indemnified Parties (as defined in the Administration Agreement) will not be entitled to indemnification for any loss or liability to the Fund or its shareholders by reason of the Indemnified Parties’ negligence or misconduct, in accordance with the Omnibus Guidelines.

For the three and nine months ended September 30, 2023, the Fund incurred $124 and $362, respectively, in fees under the Sub-Administrative Agreement, which are included in administration fees in the consolidated statement of operations. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company incurred $74 and $149, respectively, in fees under the Sub-Administration Agreement, which are included in administration fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $505 and $246, respectively, was unpaid and included in accounts payable and accrued expenses in the consolidated statement of assets and liabilities.

Intermediary Manager Agreement

On March 31, 2022, the Fund entered into an Intermediary Manager Agreement (the “Intermediary Manager Agreement”) with the Intermediary Manager, an affiliate of the Adviser. Under the terms of the Intermediary Manager Agreement, the Intermediary Manager serves as the agent and principal distributor for the Fund’s public offering of its Common Shares. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.85% of the value of the Fund’s net assets attributable to Class S shares as of the beginning of the first calendar day of the month. The Intermediary Manager is entitled to receive distribution and/or shareholder servicing fees monthly at an annual rate of 0.25% of the value of the Fund’s net assets attributable to Class D shares as of the beginning of the first calendar day of the month. No distribution and/or shareholder servicing fees will be paid with respect to Class I shares.

The Fund will cease paying the distribution and/or shareholder servicing fees on any Class S share and Class D share in a shareholder’s account at the end of the month in which the Intermediary Manager in conjunction with the transfer agent determines that total brokerage commissions and distribution and/or shareholder servicing fees paid with respect to any such share held by such shareholder within such account would exceed, in the aggregate, 10% of the gross proceeds from the sale of such share. At the end of such month, each such Class S share or Class D share will convert into a number of Class I shares (including any fractional shares), with an equivalent aggregate NAV as such share. The total underwriting compensation and total organization and offering expenses will not exceed 10% and 15%, respectively, of the gross proceeds from the offering.

The Intermediary Manager Agreement may be terminated at any time, without the payment of any penalty, by vote of a majority of the Independent Trustees and the trustees who have no direct or indirect financial interest in the operation of the Fund’s distribution plan or the Intermediary Manager Agreement or by vote a majority of the outstanding voting securities of the Fund, on not more than 60 days’ written notice to the Intermediary Manager or the Adviser. The Intermediary Manager Agreement will automatically terminate in the event of its assignment, as defined in the 1940 Act.

Expense Support and Conditional Reimbursement Agreement

On March 31, 2022, the Fund entered into an expense support and conditional reimbursement agreement (the “Expense Support Agreement”) with the Adviser. The Expense Support Agreement provides that, Nuveen Alternative Holdings, an affiliate of the Adviser may pay (or cause one or more of its affiliates to pay) certain expenses of the Fund, provided that no portion of the payment will be used to pay any interest expenses of the Fund and/or shareholder servicing fees of the Fund (each, an “Expense Payment’). Such expense payment will be made in any combination of cash or other immediately available funds no later than forty-five days after a written commitment from Nuveen Alternative Holdings to pay such expense, and/or by an offset against amounts due from the Fund to Nuveen Alternative Holdings.

Following any calendar quarter in which Available Operating Funds (as defined below) exceed the cumulative distributions accrued to the Fund’s shareholders based on distributions declared with respect to record dates occurring in such calendar quarter (such amount referred to as the “Excess Operating Funds”), the Fund will pay such Excess Operating Funds, or a portion thereof (each, a “Reimbursement Payment”), to Nuveen Alternative Holdings until such time as all Expense Payments made by the entity to the Fund within three years prior to the last business day of such calendar quarter have been reimbursed. Available Operating Funds means the sum of (i) the Fund’s net investment income (including net realized short-term capital gains reduced by net realized long-term capital losses), (ii) the Fund’s net capital gains (including the excess of net realized long-term capital gains over net realized short-term capital losses) and (iii) dividends and other distributions paid to the Fund on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above). The amount of the Reimbursement Payment for any calendar quarter will equal the lesser of (i) the Excess Operating Funds in such quarter and (ii) the aggregate amount of all Expense Payments made by Nuveen Alternative Holdings to the Fund within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Fund to Nuveen Alternative Holdings.

No Reimbursement Payment for any month will be made if (1) the annualized rate of regular cash distributions declared by the Fund at the time of such Reimbursement Payment is less than the annualized rate of regular cash distributions declared by the Fund at the time the Expense Payment was made to which such Reimbursement Payment relates, or (2) the Fund’s Operating Expense Ratio (as defined below) at the time of such Reimbursement Payment is greater than the Operating Expense Ratio at the time the Expense Payment was made to which such Reimbursement Payment relates. The Operating Expense Ratio is calculated by dividing the Fund’s operating costs and expenses incurred, less organizational and offering expenses, base management and incentive fees owed to the Adviser, and interest expense, by the Fund’s net assets. The Fund’s obligation to make a Reimbursement Payment will automatically become a liability of the Fund on the last business day of the applicable calendar month, except to the extent the Adviser has waived its right to receive such payment for the applicable month.

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Reimbursement Eligibility Expiration
March 31, 2022	$	983	$	—	$	983	March 31, 2025
June 30, 2022	677		—		677		June 30, 2025
September 30, 2022	379		—		379		September 30, 2025
December 31, 2022	176		—		176		December 31, 2025
March 31, 2023	198		—		198		March 31, 2026
June 30, 2023	113		—		113		June 30, 2026
September 30, 2023	327		—		327		September 30, 2026
Total	$	2,853	$	—	$	2,853

Board of Trustees’ Fees

The Board consists of seven members, four of whom are Independent Trustees. On March 30, 2022, the Board established an Audit Committee, a Nominating and Corporate Governance Committee and a Special Transactions Committee, each consisting solely of the Independent Trustees, and may establish additional committees in the future. For the three and nine months ended September 30, 2023, the Fund incurred $128 and $380, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) through September 30, 2022, the Fund incurred $128 and $257, respectively, in fees which are included in Board of Trustees’ fees in the accompanying consolidated statements of operations. As of September 30, 2023 and December 31, 2022, $128 and $128, respectively, were unpaid and are included in Board of Trustees’ fees payable in the accompanying consolidated statements of assets and liabilities.

Other Related Party Transactions

From time to time, the Adviser may pay amounts owed by the Fund to third-party providers of goods or services and the Fund will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. As of September 30, 2023 and December 31, 2022, the Fund owed the Adviser $344 and $231, respectively, for reimbursements including the Fund’s allocable portion of overhead, which is included in accounts payable and accrued expenses in the accompanying consolidated statement of assets and liabilities.

Promissory Note

On March 31, 2022, the Fund entered into the Note with TIAA as the lender. The Note is issued under the purchase and sales agreement, dated as of March 31, 2022, by and among the Fund, SPV I and TIAA in connection with the contribution of portfolio investments by TIAA to the Fund (as discussed further in Note 7). The principal amount of the Note equals (i) the fair value of portfolio investments contributed as of March 31, 2022, minus (ii) $263,500. The Note was due to mature on March 30, 2023, with an interest rate of 4% per annum on the unpaid principal amount, compounded quarterly.

On June 3, 2022, the Fund fully repaid the balance on the Note which was comprised of $32,731 and $226 of principal and interest, respectively.

XML

SECURED BORROWINGS

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

SECURED BORROWINGS

SECURED BORROWINGS

In accordance with the 1940 Act, the Fund is only permitted to borrow amounts such that its asset coverage, as defined in the 1940 Act, is maintained at a level of at least 150% after such borrowing. As of September 30, 2023 and December 31, 2022, the Fund’s asset coverage was 350.22% and 267.94%, respectively.

On April 19, 2022, SPV I entered into a credit agreement with the lenders from time to time parties thereto, Bank of America, N.A., as administrative agent, the Fund, as servicer, U.S. Bank Trust Company, National Association, as collateral administrator, and U.S. Bank National Association, as collateral custodian (the “Credit Agreement” and the revolving credit facility thereunder, the “Bank of America Credit Facility”).

On October 4, 2022, SPV I entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things: (i) increased the maximum amount available under the Bank of America Credit Facility from $200,000 to $250,000; and (ii) increased the rate to be paid from Daily SOFR +2.00% to Daily SOFR +2.15% with a “step up” on the one year anniversary of the Closing Date (as defined in the Amendment) increasing from Daily SOFR +2.15% to Daily SOFR +2.40%, as reflected in the Amendment.

Borrowings under the Credit Agreement are secured by all of the assets held by SPV I and bear interest based on either (x) an annual rate equal to SOFR determined for any day (“Daily SOFR”) for the relevant interest period, plus an applicable spread, or (y) the highest of (i) the Federal Funds Rate plus an applicable spread, (ii) the Prime Rate in effect for any day and (iii) Daily SOFR plus an applicable spread. Interest is payable monthly in arrears. Advances under the Credit Agreement are secured by a pool of broadly-syndicated and middle-market loans subject to eligibility criteria and advance rates specified in the Credit Agreement. Advances under the Credit Agreement may be prepaid and reborrowed at any time during the Availability Period (as defined therein), and SPV I may terminate or reduce the facility amount subject to certain conditions. As of September 30, 2023, the Bank of America Credit Facility bears interest at a rate of Daily SOFR plus 2.40% per annum. Interest is payable monthly in arrears. Any amounts borrowed under the Credit Agreement will mature, and all accrued and unpaid interest thereunder will be due and payable, on the earlier of (i) April 19, 2027, the fifth anniversary of the effective date of April 19, 2022, or (ii) upon certain other events in connection with a refinancing under the Credit Agreement. Borrowing under the Credit Agreement is subject to certain restrictions contained in the 1940 Act.

Prior to entering into the Bank of America Credit Facility, the Fund contributed and/or sold certain assets to SPV I pursuant to a contribution and sale agreement and TIAA contributed and/or sold certain assets to SPV I pursuant to a master participation and assignment agreement, and the Fund expects to contribute and/or sell additional assets to SPV I pursuant to a contribution and sale agreement in the future. The Fund may, but will not be required to, repurchase and/or substitute certain assets previously transferred to SPV I subject to the conditions specified in the contribution and sale agreement and the Credit Agreement.

The fair value of the Bank of America Credit Facility, which would be categorized as Level 3 within the fair value hierarchy as of September 30, 2023, approximates its carrying value. The carrying amounts of the Fund’s assets and liabilities, including the credit facilities, other than investments at fair value, approximate fair value due to their short maturities. The borrowing consisted of the following as of September 30, 2023 and December 31, 2022:

	September 30, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	120,750		120,750
Unused Portion (2)	129,250		129,250
Amount Available (3)	103,112		103,112

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022 and from February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022 (1)
Borrowing interest expense	$	2,469		$	1,189		$	7,238		$	1,654
Unused fees	124			117			351			203
Amortization of deferred financing costs (2)	44			19			122			35
Total interest and debt financing expenses	$	2,637		$	1,325		$	7,711		$	1,892
Average interest rate (3)	8.02		%	4.67		%	7.57		%	4.01		%
Average daily borrowings	$	128,192		$	110,788		$	133,903		$	102,442

_______________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

(2)For the three and nine months ended September 30, 2023, $0 and $2, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the three and nine months ended September 30, 2022, $373 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIESIn the ordinary course of its business, the Fund enters into contracts or agreements that contain indemnifications or warranties. Future events could occur that might lead to the enforcement of these provisions against the Fund. The Fund believes that the likelihood of such an event is remote; however, the maximum potential exposure is unknown. No accrual has been made in the consolidated financial statements as of September 30, 2023 for any such exposure.

As of September 30, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

Portfolio Company	September 30, 2023		December 31, 2022
Acclaim MidCo	$	891	$	—
ADPD Holdings, LLC	1,919		2,149
ASTP Holdings Co-Investment LP	26		—
Chroma Color Corporation	381		—
COP Exterminators	503		—
Evergreen Services Group, LLC	—		267
Health Management Associates	415		—
Heartland Veterinary Partners, LLC	2,210		5,000
Impact Parent Corporation	1,832		—
Infobase Acquisition, Inc.	122		122
INS Intermediate	1,139		—
ISG Merger Sub, LLC	766		1,282
ITSavvy, LLC	36		480
Kenco Group, Inc.	850		850
Keng Acquisition	2,041		—
KL Bronco Acquisition, Inc.	599		599
KRIV Acquisition	779		—
Legacy Service Partners	479		—
LMI Consulting, LLC	2		—
MEI Rigging & Crating	501		—
Omnia Partners	129		—
Orion Group	2,571		—
Ovation Holdings, Inc.	470		—
Palmetto AcquisitionCo	1,217		—
Patriot Growth Insurance Service	2,091		5,568
Perennial Services	1,319		—
Pinnacle Supply Partners	1,455		—
Randys Holdings, Inc	1,332		1,332
RTH	323		—
SCP Eye Care Holdco, LLC	386		735
Transit Buyer LLC	1,157		—
Trilon Group, LLC	—		363
Victors CCC Buyer LLC	560		560
Wellspring Pharmaceutical	—		1,895
WSB Engineering Holdings	1,096		—
Total unfunded commitments	$	29,597	$	21,202

The Fund believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of September 30, 2023, the Fund had cash and cash equivalents of $6,344 and available borrowings under the Bank of America Credit Facility of $103,112.

XML

NET ASSETS

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

NET ASSETS

NET ASSETS

In connection with its formation, the Fund has the authority to issue an unlimited number of Common Shares.

On March 30, 2022, an affiliate of the Adviser, TIAA, purchased 40 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share.

On March 31, 2022, TIAA contributed certain portfolio investments to the Fund in the amount of $296,231 (fair value as of March 31, 2022). In connection therewith, the Fund entered into the Note with TIAA as the lender (as described in Note 4), and issued to TIAA 10,540,000 shares of the Fund’s Class I shares of beneficial interest at $25.00 per share. The Fund fully repaid the balance of the Note to TIAA on June 3, 2022.

On the Escrow Break Date, the Fund had satisfied the minimum offering requirement and the Board authorized the release of proceeds from escrow. During the nine months ending September 30, 2023, the Fund issued 1,735,030 Class I shares for total proceeds of $42,690. As of September 30, 2023, the Fund has not repurchased any Class I shares and has not issued any Class S or D shares. As of September 30, 2023, the Fund recorded $1,145 as a result of excess capital funding received in connection with its September capital contributions, this amount is included in due to transfer agent on the statement of assets and liabilities.

Distributions

The following table summarizes the Fund’s dividends declared for the period from February 8, 2022 (inception) through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Dividend per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain.

Distribution Reinvestment Plan

The Fund has adopted a distribution reinvestment plan, pursuant to which it will reinvest all cash dividends declared by the Board of Trustees on behalf of its shareholders who do not elect to receive their dividends in cash, except for shareholders in certain states. As a result, if the Board of Trustees authorizes, and we declare, a cash dividend or other distribution, then our shareholders who have not opted out of our distribution reinvestment plan will have their cash distributions automatically reinvested in additional Common Shares, rather than receiving the cash dividend or other distribution. Alabama, Arkansas, Idaho, Kansas, Kentucky, Maine, Maryland, Massachusetts, Nebraska, New Jersey, North Carolina, Ohio, Oregon, Vermont and Washington investors and clients of certain participating brokers that do not permit automatic enrollment in our distribution reinvestment plan will automatically receive their distributions in cash unless they elect to have their cash distributions reinvested in additional Common Shares. Distributions on fractional shares will be credited to each participating shareholder’s account to three decimal places.

The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Shares Issued
June 28, 2023	June 30, 2023	July 28, 2023	573
July 28, 2023	July 31, 2023	August 28, 2023	1,426
August 23, 2023	August 31, 2023	September 28, 2023	2,316

Share Repurchase Program

Beginning with the fiscal quarter ended September 30, 2023, the Fund commenced a share repurchase program in which it intends to repurchase in each quarter, at the discretion of the Board of Trustees, up to 5% of its Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. The Board of Trustees, in its sole discretion, may amend, suspend or terminate the share repurchase program if it deems such action to be in the best interest of the Fund’s shareholders. As a result, share repurchases may not be available each quarter, such as when a repurchase offer would place an undue burden on our liquidity, adversely affect the Fund’s operations or risk having an adverse impact on the Fund that would outweigh the benefit of the repurchase offer. Following any such suspension, the Board of Trustees will consider on at least a quarterly basis whether the continued suspension of the Share Repurchase Program is in the best interest of the Fund and shareholders, and will reinstate the Share Repurchase Program when and if appropriate and subject to its fiduciary duty to the Fund and shareholders. However, our Board is not required to authorize the recommencement of our Share Repurchase Program within any specified period of time. The Fund intends to conduct such repurchase offers in accordance with the requirements of Rule 13e-4 promulgated under the Securities Exchange Act of 1934, as amended, and the 1940 Act. All Common Shares purchased by the Fund pursuant to the terms of each tender offer will be retired and thereafter will be authorized and unissued Common Shares.

Under the share repurchase program, to the extent the Fund offers to repurchase Common Shares in any particular quarter, the Fund expects to repurchase Common Shares pursuant to tender offers using a purchase price equal to the NAV per share as of the last calendar day of the applicable quarter, except that Common Shares that have not been outstanding for at least one year will be repurchased at 98% of such NAV (an “Early Repurchase Deduction”). The one-year holding period is measured as of the subscription closing date immediately following the prospective repurchase date. The Early Repurchase Deduction may be waived in the case of repurchase requests arising from the death, divorce or qualified disability of the holder. The Early Repurchase Deduction will be retained by the Fund for the benefit of remaining shareholders.Common Shares. The repurchase of the Adviser’s shares, if any, will be on the same terms and subject to the same limitations as other shareholders under the Share Repurchase Program.

Payment for repurchased shares may require us to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. Our Adviser intends to take measures, subject to policies as may be established by our Board of Trustees, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares. Class I shares owned by TIAA will be subject to the following restrictions. TIAA may submit its Class I shares for repurchase beginning on March 31, 2027. Beginning March 31, 2027, the total amount of TIAA shares eligible for repurchase will be limited to no more than 1.67% of our aggregate NAV per calendar quarter; provided that, if in any quarter the total amount of aggregate repurchase requests of all classes of Common Shares does not exceed the Share Repurchase Plan limit of 5% of the aggregate NAV per calendar quarter, these redemption limits on the TIAA shares will not apply for that quarter, and TIAA will be entitled to submit its shares for repurchase up to the overall Share Repurchase Plan limits.

For the nine months ended September 30, 2023, no Common Shares were repurchased.

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS

9 Months Ended

Sep. 30, 2023

Investment Company [Abstract]

CONSOLIDATED FINANCIAL HIGHLIGHTS

CONSOLIDATED FINANCIAL HIGHLIGHTS

The following is a schedule of financial highlights for the nine months ended September 30, 2023 and for the period from February 8, 2022 (inception) through September 30, 2022:

	Nine Months Ended September 30,
	2023			2022*
Per share data:
Net asset value at beginning of period	$	24.70		$	—
Net investment income (loss)	2.18			0.99
Net realized gains (losses) (1)	0.06			(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.18)			(0.22)
Net increase (decrease) in net assets resulting from operations	2.06			0.75
Stockholder distributions from income (2)	(2.14)			(0.87)
Issuance of common shares	—			25.00
Other (3)	(0.01)			—
Net asset value at end of period	$	24.61		$	24.88
Supplemental Data:
Net assets at end of period	$	302,138		$	262,221
Shares outstanding at end of period (1)	12,279,386			10,540,040
Total return	8.63		%	2.93		%
Ratio to average net assets:
Ratio of net expenses to average net assets (4) (5)	4.73		%	1.82		%
Ratio of net investment income (loss) to average net assets (4)	11.75		%	6.17		%
Portfolio turnover rate (6)	6.36		%	9.10		%
Asset coverage ratio	350.22		%	309.78		%

_______________

*For the period February 8, 2022 (inception) through September 30, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 6.48% and 2.43% for the period ending September 30, 2023 and for the period September 30, 2022, respectively, on an annualized basis, excluding the effect of expense support which represented (0.27)% and (0.61)%, respectively, of average net assets, and excluding the effect of waived management fees and incentive fees which represented (0.45)% and (1.03)% of average net assets for the period ending September 30, 2023. There were no management fees or incentive fees incurred or waived for the period February 8, 2022 (inception) through September 30, 2022. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period ending September 30, 2023 and the period February 8, 2022 (inception) through September 30, 2022, was 3.78% and 1.11%%, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

The Fund’s management evaluated subsequent events through the date of issuance of the consolidated financial statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in, the consolidated financial statements as of September 30, 2023, except as discussed below.

On October 27, 2023, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

Through the date of issuance of the consolidated financial statements, the Fund has accepted approximately $342.4 million net proceeds relating to the issuance of Class I shares, Class S shares, and Class D shares. In connection with the October 2023 subscription closing, the net asset value for each of Class I shares, Class S shares, and Class D shares was $24.61 per share.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Pay vs Performance Disclosure
Net increase (decrease) in net assets resulting from operations	$ 9,065	$ 4,088	$ 7,890	[1]	$ 22,629

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

SIGNIFICANT ACCOUNTING POLICIES (Policies)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The Fund is an investment company for the purposes of accounting and financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies (“ASC 946”), and pursuant to Regulation S-X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair statement of the consolidated financial statements for the period presented, have been included. U.S. GAAP for an investment company requires investments to be recorded at fair value. The carrying value for all other assets and liabilities approximates their fair value unless otherwise disclosed within.

Consolidation

Consolidation

As provided under ASC 946, the Fund will generally not consolidate its investment in a company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Fund. Accordingly, the consolidated financial statements include the accounts of the Fund and its wholly owned subsidiaries, SPV I and Equity Holdings. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Fund to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Cash, Restricted Cash and Cash Equivalents

Cash, Restricted Cash and Cash Equivalents

Cash and restricted cash represent cash deposits held at financial institutions, which at times may exceed U.S. federally insured limits. Cash equivalents include short-term highly liquid investments, such as money market funds, that are readily convertible to cash and have original maturities of three months or less. Cash, restricted cash and cash equivalents are carried at cost, which approximates fair value. As of September 30, 2023, the Fund did not hold any restricted cash.

Valuation of Portfolio Investments

Valuation of Portfolio Investments

Investments are valued in accordance with the fair value principles established by FASB ASC Topic 820, Fair Value Measurement (“ASC Topic 820”) and in accordance with the 1940 Act. ASC Topic 820’s definition of fair value focuses on the amount that would be received to sell the asset or paid to transfer the liability in the principal or most advantageous market, and prioritizes the use of market-based inputs (observable) over entity-specific inputs (unobservable) within a measurement of fair value.

ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings, and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below:

•Level 1 — Valuations are based on unadjusted, quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

•Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

•Level 3 — Valuations are based on inputs that are unobservable and significant to the overall fair value measurement.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the investment.

Active, publicly traded instruments are classified as Level 1 and their values are generally based on quoted market prices, even if both the market’s normal daily trading volume is not sufficient to absorb the quantity held and placing orders to sell the position in a single transaction might affect the quoted price.

Fair value is generally determined as the price that would be received for an investment in a current sale, which assumes an orderly market is available for the market participants at the measurement date. If available, fair value of investments is based on directly observable market prices or on market data derived from comparable assets. The Fund’s valuation policy considers the fact that no ready market may exist for many of the securities in which it invests and that fair value for its investments must be determined using unobservable inputs.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Fund's valuation designee (the “Valuation Designee”) to determine the fair value of the Fund's investments that do not have readily available market quotations, effective beginning with the fiscal quarter ended March 31, 2023. Pursuant to the Fund's valuation policy approved by the Board, a valuation committee comprised of employees of the Adviser (the “Valuation Committee”) is responsible for determining the fair value of the Fund's assets for which market quotations are not readily available, subject to the oversight of the Board.

With respect to investments for which market quotations are not readily available (Level 3), the Valuation Designee, subject to the oversight of the Board as described below, undertakes a multi-step valuation process each quarter, as follows:

i.the quarterly valuation process begins with each portfolio company or investment being initially valued by either the professionals of the applicable investment team that are responsible for the portfolio investment or an independent third-party valuation firm;

ii.to the extent that an independent third-party valuation firm has not been engaged by, or on behalf of, the Board of Trustees to value 100% of the portfolio, then at a minimum, an independent third-party valuation firm will be engaged by, or on behalf of, the Fund will provide positive assurance of the portfolio each quarter (such that each investment is reviewed by a third-party valuation firm at least once on a rolling 12-month basis and each watch-list investment will be reviewed each quarter), including a review of management’s preliminary valuation and recommendation of fair value;

iii.the Valuation Committee then reviews and discusses the valuations with any input, where appropriate, from the independent third-party valuation firm(s), and determine the fair value of each investment in good faith based on the Fund’s valuation policy, subject to the oversight of the Board; and

iv.the Valuation Designee provides the Board with the information relating to the fair value determination pursuant to the Fund's valuation policy in connection with each quarterly Board meeting and discuss with the Board its determination of the fair value of each investment in good faith.

The Valuation Designee makes this fair value determination on a quarterly basis and in such other instances when a decision regarding the fair value of the portfolio investments is required. Factors considered by the Valuation Designee as part of the valuation of investments include each portfolio company’s credit ratings/risk, current and projected earnings, current and expected leverage, ability to make interest and principal payments, liquidity, compliance with applicable loan covenants, and price to earnings (or other financial) ratios and those of comparable companies, as well as the estimated remaining life of the investment and current market yields and interest rate spreads of similar securities as of the measurement date. Other factors taken into account include changes in the interest rate environment and credit markets that may affect the price at which similar investments would trade. The Valuation Designee may also base its valuation of an investment on recent investments and securities with similar structure and risk characteristics. The Valuation Designee obtains market data from its ongoing investment purchase efforts, in addition to monitoring transactions that have closed or are disclosed in industry publications. External information may include (but is not limited to) observable market data derived from the U.S. loan and equity markets. As part of compiling market data as an indication of current market conditions, management may utilize third-party sources.

When determining NAV as of the last day of a month that is not also the last day of a calendar quarter, the Adviser updates the value of securities with “readily available market quotations” (as defined in Rule 2a-5 under the 1940 Act) to the most recent market quotation. For securities without readily available market quotations, the Adviser generally values such assets at the most recent quarterly valuation unless the Adviser determines that a significant observable change has occurred since the most recent quarter end with respect to the investment (which determination may be as a result of a material event at a portfolio company, material change in market spreads, secondary market transaction in the securities of an investment or otherwise). If the Adviser determines such a change has occurred with respect to one or more investments, the Adviser will determine whether to update the value for each relevant investment.

The values assigned to investments are based on available information and may fluctuate from period to period. In addition, such value do not necessarily represent the amount that ultimately might be realized upon a portfolio investment's sale. Due to the inherent uncertainty of valuation, the estimated fair value of an investment may differ from the value that would have been used had a ready market for the security existed, and the difference could be material.

The Board is responsible for overseeing the Valuation Designee’s process for determining the fair value of the Fund’s assets for which market quotations are not readily available, taking into account the Fund’s valuation risks. To facilitate the Board’s oversight of the valuation process, the Valuation Designee provides the Board with quarterly reports, annual reports, and prompt reporting of material matters affecting the Valuation Designee’s determination of fair value. As part of the Board’s oversight role, the Board may request and review additional information to be informed of the Valuation Designee’s process for determining the fair value of the Fund's investments.

Investment Transactions

Investment transactions are recorded on the applicable trade date. Any amounts related to purchases, sales and principal paydowns that have traded, but not settled, are reflected as either a receivable for investments sold or payable for investments purchased on the consolidated statements of assets and liabilities. Realized gains and losses on investment transactions are determined on a specific identification basis and are included as net realized gain (loss) on investments in the consolidated statements of operations. Net change in unrealized appreciation (depreciation) on investments is recognized in the consolidated statements of operations and reflects the period-to-period change in fair value and cost of investments.

Revenue Recognition

Interest income, including amortization of premium and accretion of discount on loans, and expenses are recorded on the accrual basis. The Fund accrues interest income if it expects that ultimately it will be able to collect such income.

The Fund may have loans in its portfolio that contain payment-in-kind (“PIK”) income provisions. PIK represents interest that is accrued and recorded as interest income at the contractual rates, increases the loan principal on the respective capitalization dates, and is generally due at maturity. If at any point the Fund believes PIK is not expected to be realized, the investment generating PIK will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest is generally reversed through PIK income. This non-cash source of income is included when determining what must be paid out to shareholders in the form of distributions in order for the Fund to maintain its tax treatment as a RIC, even though the Fund has not yet collected cash. As of September 30, 2023 and December 31, 2022, the fair value of the loans in the portfolio with PIK income provisions was $67,603 and $70,361, respectively, which represents approximately 15.17% and 20.13% of total investments at fair value, respectively. For the three and nine months ended September 30, 2023, the Company earned $573 and $1,647, respectively, in PIK income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company earned $211 and $450, respectively, in PIK income. As of September 30, 2023 and 2022, there were no PIK loans in the Fund's portfolio on non-accrual status.

Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio companies and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. For the three and nine months ended September 30, 2023, the Company earned $17 and $115, respectively, in dividend income. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not earn any dividend income on its equity investments.

Other income may include income such as consent, waiver, amendment, unused, and prepayment fees associated with the Fund’s investment activities, as well as any fees for managerial assistance services rendered by the Fund to its portfolio companies. Such fees are recognized as income when earned or the services are rendered. For the three and nine months ended September 30, 2023, the Company earned other income of $100 and $131, respectively, primarily related to prepayment and amendment fees. For the three months ended September 30, 2022 and for the period from February 8, 2022 (inception) to September 30, 2022, the Fund earned other income of $446 and $446, respectively, primarily related to prepayment and amendment fees.

Loans are generally placed on non-accrual status when a payment default occurs on a loan in the portfolio, or if management otherwise believes that the issuer of the loan will not be able to make contractual interest payments or principal payments. The Fund will cease recognizing interest income on that loan until all principal and interest is current through payment, or until a restructuring occurs such that the interest income is deemed to be collectible. However, the Fund remains contractually entitled to this interest. The Fund may make exceptions to this policy if the loan has sufficient collateral value and is in the process of collection. Accrued interest is written-off when it becomes probable that the interest will not be collected and the amount of uncollectible interest can be reasonably estimated. As of September 30, 2023 and December 31, 2022, there were no loans in the Fund's portfolio on non-accrual status.

Deferred Financing Costs

Deferred Financing Costs

Deferred financing costs include capitalized expenses related to the closing or amendments of borrowings. Amortization of deferred financing costs is computed on the straight-line basis over the term of the borrowings. The amortization of such costs is included in interest and debt financing expenses in the accompanying consolidated statements of operations. The unamortized balance of such costs is included as a direct deduction from the related liability in the accompanying consolidated statements of assets and liabilities.

Organization and Offering Costs

Organization and Offering Costs

Organization costs consist of primarily legal, incorporation and accounting fees incurred in connection with the organization of the Fund. Organization costs are expensed as incurred and are shown in the Fund's consolidated statements of operations. Refer to Note 4 for further details on the Expense Support Agreement.

Offering costs consist primarily of fees and expenses incurred in connection with the offering of Common Shares, as well as legal, printing and other costs associated with the preparation and filing of the registration statements and offering materials. Offering costs are recognized as a deferred charge, amortized on a straight-line basis over 12 months and are shown in the Fund's consolidated statements of operations. For the three and nine months ended September 30, 2023, offering costs of $326 and $660, respectively, were incurred, and $187 and $468, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, offering costs of $225 and $375, respectively, were incurred, and $78 and $118, respectively, were amortized and recognized as offering costs on the consolidated statements of operations, and covered under the Expense Support Agreement. Refer to Note 4 for further details on the Expense Support Agreement.

Income Taxes

Income Taxes

For U.S. federal income tax purposes, the Fund has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. In order to qualify as a RIC, the Fund must meet certain minimum distribution, source-of-income and asset diversification requirements. If such requirements are met, then the Fund is generally required to pay U.S. federal income taxes only on the portion of its taxable income and capital gains it does not distribute.

The minimum distribution requirements applicable to RICs require the Fund to distribute to its shareholders at least 90% of its investment company taxable income (“ICTI”), as defined by the Code, each year. Depending on the level of ICTI earned in a tax year, the Fund may choose to carry forward ICTI in excess of current year distributions into the next tax year. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI.

In addition, based on the excise distribution requirements, the Fund is subject to a 4% nondeductible U.S. federal excise tax on undistributed income unless the Fund distributes in a timely manner an amount at least equal to the sum of (1) 98% of its ordinary income for each calendar year, (2) 98.2% of capital gain net income (both long-term and short-term) for the one-year period ended October 31 in that calendar year and (3) any income realized, but not distributed, in the preceding year. For this purpose, however, any ordinary income or capital gain net income retained by the Fund that is subject to U.S. federal income tax is considered to have been distributed. The Fund intends to timely distribute to our shareholders substantially all of our annual taxable income for each year, except that the Fund may retain certain net capital gains for reinvestment and, depending upon the level of taxable income earned in a year, we may choose to carry forward ICTI for distribution in the following year and pay any applicable U.S. federal excise tax.

The Fund evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely than not” to be sustained by the applicable tax authority. SPV I is a disregarded entity for tax purposes and will be consolidated with the tax return of the Fund. Equity Holdings has elected to be classified as a corporation for U.S. federal income tax purposes. All penalties and interest associated with income taxes, if any, are included in income tax expense. For the three and nine months ended September 30, 2023, the Company did not incur any excise tax expense. For the three months ended September 30, 2022 and for the period February 8, 2022 (inception) through September 30, 2022, the Company did not incur any excise tax expense.

Dividends and Distributions to Common Shareholders

Dividends and Distributions to Common Shareholders

The Fund has declared distributions each month beginning in September 2022 through the date of this Quarterly Report on Form 10-Q, and expects to continue to pay regular monthly distributions to the extent the Fund has taxable income available. Distributions to shareholders are recorded on the record date. The amount to be distributed to shareholders is determined by the Board and is generally based upon the taxable earnings estimated by management and available cash. Net realized capital gains, if any, will generally be distributed at least annually, although the Fund may decide to retain such capital gains for investment. Although the gross distribution per share is generally equivalent for each share class, the net distribution for each share class is reduced for any class specific expenses, including distribution and shareholder servicing fees, if any.

Functional Currency

Functional Currency

The functional currency of the Fund is the U.S. Dollar and all transactions were in U.S. Dollars.

Recent Accounting Standards Updates

Recent Accounting Standards Updates The FASB issued ASU 2020-04, Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting in March 2020. This update provides temporary optional expedients and exceptions for applying U.S. GAAP to contract modifications, hedge accounting, and other transactions subject to meeting certain criteria. The amendments apply only to contracts, hedging relationships, and other transactions that reference London Interbank Offered Rate ("LIBOR") or another reference rate expected to be discounted because of reference rate reform, and was effective upon issuance through December 31, 2022. As of September 30, 2023, the Fund has amended substantially all of its agreements that have LIBOR as a reference rate to an alternate rate. Contract modifications may be required to be evaluated in determining whether the modifications result in the establishment of new contracts or the continuation of existing contracts. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848 (“ASU 2022-06”), which defers the sunset date of Topic 848 from December 31, 2022 to December 31, 2024. The Fund has adopted the accounting relief and noted no material impact on the consolidated financial statements, as relevant contract relationship modifications are made during the course of the reference rate reform transition period.

XML

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value Measurements of Investments

The following table presents fair value measurements of investments, by major class as of September 30, 2023 and December 31, 2022, according to the fair value hierarchy:

As of September 30, 2023	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	31,383	$	310,315	$	341,698
Subordinated Debt (1)	—		—		94,751		94,751
Equity Investments	—		—		9,328		9,328
Cash Equivalents	5,417		—		—		5,417
Total	$	5,417	$	31,383	$	414,394	$	451,194

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $45,206 and mezzanine debt of $49,545.

As of December 31, 2022	Level 1		Level 2		Level 3		Total
Assets:
First Lien Term Loans	$	—	$	1,704	$	249,667	$	251,371
Subordinated Debt (1)	—		—		93,809		93,809
Equity Investments	—		—		4,338		4,338
Total	$	—	$	1,704	$	347,814	$	349,518

_______________

(1)Subordinated Debt is further comprised of second lien term loans and/or second lien notes of $30,906 and mezzanine debt of $62,903.

Schedule of Reconciliation of the Beginning and Ending Balances for Investments and Fair value Debt Obligations

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three and nine months ended September 30, 2023:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2023	$	294,555	$	89,541	$	5,490	$	389,586
Purchase of investments	28,637		4,509		3,763		36,909
Proceeds from principal repayments and sales of investments	(11,251)		—		—		(11,251)
Payment-in-kind interest	—		447		—		447
Amortization of premium/accretion of discount, net	67		47		—		114
Net realized gain (loss) on investments	75		—		—		75
Net change in unrealized appreciation (depreciation) on investments	34		207		75		316
Transfers out of Level 3 (1)	(1,802)		—		—		(1,802)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	53	$	207	$	75	$	335

________________

(1) Transfers between levels, if any, are recognized at the beginning of the period in which the transfers occur. For the three and nine months ended September 30, 2023, transfers into Level 3 from Level 2 were a result of changes in the observability of significant inputs for one portfolio company.

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of December 31, 2022	$	249,668	$	93,808	$	4,338	$	347,814
Purchase of investments	75,150		9,976		5,312		90,438
Proceeds from principal repayments and sales of investments	(14,041)		(10,212)		(392)		(24,645)
Payment-in-kind interest	—		1,521		—		1,521
Amortization of premium/accretion of discount, net	412		185		—		597
Net realized gain (loss) on investments	90		311		291		692
Net change in unrealized appreciation (depreciation) on investments	(964)		(838)		(221)		(2,023)
Balance as of September 30, 2023	$	310,315	$	94,751	$	9,328	$	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2023	$	(905)	$	(514)	$	(45)	$	(1,464)

The following tables provide a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended September 30, 2022 and for the period February 28, 2022 (inception) through September 30, 2022:

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of June 30, 2022	$	197,343	$	94,727	$	1,725	$	293,795
Purchase of investments	25,868		3,556		1,002		30,426
Proceeds from principal repayments and sales of investments	(1,102)		—		—		(1,102)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	82		52		—		134
Net realized gain (loss) on investments	3		—		—		3
Net change in unrealized appreciation (depreciation) on investments	(746)		(624)		113		(1,257)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(746)	$	(624)	$	113	$	(1,257)

	First Lien Term Loans		Subordinated Debt		Equity Investments		Total
Balance as of February 8, 2022 (inception)	$	—	$	—	$	—	$	—
Purchase of investments	231,983		117,526		2,383		351,892
Proceeds from principal repayments and sales of investments	(8,692)		(19,000)		—		(27,692)
Payment-in-kind interest	—		409		—		409
Amortization of premium/accretion of discount, net	198		127		—		325
Net realized gain (loss) on investments	17		(281)		—		(264)
Net change in unrealized appreciation (depreciation) on investments	(2,058)		(661)		457		(2,262)
Balance as of September 30, 2022	$	221,448	$	98,120	$	2,840	$	322,408
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held as of September 30, 2022	$	(2,058)	$	(661)	$	457	$	(2,262)

Schedule of Fair Value Measurement Inputs and Valuation Techniques

The valuation techniques and significant unobservable inputs used in Level 3 fair value measurements of assets as of September 30, 2023 and December 31, 2022 were as follows:

Investment Type	Fair Value at September 30, 2023		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	258,715	Yield Method	Discount Rate	6.13	%	19.50	%	11.72	%
First Lien Term Loans	51,600		Recent Transaction	Transaction Price	97.08		100.00		99.06
Subordinated Debt	92,577		Yield Method	Discount Rate	11.57	%	21.63	%	14.32	%
Subordinated Debt	2,174		Recent Transaction	Transaction Price	97.27		97.31		97.28
Equity Investments	5,530		Market Approach	EBITDA Multiple	3.50		19.50		10.18
Total	$	410,596

Equity investments in the amount of $3,798 at September 30, 2023 have been excluded from the table above as the investments are valued using recent transaction price.

Investment Type	Fair Value at December 31, 2022		Valuation Techniques	Unobservable Inputs	Ranges				Weighted Average
First Lien Term Loans	$	228,304	Yield Method	Implied Discount Rate	8.98	%	13.37	%	10.63	%
First Lien Term Loans	21,363		Recent Transaction	Transaction Price	98.01		98.08		98.05
Subordinated Debt	88,391		Yield Method	Implied Discount Rate	8.88	%	17.94	%	13.39	%
Subordinated Debt	5,418		Recent Transaction	Transaction Price	97.58		98.08		97.82
Equity Investments	3,144		Enterprise Value	EBITDA Multiple	9.25x		13.50x		10.93x
Total	$	346,620

Equity investments in the amount of $1,194 at December 31, 2022 have been excluded from the table above as the investments are valued using recent transaction price.

XML

RELATED PARTY TRANSACTIONS (Tables)

9 Months Ended

Sep. 30, 2023

Related Party Transactions [Abstract]

Schedule of Expenses Reimbursed by the Advisor

The following table presents a cumulative summary of the expense payments and reimbursement payments since the Fund’s commencement of operations, comprised primarily of organizational expenses, offering costs and professional fees:

For the Quarter Ended	Expense Payments by Adviser		Reimbursement Payments to Adviser		Unreimbursed Expense Payments		Reimbursement Eligibility Expiration
March 31, 2022	$	983	$	—	$	983	March 31, 2025
June 30, 2022	677		—		677		June 30, 2025
September 30, 2022	379		—		379		September 30, 2025
December 31, 2022	176		—		176		December 31, 2025
March 31, 2023	198		—		198		March 31, 2026
June 30, 2023	113		—		113		June 30, 2026
September 30, 2023	327		—		327		September 30, 2026
Total	$	2,853	$	—	$	2,853

XML

SECURED BORROWINGS (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Borrowings

The borrowing consisted of the following as of September 30, 2023 and December 31, 2022:

	September 30, 2023
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	120,750		120,750
Unused Portion (2)	129,250		129,250
Amount Available (3)	103,112		103,112

_______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

	December 31, 2022
	Bank of America Credit Facility		Total
Total Commitment	$	250,000	$	250,000
Borrowings Outstanding (1)	155,000		155,000
Unused Portion (2)	95,000		95,000
Amount Available (3)	81,855		81,855

______________

(1)Borrowings outstanding on the consolidated statement of assets and liabilities are net of deferred financing costs.

(2)The unused portion is the amount upon which commitment fees are based.

(3)Available for borrowing based on the computation of collateral to support the borrowings and subject to compliance with applicable covenants and financial ratios.

For the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022 and from February 8, 2022 (inception) through September 30, 2022, the components of interest expense and debt financing expenses were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022 (1)
Borrowing interest expense	$	2,469		$	1,189		$	7,238		$	1,654
Unused fees	124			117			351			203
Amortization of deferred financing costs (2)	44			19			122			35
Total interest and debt financing expenses	$	2,637		$	1,325		$	7,711		$	1,892
Average interest rate (3)	8.02		%	4.67		%	7.57		%	4.01		%
Average daily borrowings	$	128,192		$	110,788		$	133,903		$	102,442

_______________

(1)Period from February 8, 2022 (inception) through September 30, 2022.

(2)For the three and nine months ended September 30, 2023, $0 and $2, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement. For the three and nine months ended September 30, 2022, $373 and $373, respectively, of deferred financing costs were designated for reimbursement pursuant to the Expense Support Agreement.

(3)Average interest rate includes interest expense and unused fees.

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Sep. 30, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Unfunded Commitments to Fund Delayed Draw Loans

As of September 30, 2023 and December 31, 2022, the Fund had the following unfunded commitments to fund delayed draw loans:

Portfolio Company	September 30, 2023		December 31, 2022
Acclaim MidCo	$	891	$	—
ADPD Holdings, LLC	1,919		2,149
ASTP Holdings Co-Investment LP	26		—
Chroma Color Corporation	381		—
COP Exterminators	503		—
Evergreen Services Group, LLC	—		267
Health Management Associates	415		—
Heartland Veterinary Partners, LLC	2,210		5,000
Impact Parent Corporation	1,832		—
Infobase Acquisition, Inc.	122		122
INS Intermediate	1,139		—
ISG Merger Sub, LLC	766		1,282
ITSavvy, LLC	36		480
Kenco Group, Inc.	850		850
Keng Acquisition	2,041		—
KL Bronco Acquisition, Inc.	599		599
KRIV Acquisition	779		—
Legacy Service Partners	479		—
LMI Consulting, LLC	2		—
MEI Rigging & Crating	501		—
Omnia Partners	129		—
Orion Group	2,571		—
Ovation Holdings, Inc.	470		—
Palmetto AcquisitionCo	1,217		—
Patriot Growth Insurance Service	2,091		5,568
Perennial Services	1,319		—
Pinnacle Supply Partners	1,455		—
Randys Holdings, Inc	1,332		1,332
RTH	323		—
SCP Eye Care Holdco, LLC	386		735
Transit Buyer LLC	1,157		—
Trilon Group, LLC	—		363
Victors CCC Buyer LLC	560		560
Wellspring Pharmaceutical	—		1,895
WSB Engineering Holdings	1,096		—
Total unfunded commitments	$	29,597	$	21,202

XML

NET ASSETS (Tables)

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Fund's Dividends Declared

The following table summarizes the Fund’s dividends declared for the period from February 8, 2022 (inception) through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Dividend per Share		Distribution Amount
September 30, 2022	September 30, 2022	October 28, 2022	$0.870	(1)	$9,170
October 31, 2022	October 31, 2022	November 28, 2022	$0.180		$1,897
November 30, 2022	November 30, 2022	December 28, 2022	$0.190		$2,003
December 31, 2022	December 31, 2022	January 28, 2023	$0.295	(2)	$3,109
January 31, 2023	January 31, 2023	February 28, 2023	$0.200		$2,108
February 28, 2023	February 28, 2023	March 28, 2023	$0.200		$2,108
March 31, 2023	March 31, 2023	April 28, 2023	$0.230		$2,424
April 28, 2023	April 30, 2023	May 26, 2023	$0.240		$2,530
May 25, 2023	May 31, 2023	June 28, 2023	$0.240		$2,530
June 28, 2023	June 30, 2023	July 28, 2023	$0.240		$2,605
July 28, 2023	July 31, 2023	August 28, 2023	$0.270	(3)	$3,081
August 23, 2023	August 31, 2023	September 28, 2023	$0.270	(3)	$3,133
September 29, 2023	September 30, 2023	October 27, 2023	$0.250		$3,070

_______________

(1)Represents monthly dividend of $0.14 per share for each of April 2022, May 2022 and June 2022, and monthly dividend of $0.15 per share for each of July 2022, August 2022 and September 2022.

(2)Comprised of $0.19 regular dividend and $0.105 supplemental dividend attributable to accrued net investment income.

(3)Comprised of $0.25 regular dividend and $0.020 special dividend attributable to accrued net investment income and capital gain.

Schedule of Shares Issued

The following table reflects the shares issued pursuant to the distribution reinvestment plan from inception through September 30, 2023.

			Class I
Declaration Date	Record Date	Payment Date	Shares Issued
June 28, 2023	June 30, 2023	July 28, 2023	573
July 28, 2023	July 31, 2023	August 28, 2023	1,426
August 23, 2023	August 31, 2023	September 28, 2023	2,316

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Tables)

9 Months Ended

Sep. 30, 2023

Investment Company [Abstract]

Schedule of Financial Highlights

The following is a schedule of financial highlights for the nine months ended September 30, 2023 and for the period from February 8, 2022 (inception) through September 30, 2022:

	Nine Months Ended September 30,
	2023			2022*
Per share data:
Net asset value at beginning of period	$	24.70		$	—
Net investment income (loss)	2.18			0.99
Net realized gains (losses) (1)	0.06			(0.02)
Net change in unrealized appreciation (depreciation) (1)	(0.18)			(0.22)
Net increase (decrease) in net assets resulting from operations	2.06			0.75
Stockholder distributions from income (2)	(2.14)			(0.87)
Issuance of common shares	—			25.00
Other (3)	(0.01)			—
Net asset value at end of period	$	24.61		$	24.88
Supplemental Data:
Net assets at end of period	$	302,138		$	262,221
Shares outstanding at end of period (1)	12,279,386			10,540,040
Total return	8.63		%	2.93		%
Ratio to average net assets:
Ratio of net expenses to average net assets (4) (5)	4.73		%	1.82		%
Ratio of net investment income (loss) to average net assets (4)	11.75		%	6.17		%
Portfolio turnover rate (6)	6.36		%	9.10		%
Asset coverage ratio	350.22		%	309.78		%

_______________

*For the period February 8, 2022 (inception) through September 30, 2022

(1)The per share data was derived by using the weighted average shares outstanding during the period.

(2)The per share data for distributions reflects the actual amount of distributions declared during the period.

(3)Includes the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the period and certain per share data based on shares outstanding as of a period end or transaction date.

(4)Ratios are annualized except for expense support amounts relating to organizational costs and interest expense on the Note. The ratio of total expenses to average net assets was 6.48% and 2.43% for the period ending September 30, 2023 and for the period September 30, 2022, respectively, on an annualized basis, excluding the effect of expense support which represented (0.27)% and (0.61)%, respectively, of average net assets, and excluding the effect of waived management fees and incentive fees which represented (0.45)% and (1.03)% of average net assets for the period ending September 30, 2023. There were no management fees or incentive fees incurred or waived for the period February 8, 2022 (inception) through September 30, 2022. Average net assets is calculated utilizing quarterly net assets.

(5)The ratio of interest and debt financing expenses to average net assets for the period ending September 30, 2023 and the period February 8, 2022 (inception) through September 30, 2022, was 3.78% and 1.11%%, respectively, Average net assets is calculated utilizing quarterly net assets.

(6)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value for the periods reported.

XML

SUBSEQUENT EVENTS (Tables)

9 Months Ended

Sep. 30, 2023

Subsequent Events [Abstract]

Schedule of Aggregate Distributions Declared for Each Class of Common Share

On October 27, 2023, the Fund declared regular distributions for each class of its common shares of beneficial interest in the amounts per share set forth below. The distributions for each class of common shares are payable on November 28, 2023 to shareholders of record as of October 31, 2023.

	Gross Distribution	Shareholder Servicing Fee	Net Distribution
Class I Common Shares	$0.250	$—	$0.250
Class S Common Shares	$0.250	$0.017	$0.233
Class D Common Shares	$0.250	$0.005	$0.245

XML

ORGANIZATION (Details) - USD ($) $ / shares in Units, $ in Thousands				9 Months Ended
	Jun. 03, 2022	Mar. 31, 2022	Mar. 30, 2022	Sep. 30, 2023	Jun. 30, 2022
Schedule of Equity Method Investments [Line Items]
Sale of stock				$ 2,500,000
Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Issuance of shares (in shares)				1,735,030
TIAA
Schedule of Equity Method Investments [Line Items]
Portfolio investments to the fund amount					$ 296,231
TIAA | Affiliated Entity
Schedule of Equity Method Investments [Line Items]
Capital commitments		$ 263,500
Debt instrument, periodic payment, principal	$ 32,731
Debt instrument, periodic payment, interest	$ 226
TIAA | Class I Common Shares
Schedule of Equity Method Investments [Line Items]
Purchased and sold shares (in share)			40
Issuance Price per share (in dollars per share)			$ 25.00
Issuance of shares (in shares)		10,540,000
Shares issued price per share (in dollars per share)					$ 25.00

XML

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended		8 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 451,194,000				$ 451,194,000		$ 349,518,000
Payment-in-kind interest income	573,000	$ 211,000	$ 450,000		1,647,000
Dividend income	17,000	0	0		115,000
Other income	100,000	446,000	446,000		131,000
Offering costs	326,000	225,000	375,000		660,000
Noninterest expense offering cost	187,000	$ 78,000	$ 118,000	[1]	468,000	$ 118,000
Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Fair Value	$ 67,603,000				$ 67,603,000		$ 70,361,000
Investment Type Concentration Risk | Investments At Fair Value | Payment in Kind (PIK) Note
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage					15.17%		20.13%

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurements of Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 451,194	$ 349,518
First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	341,698	251,371
Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	94,751	93,809
Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	9,328	4,338
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417
Second Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	45,206	30,906
Mezzanine Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	49,545	62,903
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417	0
Level 1 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 1 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	5,417
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,383	1,704
Level 2 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	31,383	1,704
Level 2 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0	0
Level 2 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	414,394	347,814
Level 3 | First Lien Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	310,315	249,667
Level 3 | Subordinated Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	94,751	93,809
Level 3 | Equity Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	9,328	$ 4,338
Level 3 | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 0

XML

FAIR VALUE MEASUREMENTS - Schedule of Reconciliation of the Beginning and Ending Balances for Investments (Details) - USD ($) $ in Thousands	3 Months Ended		8 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2023
Total
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 389,586	$ 293,795	$ 0	$ 347,814
Purchase of investments	36,909	30,426	351,892	90,438
Proceeds from principal repayments and sales of investments	(11,251)	(1,102)	(27,692)	(24,645)
Payment-in-kind interest	447	409	409	1,521
Amortization of premium/accretion of discount, net	114	134	325	597
Transfers out of Level 3	(1,802)
Ending balance	414,394	322,408	322,408	414,394
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	335	(1,257)	(2,262)	(1,464)
Total | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	75	3	(264)	692
Total | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	316	(1,257)	(2,262)	(2,023)
First Lien Term Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	294,555	197,343	0	249,668
Purchase of investments	28,637	25,868	231,983	75,150
Proceeds from principal repayments and sales of investments	(11,251)	(1,102)	(8,692)	(14,041)
Payment-in-kind interest	0	0	0	0
Amortization of premium/accretion of discount, net	67	82	198	412
Transfers out of Level 3	(1,802)
Ending balance	310,315	221,448	221,448	310,315
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	53	(746)	(2,058)	(905)
First Lien Term Loans | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	75	3	17	90
First Lien Term Loans | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	34	(746)	(2,058)	(964)
Subordinated Debt
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	89,541	94,727	0	93,808
Purchase of investments	4,509	3,556	117,526	9,976
Proceeds from principal repayments and sales of investments	0	0	(19,000)	(10,212)
Payment-in-kind interest	447	409	409	1,521
Amortization of premium/accretion of discount, net	47	52	127	185
Transfers out of Level 3	0
Ending balance	94,751	98,120	98,120	94,751
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	207	(624)	(661)	(514)
Subordinated Debt | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	(281)	311
Subordinated Debt | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	207	(624)	(661)	(838)
Equity Investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	5,490	1,725	0	4,338
Purchase of investments	3,763	1,002	2,383	5,312
Proceeds from principal repayments and sales of investments	0	0	0	(392)
Payment-in-kind interest	0	0	0	0
Amortization of premium/accretion of discount, net	0	0	0	0
Transfers out of Level 3	0
Ending balance	9,328	2,840	2,840	9,328
Net change in unrealized appreciation (depreciation) on non-controlled/non-affiliated company investments still held	75	113	457	(45)
Equity Investments | Net realized gain (loss) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	0	0	0	291
Equity Investments | Net change in unrealized appreciation (depreciation) on investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total gains or losses included in earnings	$ 75	$ 113	$ 457	$ (221)

XML

FAIR VALUE MEASUREMENTS - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 410,596,000	$ 346,620,000
First Lien Term Loans | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 258,715,000	$ 228,304,000
First Lien Term Loans | Yield Method | Low | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0613	0.0898
First Lien Term Loans | Yield Method | High | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1950	0.1337
First Lien Term Loans | Yield Method | Weighted Average | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1172	0.1063
First Lien Term Loans | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 51,600,000	$ 21,363,000
First Lien Term Loans | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.08	98.01
First Lien Term Loans | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	100.00	98.08
First Lien Term Loans | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	99.06	98.05
Subordinated Debt | Yield Method
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 92,577,000	$ 88,391,000
Subordinated Debt | Yield Method | Low | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1157	0.0888
Subordinated Debt | Yield Method | High | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.2163	0.1794
Subordinated Debt | Yield Method | Weighted Average | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.1432	0.1339
Subordinated Debt | Recent Transaction
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 2,174,000	$ 5,418,000
Subordinated Debt | Recent Transaction | Low | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.27	97.58
Subordinated Debt | Recent Transaction | High | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.31	98.08
Subordinated Debt | Recent Transaction | Weighted Average | Transaction Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	97.28	97.82
Equity Investments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments valued using recent transactions	$ 3,798,000	$ 1,194,000
Equity Investments | Market Approach
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value	$ 5,530,000
Equity Investments | Market Approach | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	3.50
Equity Investments | Market Approach | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	19.50
Equity Investments | Market Approach | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	10.18
Equity Investments | Enterprise Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value		$ 3,144,000
Equity Investments | Enterprise Value | Low | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		9.25
Equity Investments | Enterprise Value | High | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		13.5
Equity Investments | Enterprise Value | Weighted Average | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		10.93

XML

RELATED PARTY TRANSACTIONS - Narrative (Details)						3 Months Ended			8 Months Ended		9 Months Ended
	Jan. 10, 2023	Aug. 03, 2022	Aug. 02, 2022	Jun. 03, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($) member	Sep. 30, 2022 USD ($)	Mar. 31, 2022	Sep. 30, 2022 USD ($)		Sep. 30, 2023 USD ($) member part	Dec. 31, 2022 USD ($)
Related Party Transaction [Line Items]
Management fees						$ 547,000	$ 0		$ 0	[1]	$ 712,000
Income based incentive fees						1,219,000	0		0	[1]	1,592,000
Administration fees						$ 124,000	74,000		149,000	[1]	$ 362,000
Number of board members | member						7					7
Number of independent directors | member						4					4
Directors' fees						$ 128,000	128,000		257,000	[1]	$ 380,000
Directors’ fees payable						128,000					128,000	$ 128,000
Accounts payable and accrued expenses						1,924,000					1,924,000	1,386,000
Affiliated Entity
Related Party Transaction [Line Items]
Income based incentive fees						1,219,000	0		0		1,592,000
Income based incentive fee payable						0					$ 0
Affiliated Entity | TIAA
Related Party Transaction [Line Items]
Capital commitments					$ 263,500,000
Interest rate, stated percentage					4.00%			4.00%
Debt instrument, periodic payment, principal				$ 32,731,000
Debt instrument, periodic payment, interest				$ 226,000
Investment Advisory Agreements | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of written notice		120 days	60 days
Related party transaction, initial term					2 years
Related party transaction period of written notice by fund	60 days
Number of components | part											2
Base Management Fee | Affiliated Entity
Related Party Transaction [Line Items]
Base management fee percentage								0.75%
Management fees						547,000	0		0		$ 712,000
Management fees payable						0					0
Quarterly Hurdle Rate | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								1.50%
Annualized Hurdle Rate | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								6.00%
Pre-Incentive Fee Net Investment Income below catch-up threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								100.00%
Quarterly Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								1.76%
Investment Advisory Agreement - Incentive Rate, Annualized Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								7.06%
Pre-Incentive Fee Net Investment Income Exceeds Catch-Up Threshold | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								15.00%
Realized Capital Gains | Affiliated Entity
Related Party Transaction [Line Items]
Incentive fee percentage								15.00%
Sub-Advisory Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of written notice		120 days	60 days
Related party transaction, initial term		2 years
Management and service fees, rate					0.375%
Administrative Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Administration fees						124,000	$ 74,000		$ 149,000		362,000
Administration fees payable						505,000					505,000	246,000
Intermediary Manager Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction period of written notice by fund					60 days
Percentage of shareholder servicing fees, proceeds from sale of such share					10.00%			10.00%
Percentage of underwriting compensation, net					10.00%			10.00%
Percentage of expense, proceeds from offering					15.00%			15.00%
Intermediary Manager Agreement | Affiliated Entity | Class S Common Shares
Related Party Transaction [Line Items]
Shareholder servicing fees monthly, annual rate					0.85%			0.85%
Intermediary Manager Agreement | Affiliated Entity | Class D Common Shares
Related Party Transaction [Line Items]
Shareholder servicing fees monthly, annual rate					0.25%			0.25%
Expense Support Agreement
Related Party Transaction [Line Items]
Related party transaction, expense payment period					45 days
Expense Support Agreement | Affiliated Entity
Related Party Transaction [Line Items]
Related party transaction, period of reimbursement payment					3 years
Advisor And Administrator | Affiliated Entity
Related Party Transaction [Line Items]
Accounts payable and accrued expenses						$ 344,000					$ 344,000	$ 231,000

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

RELATED PARTY TRANSACTIONS - Schedule of Expenses Reimbursed by the Adviser (Details) - Expense Support Agreement - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended							21 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023
Related Party Transaction [Line Items]
Expense Payments by Adviser	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,853
Reimbursement Payments to Adviser	0	0	0	0	0	0	0	0
Unreimbursed Expense Payments	$ 327	$ 113	$ 198	$ 176	$ 379	$ 677	$ 983	$ 2,853

XML

SECURED BORROWINGS - Narrative (Details) - USD ($)			9 Months Ended
	Oct. 04, 2022	Oct. 03, 2022	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Asset coverage ratio			350.22%	267.94%
Maximum facility amount available			$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Maximum facility amount available	$ 250,000,000	$ 200,000,000	$ 250,000,000	$ 250,000,000
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility
Debt Instrument [Line Items]
Percentage of interest rate	2.15%	2.00%	2.40%
Bank of America Credit Facility | Secured Borrowings | Secured Overnight Financing Rate (SOFR) | Credit Facility | One Year After Closing Date
Debt Instrument [Line Items]
Percentage of interest rate	2.40%

XML

SECURED BORROWINGS - Schedule of Borrowings (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Oct. 04, 2022	Oct. 03, 2022
Debt Instrument [Line Items]
Total Commitment	$ 250,000,000	$ 250,000,000
Borrowings Outstanding	120,750,000	155,000,000
Unused Portion	129,250,000	95,000,000
Amount Available	103,112,000	81,855,000
Bank of America Credit Facility | Secured Borrowings | Credit Facility
Debt Instrument [Line Items]
Total Commitment	250,000,000	250,000,000	$ 250,000,000	$ 200,000,000
Borrowings Outstanding	120,750,000	155,000,000
Unused Portion	129,250,000	95,000,000
Amount Available	$ 103,112,000	$ 81,855,000

XML

SECURED BORROWINGS - Schedule of Components of Interest Expense and Debt Financing Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		8 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2022		Sep. 30, 2023
Debt Disclosure [Abstract]
Borrowing interest expense	$ 2,469	$ 1,189	$ 1,654		$ 7,238
Unused fees	124	117	203		351
Amortization of Debt Issuance Costs	44	19	35		122
Total interest and debt financing expenses	$ 2,637	$ 1,325	$ 1,892	[1]	$ 7,711
Average interest rate	8.02%	4.67%	4.01%		7.57%
Average daily borrowings	$ 128,192	$ 110,788	$ 102,442		$ 133,903
Deferred financing costs were designated for reimbursement	$ 0	$ 373	$ 373		$ 2

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

COMMITMENTS AND CONTINGENCIES - Schedule of Unfunded Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 29,597	$ 21,202
Investment, Identifier [Axis]: ADPD Holdings, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,919	2,149
Investment, Identifier [Axis]: ASTP Holdings Co-Investment LP
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	26	0
Investment, Identifier [Axis]: Acclaim MidCo
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	891	0
Investment, Identifier [Axis]: COP Exterminators
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	503	0
Investment, Identifier [Axis]: Chroma Color Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	381	0
Investment, Identifier [Axis]: Evergreen Services Group, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	267
Investment, Identifier [Axis]: Health Management Associates
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	415	0
Investment, Identifier [Axis]: Heartland Veterinary Partners, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,210	5,000
Investment, Identifier [Axis]: INS Intermediate
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,139	0
Investment, Identifier [Axis]: ISG Merger Sub, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	766	1,282
Investment, Identifier [Axis]: ITSavvy, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	36	480
Investment, Identifier [Axis]: Impact Parent Corporation
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,832	0
Investment, Identifier [Axis]: Infobase Acquisition, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	122	122
Investment, Identifier [Axis]: KL Bronco Acquisition, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	599	599
Investment, Identifier [Axis]: KRIV Acquisition
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	779	0
Investment, Identifier [Axis]: Kenco Group, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	850	850
Investment, Identifier [Axis]: Keng Acquisition
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,041	0
Investment, Identifier [Axis]: LMI Consulting, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2	0
Investment, Identifier [Axis]: Legacy Service Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	479	0
Investment, Identifier [Axis]: MEI Rigging & Crating
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	501	0
Investment, Identifier [Axis]: Omnia Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	129	0
Investment, Identifier [Axis]: Orion Group
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,571	0
Investment, Identifier [Axis]: Ovation Holdings, Inc.
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	470	0
Investment, Identifier [Axis]: Palmetto AcquisitionCo
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,217	0
Investment, Identifier [Axis]: Patriot Growth Insurance Service
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	2,091	5,568
Investment, Identifier [Axis]: Perennial Services
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,319	0
Investment, Identifier [Axis]: Pinnacle Supply Partners
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,455	0
Investment, Identifier [Axis]: RTH
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	323	0
Investment, Identifier [Axis]: Randys Holdings, Inc
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,332	1,332
Investment, Identifier [Axis]: SCP Eye Care Holdco, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	386	735
Investment, Identifier [Axis]: Transit Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,157	0
Investment, Identifier [Axis]: Trilon Group, LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	0	363
Investment, Identifier [Axis]: Victors CCC Buyer LLC
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	560	560
Investment, Identifier [Axis]: WSB Engineering Holdings
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	1,096	0
Investment, Identifier [Axis]: Wellspring Pharmaceutical
Financial Support for Nonconsolidated Legal Entity [Line Items]
Unfunded commitments to fund delayed draw loans	$ 0	$ 1,895

XML

COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Cash	$ 6,344	$ 65,785
Unused Portion	129,250	$ 95,000
Unused Portion Under the Bank of America Credit Facility
Debt Instrument [Line Items]
Unused Portion	$ 103,112

XML

NET ASSETS - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			8 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 30, 2022	Sep. 30, 2022	[1]	Sep. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Class of Stock [Line Items]
Net proceeds received			$ 1		$ 42,690
Common shares repurchased (in shares)					0
Maximum number of shares to be repurchased, percent					5.00%
Common stock market price percent of NAV, threshold					98.00%
Due to transfer agent					$ 1,145	$ 0
Class I Common Shares
Class of Stock [Line Items]
Issuance of shares (in shares)					1,735,030
Net proceeds received					$ 42,690
Common shares repurchased (in shares)					0
Class S Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)					0
Class D Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)					0
TIAA
Class of Stock [Line Items]
Portfolio investments to the fund amount							$ 296,231
Share repurchase program, percentage of outstanding shares offered to repurchase, NAV					1.67%
TIAA | Class I Common Shares
Class of Stock [Line Items]
Purchased and sold shares (in share)		40
Issuance Price per share (in dollars per share)		$ 25.00
Issuance of shares (in shares)	10,540,000
Shares issued price per share (in dollars per share)							$ 25.00

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

NET ASSETS - Schedule of Fund's Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Thousands														1 Months Ended
	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Class of Stock [Line Items]
Gross Distribution														$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Regular Dividend
Class of Stock [Line Items]
Gross Distribution		$ 0.25	$ 0.25							$ 0.19
Supplemental Dividend
Class of Stock [Line Items]
Gross Distribution										0.105
Special Dividend
Class of Stock [Line Items]
Gross Distribution		0.020	0.020
Class I Common Shares
Class of Stock [Line Items]
Gross Distribution	$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Distribution Amount	$ 3,070	$ 3,133	$ 3,081	$ 2,605	$ 2,530	$ 2,530	$ 2,424	$ 2,108	$ 2,108	$ 3,109	$ 2,003	$ 1,897	$ 9,170

XML

NET ASSETS - Schedule of Shares Issued Pursuant to the Distribution Reinvestment Plan (Details) - shares	Sep. 28, 2023	Aug. 28, 2023	Jul. 28, 2023
Class I Common Shares
Class of Stock [Line Items]
Shares, issued (in shares)	2,316	1,426	573

XML

CONSOLIDATED FINANCIAL HIGHLIGHTS (Details) - USD ($) $ / shares in Units, $ in Thousands	8 Months Ended		9 Months Ended
	Sep. 30, 2022		Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022	Feb. 07, 2022	[1]
Per share data:
Net asset value at beginning of period (in dollars per share)	$ 0		$ 24.70
Net investment income (loss) (in dollars per share)	0.99		2.18
Net realized gains (losses) (in dollars per share)	(0.02)		0.06
Net change in unrealized appreciation (depreciation) (in dollars per share)	(0.22)		(0.18)
Net increase (decrease) in net assets resulting from operations (in dollars per share)	0.75		2.06
Shareholder distributions from income (in dollars per share)	(0.87)		(2.14)
Issuance of common shares (in dollars per share)	25.00		0
Other (in dollars per share)	0		(0.01)
Net asset value at end of period (in dollars per share)	$ 24.88		$ 24.61
Supplemental Data:
Net assets at end of period	$ 262,221	[1]	$ 302,138	$ 267,280	$ 260,301	$ 267,303	$ 0
Shares outstanding at end of period (in shares)	10,540,040		12,279,386
Total return	2.93%		8.63%
Ratio to average net assets:
Ratio of net expenses to average net assets	1.82%		4.73%
Ratio of net investment income (loss) to average net assets	6.17%		11.75%
Portfolio turnover rate	9.10%		6.36%
Asset coverage ratio	309.78%		350.22%
Ratio of total expenses to average net assets	2.43%		6.48%
Effect of expense support to average net assets ratio	(0.61%)		(0.27%)
Effect of waived management fees	0.00%		(0.45%)
Effect of waived incentive fees	0.00%		(1.03%)
Ratio of interest and debt financing expenses to average net assets	1.11%		3.78%

[1] Period from February 8, 2022 (inception) through September 30, 2022.

XML

SUBSEQUENT EVENTS - Schedule of Aggregate Distributions Declared for Each Class of Common Share (Details) - $ / shares															1 Months Ended
	Oct. 27, 2023	Sep. 29, 2023	Aug. 23, 2023	Jul. 28, 2023	Jun. 28, 2023	May 25, 2023	Apr. 28, 2023	Mar. 31, 2023	Feb. 28, 2023	Jan. 31, 2023	Dec. 31, 2022	Nov. 30, 2022	Oct. 31, 2022	Sep. 30, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Jun. 30, 2022	May 31, 2022	Apr. 30, 2022
Subsequent Event [Line Items]
Gross Distribution															$ 0.15	$ 0.15	$ 0.15	$ 0.14	$ 0.14	$ 0.14
Class I Common Shares
Subsequent Event [Line Items]
Gross Distribution		$ 0.250	$ 0.270	$ 0.270	$ 0.240	$ 0.240	$ 0.240	$ 0.230	$ 0.200	$ 0.200	$ 0.295	$ 0.190	$ 0.180	$ 0.870
Class I Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	$ 0.250
Shareholder Servicing Fee	0
Gross Distribution	0.250
Class S Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250
Shareholder Servicing Fee	0.017
Gross Distribution	0.233
Class D Common Shares | Subsequent Event
Subsequent Event [Line Items]
Gross Distribution	0.250
Shareholder Servicing Fee	0.005
Gross Distribution	$ 0.245

XML

SUBSEQUENT EVENTS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended
	Oct. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Feb. 07, 2022
Subsequent Event [Line Items]
Net asset value per share (in dollars per share)		$ 24.61	$ 24.70	$ 24.88	$ 0
Subsequent Event
Subsequent Event [Line Items]
Net proceeds received	$ 342.4
Net asset value per share (in dollars per share)	$ 24.61